Sentence,class,file
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/14/ijn-10-711.PMC4309779.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/60/78/jir-8-029.PMC4309780.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Inflammation Research 2015:8 29–47Journal of Inflammation Research Dove press submit your manuscript | www.dovepress.co m Dove press  29ORIg Inal ReseaRchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JIR.S7604 5Killing of Staphylococcus aureus  in murine  macrophages by chloroquine used alone and in  combination with ciprofloxacin or azithromycin somrita Dey Biswadev Bishayi Department of Physiology,   Immunology laboratory, University  of calcutta, University colleges of  science and T echnology, calcutta, India correspondence: Biswadev Bishayi   Department of Physiology, Immunology  laboratory, University of calcutta,  University colleges of science and  Technology,  92 aPc Road,   calcutta  700009, West Bengal, India   Tel +91 33 2350 8386 ext  225  Fax +91 33 2351 9755  email biswa_dev2@yahoo.co m Abstract:  This study aimed to determine any alteration in the killing of Staphylococcus aureus   in murine peritoneal macrophages when chloroquine (CQ) is used alone compared with when it  is used in combination with ciprofloxacin (CIP) or azithromycin (AZM).",Non-OADS,/arxiv_data1/oa_pdf/60/78/jir-8-029.PMC4309780.pdf
Avail - able from: http://www.ncbi.nlm.nih.gov/pubmed/2512905 9.,Non-OADS,/arxiv_data1/oa_pdf/60/78/jir-8-029.PMC4309780.pdf
"Journal of Inflammation Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-inflammation-research-journa lThe Journal of Inflammation Research is an international, peer-reviewed  open-access journal that welcomes laboratory and clinical findings on the  molecular basis, cell biology and pharmacology of inflammation including  original research, reviews, symposium reports, hypothesis formation and  commentaries on: acute/chronic inflammation; mediators of inflamma -tion; cellular processes; molecular mechanisms; pharmacology and novel  anti-inflammatory drugs; clinical conditions involving inflammation.",Non-OADS,/arxiv_data1/oa_pdf/60/78/jir-8-029.PMC4309780.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/60/78/jir-8-029.PMC4309780.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/3d/ott-8-223.PMC4309781.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpOncoTargets and Therapy 2015:8 223–231OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  223Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7407 5impact on growth and invasion of gastric cancer  cell lines by silencing neDD9 sisen Zhang1 lihua Wu1 Qing liu1 Kuisheng chen2 Xiefu Zhang2 1Zhengzhou People’s hospital  affiliated to southern Medical  University, 2The First affiliated  hospital of Zhengzhou University,   Zhengzhou, People’s republic  of chinaBackground:  Gastric adenocarcinoma is a predominant disease with latent attribute, high  malignancy, and poor prognosis in People’s Republic of China.",Non-OADS,/arxiv_data1/oa_pdf/ff/3d/ott-8-223.PMC4309781.pdf
"33, Zhengzhou 450003,  People’s republic of china email zsshnn@163.co m Journal name: OncoTargets and Therapy Article Designation: Original Research Y ear: 2015 Volume: 8 Running head verso: Zhang et al Running head recto: Impact of silencing NEDD9 on gastric cancer cell lines DOI: http://dx.doi.org/10.2147/OTT.S74075",Non-OADS,/arxiv_data1/oa_pdf/ff/3d/ott-8-223.PMC4309781.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open  access journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/ff/3d/ott-8-223.PMC4309781.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/3d/ott-8-223.PMC4309781.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/d9/1c/ppa-9-121.PMC4309782.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 121–131Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  121OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7083 4reasons for discontinuation of subcutaneous  biologic therapy in the treatment of rheumatoid  arthritis: a patient perspective susan c Bolge1 Amir goren2 neeta Tandon1 1health economics and Outcomes  research, Janssen scientific Affairs,   llc, horsham, PA, UsA; 2health  Outcomes Practice, Kantar health,   new Y ork, nY, UsAObjective:  To examine reasons why rheumatoid arthritis patients discontinued subcutaneous  (SQ) anti-tumor necrosis factor (anti-TNF) treatment in the past 12 months, so as to help inform  successful, uninterrupted therapy.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/ppa-9-121.PMC4309782.pdf
"However, large population studies now recognize that patients with RA  have a 1.5- to 1.6-fold higher mortality rate than unaffected individuals.6 This risk of correspondence: susan c Bolge Janssen Scientific Affairs, LLC, 1000  route 202, raritan, nJ, UsA Tel +1 908 927 7426 email sbolge@its.jnj.co m Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Bolge et al Running head recto: Discontinuation of subcutaneous anti-TNF in rheumatoid arthritis DOI: http://dx.doi.org/10.2147/PPA.S70834",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/ppa-9-121.PMC4309782.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/d9/1c/ppa-9-121.PMC4309782.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/07/77/ott-8-233.PMC4309783.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOncoTargets and Therapy 2015:8 233–240OncoTargets and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  233Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OTT .S7141 4T umor deposit is a poor prognostic indicator in  patients who underwent simultaneous resection  for synchronous colorectal liver metastases Qi lin# Ye Wei# li ren# Yunshi Zhong# chunzhi Qin Peng Zheng Pingping Xu Dexiang Zhu Meiling Ji Jianmin Xu Department of general surgery,   Zhongshan hospital, Fudan University,   shanghai, People’s republic of china #These authors contributed equally to  this work correspondence: Jianmin Xu   T el +86 135 0198 4869   Fax +86 021 6403 8038   email xujmin@aliyun.co mBackground:  Tumor deposits are one of the important influencing factors among the different  editions of Tumor, Node, Metastasis classification.",Non-OADS,/arxiv_data1/oa_pdf/07/77/ott-8-233.PMC4309783.pdf
"OncoTargets and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/oncotargets-and-therapy-journa lOncoTargets and Therapy is an international, peer-reviewed, open access  journal focusing on the pathological basis of all cancers, potential  targets for therapy and treatment protocols employed to improve the  management of cancer patients.",Non-OADS,/arxiv_data1/oa_pdf/07/77/ott-8-233.PMC4309783.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/07/77/ott-8-233.PMC4309783.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 151–159Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  151OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7406 4The professional perspective on patient involvement  in the development of quality indicators: a qualitative  analysis using the example of chronic heart failure  in the german health care setting correspondence:  nadine Janis Pohontsch  Universitätsklinikum hamburg-eppendorf,  institut für Allgemeinmedizin, Martinistr  52, 20246 hamburg, germany Tel +49 40 7410 55537  Fax +49 40 7410 53681 email n.pohontsch@uke.d e nadine Janis Pohontsch1 heidrun herzberg2 stefanie Joos3 Felix Welti4 Martin scherer1 eva Blozik1 1Department of Primary Medical  care, University Medical center  hamburg-eppendorf, hamberg,   germany; 2Faculty of health, nursing,   Management, neubrandenburg  University of Applied sciences,   neubrandenburg, germany;   3Department of general Practice  and health services research,   heidelberg University hospital,   heidelberg, germany; 4Faculty  of human sciences, University  of Kassel, Kassel, germanyPurpose:  There is an international consensus that quality indicators (QIs) of health care ought  to represent patient-relevant aspects.",Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
"Keywords:  quality indicators, patient involvement, national disease management guideline,  qualitative expert interviews, chronic heart failure Introduction Quality indicators (QIs) have been established in many health care settings to measure,  compare, and increase the quality of health care.1 Indicators are measurable items  referring to the structures, processes or outcomes of care.2 The interpretation of QIs Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Pohontsch et al Running head recto: Patient involvement in the development of quality indicators  DOI: http://dx.doi.org/10.2147/PPA.S74064",Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
Available from: http://www.aezq.de/aezq/publikationen/ schriftenreihe.,Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
Available from: http://www.bqs-institut.de/innovationen/ qualify-instrument.html.,Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
Available from: http://www.versorgungsleitlinien.de/ themen/herzinsuffizienz.,Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
Available from:  http://www.versorgungsleitlinien.de/methodik/reports.,Non-OADS,/arxiv_data1/oa_pdf/f5/ac/ppa-9-151.PMC4309784.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 197–205Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  197OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7549 8Predictors of remission in the treatment of major  depressive disorder: real-world evidence from  a 6-month prospective observational study Diego Novick1 Jihyung hong1 William Montgomery2 héctor Dueñas3 Magdy gado4 Josep Maria haro5 1eli lilly and company, Windlesham,   UK; 2eli lilly australia Pty ltd, West  ryde, australia; 3eli lilly de Mexico,   Mexico city, Mexico; 4eli lilly and  company, riyadh, saudi arabia; 5Parc  sanitari sant Joan de Déu, Fundació  sant Joan de Déu, Universitat de  Barcelona, Barcelona, spainBackground:  This study examined potential predictors of remission among patients treated  for major depressive disorder (MDD) in a naturalistic clinical setting, mostly in the Middle  East, East Asia, and Mexico.",Non-OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
"Most recently, the  World Mental Health survey by the World Health Organization reported the lifetime  prevalence of major depressive episode in 18 countries to range from 6.5% (People’s  Republic of China) and 6.6% (Japan) to 21.0% (France) and 19.2% (the USA).1 While  the prevalence estimates were found to be greater in Western countries, emerging correspondence:  Diego Novick global Patient Outcomes and real  World evidence (gPOrWe), eli lilly  and company, lilly research centre,  erl Wood Manor, sunninghill road,  Windlesham, surrey, gU20 6Ph, UK  Tel +44 012 7648 3832 Fax +44 012 7648 3192 email novick_diego@lilly.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Novick et al Running head recto: Predictors of remission in MDD DOI: http://dx.doi.org/10.2147/NDT.S75498",Non-OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
Available from: http://stats.oecd.org/index.,OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
Available from: http://www.who.int/classifications/icd/en/bluebook.,OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/5e/20/ndt-11-197.PMC4309785.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpPatient Preference and Adherence 2015:9 161–172Patient Preference and Adherence Dove press submit your manuscript | www.dovepress.co m Dove press  161OriginAl reseArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/PPA.S7460 2concurrent use of amphetamine stimulants and   antidepressants by undergraduate students Kim Vo1 Patricia J neafsey2 carolyn A lin3 1University of connecticut health  center, Farmington, 2school  of nursing  and center for health information  and Prevention, University of  connecticut, storrs, 3Department of  communication sciences and center  for health information and Prevention,  University of connecticut, storrs, cT,  UsAAbstract:  Undergraduate students were recruited to participate in an online survey to report  their use of amphetamine stimulants and other drugs.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
"Likewise, amphetamine stimulants  can cause a host of adverse symptoms such as cardiac dysrhythmias, anxiety, high correspondence: carolyn A lin Department of communication,  337 Mansfield Road, University of  connecticut, storrs, cT 06269-1295, UsA email carolyn.lin@uconn.ed u Journal name: Patient Preference and Adherence Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Vo et al Running head recto: Online survey of students’ self-medication practices DOI: http://dx.doi.org/10.2147/PPA.S74602",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
"Avail - able from http://www.deadiversion.usdoj.gov/schedules/orangebook/c_ cs_alpha.pd f. Accessed October 10, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
Available from http://www.deadiversion.usdoj.gov/21cfr/ cfr/1306/1306_12.htm.,OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
Available from: http://www.oir.uconn.,Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
"Available from: http://www.samhsa.gov/data/2k9/ adderall/adderall.pd f. Accessed December 6, 2012.",OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
Available from:  http://www.monitoringthefuture.org/pubs/monographs/vol2_2005.,Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
"Patient Preference and Adherence Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/patient-preference-and-adherence-journa lPatient Preference and Adherence is an international, peer-reviewed,  open access journal that focuses on the growing importance of patient   preference  and adherence throughout the therapeutic continuum.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
Available from: http://www.uptodate.,Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
"Available from:  http://emedicine.medscape.com/article/821737-overvie w. Accessed  November 26, 2014.",Non-OADS,/arxiv_data1/oa_pdf/b1/bb/ppa-9-161.PMC4309786.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/b6/03/tcrm-11-089.PMC4309787.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpTherapeutics and Clinical Risk Management 2015:11 89–94Therapeutics and Clinical Risk Management Dove press submit your manuscript | www.dovepress.co m Dove press  89REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/TCRM.S7095 4Prognostic role of serum C-reactive protein  in esophageal cancer: a systematic review  and meta-analysis Ying Huang1 Ji-Feng Feng2 Jin-Shi Liu2 Qi-Xun Chen2 1Department of Operating Theatre,   2Department of Thoracic Surgery,   Zhejiang Cancer Hospital, Hangzhou,   People’s Republic of ChinaBackground:  Recent studies have shown that C-reactive protein (CRP) is a useful predictive  factor in several cancers; however, its role in esophageal cancer (EC) is controversial.",Non-OADS,/arxiv_data1/oa_pdf/b6/03/tcrm-11-089.PMC4309787.pdf
"In an attempt to better estimate the prognosis, many prognostic factors have been  investigated, such as depth of invasion, nodal metastasis, tumor-node-metastasis (TNM)  stage, and other miscellaneous factors.5,6 Recently, systemic inflammatory response  (SIR) has been found to play an important role in cancer.7,8 Serum C-reactive protein  (CRP) is a very sensitive indicator of SIR, and was initially identified in the plasma of  patients as a substance reacting with pneumococcal C-polysaccharide, which appeared  in patients with inflammation.9–11 CRP is synthesized mainly by hepatocytes as a part  of the SIR.12,13 CRP is a representative acute-phase reactant and is the most widely  used systemic biomarker of inflammation.14,15 Previously published studies have shown that serum CRP is a predictor of sur - vival in several cancers, such as gastric cancer,16,17 colorectal cancer,18,19 pancreatic  cancer,20 hepatocellular cancer,21 urological cancer,22 ovarian cancer,23 lymphoma,24 Correspondence: Ji-Feng Feng Department of Thoracic Surgery,  Zhejiang Cancer Hospital,   No 38 Guangji Road, Hangzhou 310022,  People’s Republic of China Tel +86 571 8812 8062 Email j ifzhejiang@gmail.co m Journal name: Therapeutics and Clinical Risk Management Article Designation: REVIEW Y ear: 2015 Volume: 11 Running head verso: Huang et al Running head recto: Prognostic role of serum C-reactive protein in esophageal cancer DOI: http://dx.doi.org/10.2147/TCRM.S70954",Non-OADS,/arxiv_data1/oa_pdf/b6/03/tcrm-11-089.PMC4309787.pdf
"Therapeutics and Clinical Risk Management Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/therapeutics-and-clinical-risk-management-journa lTherapeutics and Clinical Risk Management is an international, peer- reviewed journal of clinical therapeutics and risk management, focusing  on concise rapid reporting of clinical studies in all therapeutic areas,  outcomes, safety, and programs for the effective, safe, and sustained  use of medicines.",Non-OADS,/arxiv_data1/oa_pdf/b6/03/tcrm-11-089.PMC4309787.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/b6/03/tcrm-11-089.PMC4309787.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ndt-11-191.PMC4309788.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2015:11 191–196Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  191OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7627 6hyperprolactinemia in Thai children and  adolescents with autism spectrum disorder  treated with risperidone Yaowaluck hongkaew1,2 Nattawat Ngamsamut3 apichaya Puangpetch1,2 Natchaya Vanwong1,2 Pornpen srisawasdi4 Montri chamnanphon1,2 Bhunnada  chamkrachchangpada3 T eerarat Tan-kam3 Penkhae limsila3 chonlaphat sukasem1,2 1Division of Pharmacogenomics  and Personalized Medicine,   Department of Pathology, Faculty  of Medicine, 2laboratory for  Pharmacogenomics, somdech  Phra Debaratana Medical center  (sDM c), ramathibodi hospital,   Mahidol University, 3Yuwaprasart  Waithayopathum child and  adolescent Psychiatric hospital,   Department of Mental health  services, Ministry of Public health,   4Division of clinical chemistry,   Department of Pathology, Faculty  of Medicine, ramathibodi hospital,   Mahidol University, Bangkok, ThailandAbstract:  Hyperprolactinemia is a common adverse effect observed in children with  autism spectrum disorder (ASD) during pharmacotherapy with risperidone.",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ndt-11-191.PMC4309788.pdf
"In addition, long-term hypogonadism owing correspondence: chonlaphat sukasem Division of Pharmacogenomics and  Personalized Medicine, Department  of Pathology, Faculty of Medicine,  ramathibodi hospital, Mahidol University,  Bangkok 10400, Thailand Tel +66 2 200 4331 Fax +66 2 200 4332 email chonlaphat.suk@mahidol.ac.t hJournal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2015 Volume: 11 Running head verso: Hongkaew et al Running head recto: Hyperprolactinemia in Thai autism spectrum disorder DOI: http://dx.doi.org/10.2147/NDT.S76276",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ndt-11-191.PMC4309788.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/21/5d/ndt-11-191.PMC4309788.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/21/5d/ndt-11-191.PMC4309788.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 791–800International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  791RevIewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/IJN.S7290 4Clinical and pathological implications of miRNA  in bladder cancer Cornelia Braicu,1 Roxana  Cojocneanu-Petric,1,2 Sergiu  Chira,1 Anamaria Truta,1,3  Alexandru Floares,4 Bogdan  Petrut,5,6 Patriciu Achimas- Cadariu,7,8,* Ioana Berindan- Neagoe1,9–11,* 1Research Center for Functional Genomics,   Biomedicine and Translational Medicine,   “Iuliu Hatieganu” University of Medicine  and Pharmacy, Cluj-Napoca, Romania;   2Faculty of Biology and Geology, Babeş- Bolyai University, Cluj-Napoca, Romania;   3Department of Medical Genetics, “Iuliu  Hatieganu” University of Medicine and  Pharmacy, Cluj-Napoca, Romania; 4Solutions  of Artificial Intelligence Applications,   Cluj-Napoca, Romania; 5Department of  Urology, The Oncology Institute “ Prof  Dr. Ion Chiricuta”, Cluj-Napoca, Romania;   6Department of Urology, “Iuliu Hatieganu”  University of Medicine and Pharmacy,   Cluj-Napoca, Romania; 7Department of  Surgery, The Oncology Institute “ Prof  Dr. Ion Chiricuta”, Cluj-Napoca, Romania;   8Department of Surgical Oncology and  Gynaecological Oncology, “Iuliu Hatieganu”  University of Medicine and Pharmacy,   Cluj-Napoca, Romania; 9Department of  Immunology, “Iuliu Hatieganu” University  of Medicine and Pharmacy, Cluj-Napoca,   Romania; 10Department of Functional  Genomics and experimental Pathology,   The Oncology Institute “ Prof Dr. Ion  Chiricuta”, Cluj-Napoca, Romania;   11Department of experimental Therapeutics  M.D.",Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
"The probability of developing this disease seems to increase with age, growing from  a 0.02% chance of having bladder cancer by the age of 39 years to a 3.69% (1 in 27) Correspondence: Ioana Berindan-Neagoe Research Center for Functional Genomics  and Translational Medicine, “Iuliu Hatieganu”  University of Medicine and Pharmacy, Cluj- Napoca, 23 Marinescu Street, 40015, Romania Tel +40 264 450 749 Fax +40 264 598 885 email ioana.neagoe@umfcluj.r o Patriciu Achimas-Cadariu Department of Surgery, The Oncology Institute  “Prof Dr. Ion Chiricuta”, Cluj-Napoca, Romania Tel +40 264 450 749 Fax +40 264 598 885 email pachimas@umfcluj.r oJournal name: International Journal of Nanomedicine Article Designation: Review Y ear: 2015 Volume: 10 Running head verso: Braicu et al Running head recto: miRNA in bladder cancer DOI: http://dx.doi.org/10.2147/IJN.S72904",Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
"The National Institutes of Health provides  an online database ( http://clinicaltrials.gov/ ) in which they  publish, according to their own homepage, “publicly and  privately supported clinical studies of human participants  conducted around the world.” It currently lists 155,545  clinical trials, located in all 50 states and in 185 countries  around the world, and is thus one of the most valuable sources  for centralized information on this topic.",Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
Available from: http://globocan.iarc.,Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/ea/f8/ijn-10-791.PMC4309789.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/ec/imcrj-8-037.PMC4309790.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Medical Case Reports Journal 2015:8 37–40International Medical Case Reports Journal Dove press submit your manuscript | www.dovepress.co m Dove press  37Case Repo Rtopen access to scientific and medical research open access Full text article http: //dx.doi.org/10.2147/IMCRJ.S7648 8toxoplasmosis complicating lung cancer:   a case report Nianhong Lu Caihong Liu Jiangyuan Wang Ying Ding Qing ai Department of Clinical Laboratory,   the First Hospital of Jilin University,   Changchun, people’s Republic   of China Correspondence: Qing ai   Department of Clinical Laboratory,   the First Hospital of Jilin University,   3302 Jilin Road, Changchun, Jilin,   130031, people’s Republic of China   tel +86 137 5666 1670  Fax +86 0431 8480 8288  email aiqing@jlu.edu.c nAbstract:  Toxoplasmosis complicating lung cancer has been described only rarely.",Non-OADS,/arxiv_data1/oa_pdf/26/ec/imcrj-8-037.PMC4309790.pdf
"International Medical Case Reports Journal Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-medical-case-reports-journal-journa lThe International Medical Case Reports Journal is an international,  peer-reviewed open-access journal publishing original case reports  from all medical specialties.",Non-OADS,/arxiv_data1/oa_pdf/26/ec/imcrj-8-037.PMC4309790.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/ec/imcrj-8-037.PMC4309790.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ed/43/cia-10-287.PMC4309791.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 287–295Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  287OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7008 6Objective:  This study aims to examine perceptions of the helpfulness of treatments/interventions  for depression held by elderly care recipients, to examine whether these beliefs are related to  help-seeking and whether the experience of depression affects beliefs about treatment seeking,  and to identify the characteristics of help-seekers.",Non-OADS,/arxiv_data1/oa_pdf/ed/43/cia-10-287.PMC4309791.pdf
"Keywords:  older adults, help-seeking, depression, prevalence, perceptions of treatments Introduction The perceptions older people have about the potential helpfulness of interventions for  depression are important, as they are likely to influence how individuals respond to their  own depression and whether they seek treatment.1–3 Early help-seeking for depression  is important and improves the long-term outcome of depression,4 and there is good  evidence for effective psychological and pharmacological treatments for older people  with depression.5,6 Untreated depression in older people has a number of consequences,  including increased mortality,7,8 poorer functional outcomes,9–11 and reduced quality  of life12,13 and is an independent risk factor for developing dementia.14 A number of studies have shown that older people use mental health services at a lower  rate than the general population despite having high need for such services.15–18 This low Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Atkins et al Running head recto: Elderly care recipients, depression, and help-seeking DOI: http://dx.doi.org/10.2147/CIA.S70086 elderly care recipients’ perceptions of treatment  helpfulness for depression and the relationship  with help-seeking Joanna Atkins1 sharon l naismith1 georgina M luscombe2 Ian B hickie1 1Brain and Mind research Institute,   University of sydney, sydney, nsW,   Australia; 2school of rural health,   sydney Medical school, University  of sydney, Orange, nsW, Australia Correspondence: Joanna Atkins Brain and Mind research Institute,  University of sydney, Camperdown,   nsW 2050, Australia Tel +61 2 9351 0810 Fax +61 2 9351 0652 email joanna@med.usyd.edu.a u",Non-OADS,/arxiv_data1/oa_pdf/ed/43/cia-10-287.PMC4309791.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/ed/43/cia-10-287.PMC4309791.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/ed/43/cia-10-287.PMC4309791.pdf
Available from: http://www.rcpsych.ac.uk/files/pdfversion/cr108.pdf.,Non-OADS,/arxiv_data1/oa_pdf/ed/43/cia-10-287.PMC4309791.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/27/26/ijn-10-839.PMC4309792.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 839–846International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  839OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S6900 1In vivo experimental study on bone regeneration  in critical bone defects using PIB nanogels/ boron-containing mesoporous bioactive glass  composite scaffold Xiaohui chen1,2,* Yanbing Zhao3,* shinan geng3 richard J Miron1 Qiao Zhang1 chengtie Wu4 Yufeng Zhang1,2 1state Key laboratory Breeding Base  of Basic science of  stomatology   (hubei-MO sT) and Key laboratory of  Oral Biomedicine Ministry of education,   school and  hospital of stomatology,   Wuhan  University, People’s republic  of china; 2Department of Dental  Implantology, school and hospital  of stomatology, Wuhan University,   People’s  republic of china; 3National  engineering research center for  Nanomedicine, college of life science  and Technology, huazhong University  of science and T echnology, Wuhan,   People’s republic of china; 4state  Key laboratory of  high Performance  ceramics  and superfine Microstructure,   shanghai Institute of ceramics, chinese  academy of sciences, shanghai,   People’s  republic of china *These authors contributed equally   to this workPurpose:  In the present study, the fabrication of novel p(N-isopropylacrylamide-co-butyl  methylacrylate) (PIB) nanogels was combined with boron-containing mesoporous bioactive glass  (B-MBG) scaffolds in order to improve the mechanical properties of PIB nanogels alone.",Non-OADS,/arxiv_data1/oa_pdf/27/26/ijn-10-839.PMC4309792.pdf
"Keywords:  bone graft, boron, osteoporosis, osteoporotic defect, mesoporous bioactive graft,  tissue engineering Introduction Osteoporosis is a worldwide disease characterized by low bone mass and poor bone  strength caused by an imbalance between bone forming osteoblasts and bone resorb - ing osteoclasts.1 An estimated 200 million people are affected worldwide with the  great majority being women.2 Reports demonstrate that within the lifetime of a patient  suffering from the disease, 30%–50% of women and 15%–30% of men will suffer at  minimum one osteoporotic-related fracture.3 A recent systematic review found that not  only was life quality for these patients severely decreased, but the incidence of death for  patients following hip fracture is at least doubled for an age-matched control without correspondence: chengtie Wu state Key laboratory of high Performance  Ceramics and Superfine Microstructure,  shanghai Institute of ceramics, chinese  academy of sciences, shanghai 200050,  People’s republic of china email chengtiewu@mail.sic.ac.c n Yufeng Zhang The state Key laboratory Breeding Base of  Basic science of stomatology (hubei-MOsT) &  Key laboratory of Oral Biomedicine Ministry of  education, school & hospital of stomatology,  Wuhan University, 237 luoyu road, Wuhan  430079, People’s republic of china email zyf@whu.edu.c nJournal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Chen et al Running head recto: Bone regeneration using PIB nanogels/B-MBG composite scaffold DOI: http://dx.doi.org/10.2147/IJN.S69001",Non-OADS,/arxiv_data1/oa_pdf/27/26/ijn-10-839.PMC4309792.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/27/26/ijn-10-839.PMC4309792.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/27/26/ijn-10-839.PMC4309792.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8a/8d/cia-10-311.PMC4309793.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 311–319Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  311OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7305 3Communication skills training in a nursing home:  effects of a brief intervention on residents  and nursing aides suzan sprangers Katinka Dijkstra Anna romijn-luijten Institute of Psychology, Faculty  of social sciences, erasmus  University rotterdam, rotterdam,   the n etherlandsAbstract:  Effective communication by nursing home staff is related to a higher quality of life  and a decrease in verbal and physical aggression and depression in nursing home residents.",Non-OADS,/arxiv_data1/oa_pdf/8a/8d/cia-10-311.PMC4309793.pdf
"This is called the Communication Predicament Of Aging.5  Elderspeak, a communication style with high pitch, exaggerated intonation, simpli - fied grammar, and slow speech,6 is a common communication style among nursing Correspondence: Katinka Dijkstra  Institute of Psychology, Faculty of social  sciences, erasmus University rotterdam,  Burgemeester Oudlaan 50, 3062 PA  rotterdam, the netherlands Tel +31 10 408 8657 email k.dijkstra@fsw.eur.n l Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Sprangers et al Running head recto: Communication skills training in a nursing home DOI: http://dx.doi.org/10.2147/CIA.S73053",Non-OADS,/arxiv_data1/oa_pdf/8a/8d/cia-10-311.PMC4309793.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/8a/8d/cia-10-311.PMC4309793.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/8a/8d/cia-10-311.PMC4309793.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/36/22/cia-10-321.PMC4309794.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 321–327Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  321OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7401 2elderly patients with myocardial infarction  selected for conservative or invasive treatment  strategy Berglind libungan1 Thomas Karlsson2 Per Albertsson1 Johan herlitz3 1Department of Cardiology,   sahlgrenska University hospital,   gothenburg, sweden; 2Center  for Applied Biostatistics, Occupational  and environmental Medicine,   sahlgrenska Academy at University  of gothenburg, gothenburg, sweden;   3sahlgrenska University hospital and  Center for Prehospital research,   Western sweden University of Borås,   Borås, swedenBackground:  There are limited data on patients aged 75 years with myocardial infarction  (MI), especially those who are treated conservatively.",Non-OADS,/arxiv_data1/oa_pdf/36/22/cia-10-321.PMC4309794.pdf
"This gap in evidence-based  medicine can partly be explained by the fact that elderly patients often meet exclusion  criteria in studies due to comorbidity, or due simply to exceeding the upper age limit.6 Correspondence: Berglind libungan sahlgrenska University hospital,  Department of Cardiology,  Blå stråket 3, vån 1, se-413 45  gothenburg, sweden email berglind.libungan@vgregion.s e Journal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Libungan et al Running head recto: Myocardial infarction in the elderly DOI: http://dx.doi.org/10.2147/CIA.S74012",Non-OADS,/arxiv_data1/oa_pdf/36/22/cia-10-321.PMC4309794.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/36/22/cia-10-321.PMC4309794.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/36/22/cia-10-321.PMC4309794.pdf
Available from: http://www.socialstyrelsen.se/ statistik/publiceringskalenderforofficiellstatistik/hjartinfarkter.,Non-OADS,/arxiv_data1/oa_pdf/36/22/cia-10-321.PMC4309794.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/13/70/ijn-10-811.PMC4309795.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 811–819International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  811OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7198 0Multifunction hexagonal liquid-crystal containing  modified surface TiO2 nanoparticles and terpinen- 4-ol for controlled release eloísa Berbel Manaia1 renata cristina Kiatkoski  Kaminski2 anselmo gomes de  Oliveira1 Marcos antonio corrêa1 leila aparecida chiavacci1 1Drugs and Medicines Department,   Faculty of Pharmaceutical sciences,   2Physical-chemistry Department,   chemistry Institute, são Paulo state  University – UN esP , araraquara,    BrazilAbstract:  Multifunctional products have been developed to combine the benefits of functional  components and terpinen-4-ol (TP) delivery systems.",Non-OADS,/arxiv_data1/oa_pdf/13/70/ijn-10-811.PMC4309795.pdf
"The photoisomerization of the azobenzene compound  controls the release of the ascorbic acid under ultraviolet (UV) radiation and at the same  time protects the skin from UV radiation.4 Commonly, sunscreens have vitamins C and E  as ingredients because they have been shown to maximize the UV protection of the skin  and reverse changes induced by both chronologic and photoaging.5correspondence: leila aparecida  chiavacci Drugs and Medicines Department, Faculty  of Pharmaceutical sciences of são Paulo  state University – UNesP, araraquara-Jaú  Interstate highway, Km 1, araraquara,  Brazil Tel +55 16 3301 6966 Fax +55 16 3301 6900 email leila@fcfar.unesp.b r Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Manaia et al Running head recto: Multifunction hexagonal liquid-crystal for controlled release DOI: http://dx.doi.org/10.2147/IJN.S71980",Non-OADS,/arxiv_data1/oa_pdf/13/70/ijn-10-811.PMC4309795.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/13/70/ijn-10-811.PMC4309795.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/13/70/ijn-10-811.PMC4309795.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/56/68/ccide-7-017.PMC4309796.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical, Cosmetic and Investigational Dentistry 2015:7 17–23Clinical, Cosmetic and Investigational Dentistry Dove press submit your manuscript | www.dovepress.co m Dove press  17OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/CCIDE.S7476 4The perception of smile attractiveness   among saudi population hadeel a Mokhtar layla W abuljadayel reem M al-ali Mohammed Y ousef Department of Operative Dentistry,   Faculty of Dentistry, King abdulaziz  University, Jeddah, saudi arabia Correspondence: Mohammed K Yousef   Department of Operative Dentistry,  Faculty of Dentistry, King abdulaziz  University, PO Box 80209, Jeddah,  21589, saudi arabia   email myousf@kau.edu.s aAbstract:  Parameters of dental beauty change across time for varying reasons.",Non-OADS,/arxiv_data1/oa_pdf/56/68/ccide-7-017.PMC4309796.pdf
"Clinical, Cosmetic and Investigational Dentistry Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-cosmetic-and-investigational-dentistry-journa lClinical, Cosmetic and Investigational Dentistry is an international,  peer-reviewed, open access, online journal focusing on the latest clini - cal and experimental research in dentistry with specific emphasis on  cosmetic interventions.",Non-OADS,/arxiv_data1/oa_pdf/56/68/ccide-7-017.PMC4309796.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/56/68/ccide-7-017.PMC4309796.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/f1/96/ijn-10-821.PMC4309797.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 821–838International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  821OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7539 8The efficacy and mechanism of apoptosis induction  by hypericin-mediated sonodynamic therapy in  THP-1 macrophages Xuesong Li1,* lei gao2,* Longbin Zheng1 Jiayuan Kou1 Xing Zhu1 Yueqing Jiang1 Zhaoyu Zhong1 Juhua Dan1 haobo Xu3 Yang Yang3 Hong Li1 sa shi1 Wenwu cao4,5 Yajun Zhao1 Ye Tian1,3 Liming Yang1 1Department of Pathophysiology,   Harbin Medical University, Harbin,   People’s republic of china; 2electron  Microscopy Centre, Harbin Medical  University, Harbin, People’s Republic  of china; 3Division of Cardiology,   The First affiliated hospital, harbin  Medical University, Harbin, People’s  republic of china; 4Laboratory  of Sono- and Photo-theranostic  Technologies, Harbin Institute  of Technology, Harbin, People’s  republic of china; 5Materials research  Institute, The Pennsylvania State  University, University Park, PA, USA *These authors contributed equally  to this workPurpose:  To investigate the sonoactivity of hypericin (HY), together with its sonodynamic  effect on THP-1 macrophages and the underlying mechanism.",Non-OADS,/arxiv_data1/oa_pdf/f1/96/ijn-10-821.PMC4309797.pdf
"Keywords:  apoptosis, hypericin, sonodynamic therapy, mitochondria–caspase pathway,  atherosclerosis Introduction Acute cardiovascular events, the principal cause of death worldwide, pose a severe  threat to human health, and are primarily caused by the rupture of atherosclerotic  plaques during atherosclerosis (AS).1 Macrophages play a pivotal role in atherogenesis,  and the phenotype and quantity of these cells in atherosclerotic lesions influence both  disease progression and plaque regression.2 Photodynamic therapy (PDT) has been Correspondence: Liming Yang; Ye Tian Department of Pathophysiology, Harbin  Medical University, Harbin 150081,  People’s republic of china Tel +86 451 8667 4548 Fax +86 451 8667 4548 email limingyang@ems.hrbmu.edu.c n;  yetian@ems.hrbmu.edu.c n Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Li et al Running head recto: Apoptosis induction by HY-mediated SDT in THP-1 macrophages DOI: http://dx.doi.org/10.2147/IJN.S75398",Non-OADS,/arxiv_data1/oa_pdf/f1/96/ijn-10-821.PMC4309797.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/f1/96/ijn-10-821.PMC4309797.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/f1/96/ijn-10-821.PMC4309797.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/oajsm-6-007.PMC4309798.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pOpen Access Journal of Sports Medicine 2015:6 7–21Open Access Journal of Sports Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  7OriginAl reSeArchopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/OAJSM.S7649 0Performance differences between sexes   in 50-mile to 3,100-mile ultramarathons Matthias A Zingg1 Beat Knechtle1,2 Thomas rosemann1 christoph A rüst1 1institute of Primary care, University  of Zurich, Zurich, Switzerland;   2gesundheitszentrum St gallen,   St gallen, Switzerland correspondence: Beat Knechtle   Facharzt FMh für Allgemeinmedizin,  gesundheitszentrum St gallen,  Vadianstrasse 26, 9001 St gallen,  Switzerland   Tel +41 71 226 82 82   Fax +41 71 226 82 72   email beat.knechtle@hispeed.c hAbstract:  Anecdotal reports have assumed that women would be able to outrun men in long- distance running.",Non-OADS,/arxiv_data1/oa_pdf/8c/3c/oajsm-6-007.PMC4309798.pdf
"Available from: http://us.srichinmoyraces.org/ archives/1989/24-hou r. Accessed December 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8c/3c/oajsm-6-007.PMC4309798.pdf
"Available from:  http://www.badwater.com/result s. Accessed December 8, 2014.",Non-OADS,/arxiv_data1/oa_pdf/8c/3c/oajsm-6-007.PMC4309798.pdf
"Open Access Journal of Sports Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/open-access-journal-of-sports-medicine-journa lOpen Access Journal of Sports Medicine is an international,  peer-reviewed, open access journal publishing original research,  reports, reviews and commentaries on all areas of sports  medicine.",Non-OADS,/arxiv_data1/oa_pdf/8c/3c/oajsm-6-007.PMC4309798.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/8c/3c/oajsm-6-007.PMC4309798.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution- Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"2 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"Upon arrival, patient was immediately taken to the operating room and received a right Chopart amputation and left trans-metatarsal amputation.Collagenase and negative pressure wound therapy Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"4 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"With 4 months of continued Santyl and negative pressure wound therapy, the wounds continued to close, and as of 9/8/14 the patient presented with a closed right wound (a) and nearly closed left (b).Collagenase and negative pressure wound therapy Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"6 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"During follow-up this appeared to be progressing towards healing, however, due to this patient’s signiﬁcant co- morbid state, the patient’s deteriorated and he required multiple metatarsal head resections with extensor tenotomies.Collagenase and negative pressure wound therapy Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"8 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"Within 1 month of concomitant usage, full healing of the plantar wound was noted, and conﬁrmed again at the 1 month follow-up.Collagenase and negative pressure wound therapy Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
"10 (page number not for citation purpose)Citation: Diabetic Foot & Ankle 2015, 6: 24999 - http://dx.doi.org/10.3402/dfa.v6.24999",Non-OADS,/arxiv_data1/oa_pdf/35/a6/DFA-6-24999.PMC4309834.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
HR-mediated repair of nuclease-induced DSBs enables the insertion of preplanned sequence alterations into the http://dx.doi.org/10.1016/j.fob.2014.11.009 2211-5463/ /C2112014 The Authors.,OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: DSB, double-strand break; ES, embryonic stem (cell); HR, homologous recombination; NHEJ, non-homologous end joining; sg, single guide;TAL, transcription activator-like; TALEN, TAL effector nucleases; ZFN, zinc-ﬁngernucleases ⇑Corresponding authors at: Institute of Developmental Genetics, Helmholtz Zentrum München, German Research Center for Environmental Health, 85764Neuherberg, Germany (W. Wurst).",Non-OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
CRISPR/Cas target sites and vector construction CRISPR target sites were identiﬁed using http://crispr.mit.edu/ as described [34].,OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
"Supplementary data Supplementary data associated with this article can be found, in the online version, at http://dx.doi.org/10.1016/j.fob.2014.11.009 .",OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
"Methods 8, http://dx.doi.org/ 10.1038/nmeth.2857 .",OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
"Nucleic Acids Res., http://dx.doi.org/10.1093/nar/gku936 .C.",OADS,/arxiv_data1/oa_pdf/8f/57/main.PMC4309836.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5b/ba/main.PMC4309837.pdf
"However, their physiological roles and regulations in fat tissue and non-chemosensory cells are http://dx.doi.org/10.1016/j.fob.2014.11.008 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/5b/ba/main.PMC4309837.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: CREB, cAMP response element-binding protein; OST, odorant-induced signal transduction; PNF, Piper nigrum fructus ⇑Corresponding author at: Korea Food Research Institute, 1201-62 Anyangpangyo-ro, Bundang-gu, Seongnam-si, Gyeonggi-do 463-746, Republic ofKorea.",Non-OADS,/arxiv_data1/oa_pdf/5b/ba/main.PMC4309837.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/85/cb/main.PMC4309840.pdf
"Moreover, ghrelin, a 28-amino acid peptide synthesized in the gastrointestinal tract, directly stimulates glucagon secretion [19] and eating behavior http://dx.doi.org/10.1016/j.fob.2014.12.001 2211-5463/ /C2112014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/85/cb/main.PMC4309840.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: CNS, central nervous system; H 3R, histamine H 3receptor; H3KO, histamine H 3receptor-gene knockout; KRB, Krebs–Ringer bicarbonate buffer; GLP, glucagon-like peptide; VDCCs, voltage-dependent Ca2+channels ⇑Corresponding author.",Non-OADS,/arxiv_data1/oa_pdf/85/cb/main.PMC4309840.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/8b/99/main.PMC4309841.pdf
"The ﬁrst two substitutions hinder dimer formation [8], whereas the latter two abolish erroneous http://dx.doi.org/10.1016/j.fob.2014.12.003 2211-5463/ /C2112015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/main.PMC4309841.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: SOD1, superoxide dismutase 1; HSQC, heteronuclear single- quantum coherence; TOCSY, total correlation spectroscopy; NOESY, nuclear Over-hauser enhancement spectroscopy; IDP, intrinsically disordered protein Database: The backbone chemical shift assignments for urea-denatured human SOD1 have been deposited with the Biological Magnetic Resonance Bank (BMRB)under the accession code 18968.",Non-OADS,/arxiv_data1/oa_pdf/8b/99/main.PMC4309841.pdf
"Resistance to theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.11.002 2213-2317/Published by Elsevier B.V.Abbreviations: ATN-224, choline tetrathiomolybdate; BR, BTZ resistant; BTZ, bortezomib; CI, con ﬁdence interval; Cu, copper; CuZnSOD, copper –zinc superoxide dismutase; DDC, diethyldithiocarbamate; DHE, dihydroethidium; DSF, disul ﬁram; EFS, event free survival; ER, endoplasmic reticulum; GEP, gene expression pro ﬁle; GPx, glutathione peroxidase; GSH, glutathione; GSSG, glutathione disul ﬁde; GST, glutathione S-transferase; H 2O2, hydrogen peroxide; H 2DCF-DA, carboxy-2 ′,7′-di- chlorodihydro ﬂuorescein diacetate; MFI, mean ﬂuorescence intensity; MGUS, monoclonal gammopathy of undetermined signi ﬁcance; MM, multiple myeloma; MnSOD, manganese superoxide dismutase; NAC, N-acetylcysteine; NF- κB, nuclear factor-kappa B; NPC, Normal plasma cells; NSF, normalized survival fraction; PDI,protein disul ﬁde isomerase; PE, plating ef ﬁciency; PSMB5, proteasome β5 subunit; O2/C15/C0, superoxide; Os, overall survival; ROS, reactive oxygen species; SOD, super- oxide dismutase; UPR, unfolded protein response nCorrespondence to: B180 Medical Laboratories, University of Iowa, Iowa City, IA 52242, USA.",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
Bands were visualized by auto- radiography and protein expression was quanti ﬁed using ImageJ 1.38/C2software ( http://rsbweb.nih.gov/ij/index.html ).,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
Supplementary material Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2014.11.002 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"References [1] R. Siegel, J. Ma, Z. Zou, A. Jemal, Cancer statistics, 2014, CA Cancer Journal for Clinicians 64 (1) (2014) 9 –29.http://dx.doi.org/10.3322/caac.21208 24399786 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1053/j.seminhematol.2012.05.003 22727389 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1634/theoncologist.12-8-978 17766658 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1111/ j.1365-2141.2007.06772.x 17910628 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1111/ j.1365-2141.2008.07066.x 18341633 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/sj.leu.2403109 14513055 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-03-0561 15173093 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/ blood-2002-08-2543 12393500 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1080/10428190902802323 19452319 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1007/s00011-012- 0498-7 22674324 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/nrd2803 19478820 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1146/annurev.bi.44.070175.001051 1094908 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1074/jbc.M105296200 11500508 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"Zheng, Superoxide dismutase 1 acts as a nuclear transcription factor to regulate oxidative stress resistance, Nature Communications 5 (2014) 3446. http://dx.doi.org/10.1038/ncomms4446 24647101 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1172/JCI71714 24292713 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1080/10428190500266210 16321833 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/j.drudis.2011.12.010 22192884 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/blood-2006-07-038430 17105813 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/ 10.1182/blood-2007-10-119321 18182586 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"[27] M. Jules Mattes, High-sensitivity cytotoxicity assays for nonadherent cells, Methods in Molecular Medicine 110 (2005) 29 –37.http://dx.doi.org/10.1385/ 1-59259-869-2:029 15901924 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1042/BJ20112019 22471522 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/0006-291X(76)90747-6 971321 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/0003-2697(80)90139-6 7416462 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/ 0005-2728(84)90086-0 6091750 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/S0006-2952(03)00508-2 14555231 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"[38] S. Lü, J. Wang, The resistance mechanisms of proteasome inhibitor bortezo- mib, Biomarker Research 1 (1) (2013) 13. http://dx.doi.org/10.1186/2050- 7771-1-13 24252210 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/leu.2011.256 21941364 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/leu.2010.137 20555361 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1124/jpet.108.138131 18502982 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/blood-2007-08-104950 18565852 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"Kirk, J. Anderl, et al., Interferon-gamma-induced upregulation of immunoproteasome subunit as- sembly overcomes bortezomib resistance in human hematological cell lines, Journal of Hematology & Oncology 7 (1) (2014) 7. http://dx.doi.org/10.1186/ 1756-8722-7-7 24418325 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/blood-2008-08-172734 19164601 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"Spitz, Increased levels of superoxide and H2O2 mediate the differential susceptibility of cancer cells versus normal cells to glucose deprivation, Biochemical Journal 418 (1) (2009) 29–37.http://dx.doi.org/10.1042/BJ20081258 18937644 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/ 10.1002/jcb.23387 21956712 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1089/ars.2009.2692 19778285 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/j.exphem.2005.04.005 15963854 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"[51] S. Cenci, L. Oliva, F. Cerruti, E. Milan, G. Bianchi, M. Raule, et al., Pivotal ad- vance: protein synthesis modulates responsiveness of differentiating and malignant plasma cells to proteasome inhibitors, Journal of Leukocyte Biology 92 (5) (2012) 921 – 931. http://dx.doi.org/10.1189/jlb.1011497 22685320 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"Mohrbacher, G. Chatta, C. Shustik, et al., Pharmacokinetic and pharmacodynamic study of two doses of bortezomib in patients with relapsed multiple myeloma, Cancer Chemotherapy And Phar- macology 67 (1) (2011) 57 –67.http://dx.doi.org/10.1007/s00280-010-1283-3 20306195 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/blood-2008-07-171637 19050304 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/leu.2009.123 19516276 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/blood-2011-10-386789 22932796 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1182/blood-2012-05- 426924 23018640 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1074/jbc.M312497200 14742448 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1002/jnr.10298 12125078 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1074/jbc.M603337200 16920710 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1002/ iub.114 18636510 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/sj.onc.1209607 16892079 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"[67] P. Milani, S. Gagliardi, E. Cova, C. Cereda, SOD1 transcriptional and Post- transcriptional Regulation and Its Potential Implications in ALS, Neurology Research International 2011 (2011) 458427. http://dx.doi.org/10.1155/2011/ 458427 21603028 .",Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/ 10.1016/0891-5849(94)90079-5 7982629 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1021/bi00102a024 1654093 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/j.jmb.2010.12.039 21215271 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1016/ S0891-5849(01)00480-4 11368918 .,OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
"Pronzato, et al., Role of glutathione in cancer progression and chemoresistance, Oxida- tive Medicine and Cellular Longevity 2013 (2013) 972913. http://dx.doi.org/ 10.1155/2013/972913 23766865 .",OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1371/journal.pone.0052662 23285138 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1038/306284a0 6316150 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.4161/cc.28959 24759086 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.2174/156800911794519806 21247389 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1002/ijc.27482 22322883 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1177/ 1087057106297115 17208922 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/ 10.1182/blood-2005-09-3870 16424391 .,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
http://dx.doi.org/10.1097/00000421- 199004000-00007 2180271 .K.,Non-OADS,/arxiv_data1/oa_pdf/58/5e/main.PMC4309843.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
Nuclear factor erythroid 2-related factor 2 (Nrf2) is a keytranscription factor that plays a central role in regulating theContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.002 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.2165/00002512-199303060- 00007 8312678 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.2337/dc05-2370 16801576 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1111/j.1464- 5491.2012.03684.x 22507139 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1126/science.6836290 6836290 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/j.redox.2013.01.014 24024158 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
"Levonen, The Keap1-Nrf2 pathway: mechanisms of activation and dysregulation in cancer, Redox Biol- ogy 1 (1) (2013) 45 –49.http://dx.doi.org/10.1016/j.redox.2012.10.001 24024136 .",Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1161/ATVBAHA.112.300614 23413426 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/S0074- 7742(02)50081-7 12198814 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1089/ars.2008.2235 19072199 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.1152/ajprenal.00421.2009 20007347 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1161/ATVBAHA.112.249334 22516068 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/j.re- dox.2014.02.001 24624340 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.1161/CIRCULATIONAHA.105.598698 17101869 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
"[20] K. Sato, K. Yama, Y. Murao, R. Tatsunami, Y. Tampo, Epalrestat increases in- tracellular glutathione levels in Schwann cells through transcription regula- tion, Redox Biology 2 (2013) 15 –21.http://dx.doi.org/10.1016/j.re- dox.2013.11.003 24363998 .",OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/0005-2760(90) 90314-N 2344447 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/ 0003-2697(86)90131-4 3954035 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1074/jbc.M504604200 16081425 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
"[24] M. Tsukamoto, Y. Tampo, M. Sawada, M. Yonaha, Paraquat-induced oxidative stress and dysfunction of the glutathione redox cycle in pulmonary micro- vascular endothelial cells, Toxicology and Applied Pharmacology 178 (2) (2002) 82 –92.http://dx.doi.org/10.1006/taap.2001.9325 11814328 .",Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/0167-4838(89)90090-3 2500152 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/0026-0495(79)90059-3 122298 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2008.09.013 18926903 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.1016/j.bbrc.2005.11.095 16325767 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
"[39] J. Lu, A. Holmgren, The thioredoxin antioxidant system, Free Radical Biology and Medicine 66 (2014) 75 –87.http://dx.doi.org/10.1016/j.free- radbiomed.2013.07.036 23899494 .",OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1042/ BJ20050712 16209660 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/S0014-5793(03)00517-9 12832036 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1042/BJ20031049 14616092 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1042/bj20071189 18237271 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1128/MCB.26.1.221-229.2006 16354693 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.1042/BST20140113 25109981 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2013.07.003 23851032 .,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.3164/jcbn.2008026 18545638 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1074/jbc.M113.450478 23737527 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1210/endo.139.8.6152 9681489 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.2337/diacare.23.10.1539 11023149 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1507/endocrj.K08E- 237 18997444 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/10.1093/jb/mvr032 21436140 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.1161/ATVBAHA.110.207316 20508205 .,Non-OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
http://dx.doi.org/ 10.1089/ars.2013.5658 24180608 .K.,OADS,/arxiv_data1/oa_pdf/17/d3/main.PMC4309844.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
"The expression of AnxA2 is associated with cell migration and pro- liferation, particularly in cancer, since poorly invasive tumor cells, such as MCF-7, express low level of AnxA2, whereas AnxA2 is highlyContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.005 2213-2317/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: nSMase, neutral sphingomyelinase; nSMase2, type 2 neutral sphingomyelinase; SMC, smooth muscle cell; mFbl, mouse ﬁbroblast; wt, wild type; fro, fragilitas ossium; mef, mouse embryonic ﬁbroblast; MMP, matrix metallopro- teinases; AnxA2, annexin 2; H 2O2, hydrogen peroxide; ROS, reactive oxygen species nCorresponding author at: I2MC Team 10, CHU Rangueil, 1, Avenue Jean Poulhès, 31432 Toulouse Cedex 4, France.",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.3892/ijmm.11.2.229 12525883 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
"Srivastava, Role of receptor and nonreceptor pro- tein tyrosine kinases in H 2O2-induced PKB and ERK1/2 signaling, Cell Bio- chemistry and Biophysics 47 (1) (2007) 1 –10.http://dx.doi.org/10.1385/ CBB:47:1:1 17406055 .",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1089/ ars.2006.8.243 16677071 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1016/j.bbalip.2013.04.014 23651497 .,OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
"Seguelas, N. Leducq, I. Seif, A. Parini, O. Cuvillier, Oxidative stress-dependent sphingosine kinase-1inhibition mediates monoamine oxidase A-associated cardiac cell apoptosis, Circulation Research 100 (1) (2007) 41 –49.http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1016/0092-8674(82)90031-9 6215122 .,OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1128/MCB.01247-07 18070928 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1111/j.1365- 2184.2012.00820.x 22452352 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1161/01.RES.80.3.383 9048659 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1161/ CIRCRESAHA.112.272013 22798525 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1074/jbc.M110.141028 20679347 .C.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1038/ng1603 16025116 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1128/ MCB.01485-06 17283058 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1038/ ki.2008.203 18509322 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1161/01.CIR.0000136995.83451.1D 15277330 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/ 10.7497/j.issn.2095-3941.2012.04.005 23691485 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/ 10.1111/j.1749-6632.1992.tb38653.x 1482106 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1074/jbc.M110.185058 21115493 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
"[29] C. Coatrieux, M. Sanson, A. Negre-Salvayre, A. Parini, Y. Hannun, S. Itohara, R. Salvayre, N. Auge, MAO-A-induced mitogenic signaling is mediated by re- active oxygen species, MMP-2, and the sphingolipid pathway, Free Radical Biology and Medicine 43 (1) (2007) 80 –89.http://dx.doi.org/10.1016/j.free- radbiomed.2007.03.036 17561096 .",OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1089/ars.2013.5469 24684526 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1152/jappl- physiol.00690.2002 12482769 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
"[32] B. Bauvois, New facets of matrix metalloproteinases MMP-2 and MMP-9 as cell surface transducers: outside-in signaling and relationship to tumor pro- gression, Biochimica et Biophysica Acta 1825 (1) (2012) 29 –36.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1074/jbc.272.11.7482 9054450 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1210/ en.2010-1166 21385940 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1016/j.bbamem.2006.06.015 16890187 .,OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1083/jcb.200705060 18426979 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1016/j.diff.2011.01.009 21330046 .,OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1091/mbc.8.3.533 9188103 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1074/jbc.M807043200 19193640 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1128/JVI.02561-10 21697493 .,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
http://dx.doi.org/10.1242/jcs.03378 17284520 .C.,Non-OADS,/arxiv_data1/oa_pdf/b3/5c/main.PMC4309845.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
These aldehydes formSchiff's base adducts with primary amine groups present on lysineContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.014 2213-2317/ &2015 Published by Elsevier B.V.,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/ S0006-291X(84)80086-8 6331827 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1126/science.2982211 2982211 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
"Shiue, Reaction rates of superoxide radicals with the essential amino acids, Ciba Foundation Symposium (1978) 43 –56.http://dx.doi.org/ 10.1002/9780470715413.ch4 38953 .",Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1080/09553009214552431 1361508 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1007/s00726-003- 0018-8 14661092 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/ 10.1016/j.freeradbiomed.2004.02.017 15082071 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/S0014-5793 (98)00679-6 9688559 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/ 10.1016/S0098-2997(03)00009-8 12892992 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/j.cbi.2011.02.012 21334317 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/ S0098-2997(02)00017-1 12079771 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1039/ c3an00724c 23833766 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/ 10.1016/j.jchromb.2010.08.004 20732835 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2005.06.023 16257645 .Table 3 Summary of carbonylated proteins identi ﬁed in more than one sample.,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1385/1-59259- 173-6:123 12013759 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1006/bbrc.2000.3014 10873672 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/S0891-5849(97)00104-4 9214571 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1007/s10620-006- 9214-1 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1016/ S0076-6879(02)52038-3 12125369 .,OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/10.1002/ elps.1150060905 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.org/ 10.1021/pr500324y 25010493 .,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/43/11/main.PMC4309846.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
"In hypertensive vessels, VSMCsContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.007 2213-2317/ &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1152/physrev.00041.2003 15269336 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1038/74651 10742145 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2013.08.003 23938401 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/ 10.1038/ncb2152 21258367 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/j.cmet.2011.04.004 21531332 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1042/BJ20121344 23421427 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1371/ journal.pone.0098902 24887307 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1002/ jcp.22709 21374592 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1152/ajpheart.00160.2012 23023870 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
"Yu, et al., Mitochondrial KATP channel involvement in angiotensin II-in- duced autophagy in vascular smooth muscle cells, Basic Research in Cardiol-ogy 109 (4) (2014) 416. http://dx.doi.org/10.1007/s00395-014-0416-y 24847907 .",OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
"Li, et al., Telmisartan-induced PPARgamma activity attenuates lipid ac- cumulation in VSMCs via induction of autophagy, Molecular Biology Reports (2014) , http://dx.doi.org/10.1007/s11033-014-3757-6 25249228 .",OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1159/000356656 24481040 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
"[17] N. Peng, et al., An activator of mTOR inhibits oxLDL-induced autophagy and apoptosis in vascular endothelial cells and restricts atherosclerosis in apoli- poprotein E/C0//C0mice, Scienti ﬁc Reports 4 (5519) (2014) , http://dx.doi.org/ 10.1038/srep05519 .",Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/ 10.1016/j.cmet.2012.01.022 22445600 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.2174/157340208786241336 20559453 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/S1050-1738(97)00133-3 21235913 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1042/BJ20071063 18052926 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
"Hill, Oxidized lipids activate autophagy in a JNK-dependent manner by stimulating the endoplasmic reticulum stress response, Redox Biology 1 (1) (2013) 56 –64.http://dx.doi.org/10.1016/j.redox.2012.10.003 24024137 .",Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1194/jlr.M005702 20484746 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1038/ bjp.2008.181 18469840 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1161/CIRCRESAHA.108.186064 19168440 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1161/CIRCRESAHA.107.152736 17704209 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/j.cardiores.2005.01.006 15914125 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1161/CIRCRESAHA.111.300483 23446737 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1038/cddis.2009.8 21364612 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/j.bbadis.2011.06.010 21749920 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/S0047-6374 (02)00008-8 12044962 .,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1007/s12012-013-9200-8 23408289 .,Non-OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
http://dx.doi.org/10.1016/j.yjmcc.2011.06.010 21723289 .J.K.,OADS,/arxiv_data1/oa_pdf/20/47/main.PMC4309847.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
We recently showedContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.11.010 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: 8-oxodG, 8-oxo-7,8-dihydro-2'-deoxyguanosine; 8-oxoGuo, 8- oxo-7,8-dihydroguanosine; DCGP, Diabetes Care in General Practice; UPLC, Ultra- performance liquid chromatography nCorresponding author at: Laboratory of Clinical Pharmacology Q7642, Rig- shospitalet, Copenhagen, Denmark.",Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/ 10.2337/dc10-0666 20587728 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1093/aje/ kwh161 15191933 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1677/ ERC-09-0087 19620249 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1002/ijc.24600 19623658 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
"Chen, Urinary 8-hydroxy-2 ′-deox- yguanosine (8-OHdG) and genetic polymorphisms in breast cancer patients, Mutation Research 631 (1) (2007) 62 –68.http://dx.doi.org/10.1016/j.mrgen- tox.2007.04.009 17512776 .",OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1016/S0014-5793(97) 00523-1 9202163 .,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1158/1055-9965.EPI- 07-2717 18349269 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1097/01.ju.0000116617.32728.ca 15017214 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1016/0959-8049(94)00490-0 7646926 .,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1016/j.mrrev.2003.11.001 15341901 .,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.2337/ dc11-1620 21994431 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/ 10.1136/bmj.323.7319.970 11679387 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2009.06.002 19501155 .,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
(2011) 42 –45.http://dx.doi.org/10.1177/ 1403494810393562 21775350 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1093/carcin/bgi313 16364924 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1158/1055-9965.EPI- 13-0229 23658396 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1038/nat- ure05978 17581577 .,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1089/ars.2012.5036 23216312 .,Non-OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2008.07.004 18692130 .,OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
"Kim, M. Yamada, Modulation of oxidative mutagenesis and carcinogenesis by polymorphic forms of human DNA repair enzymes, Muta- tion Research 591 (1 –2) (2005) 60 –73.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/2e/7c/main.PMC4309851.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
"The tumor suppressor protein p53 is a transcription factor that regulates the response to a variety of stimuli such as DNAdamage, hypoxia, oxidative stress, and oncogene expression [9].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.11.011 2213-2317/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).Abbreviations: Cox, cyclooxygenase; EMSAs, electrophoretic movility shift assays; GAPDH, glyceraldehyde-3-phosphate dehydrogenase; HNE, 4-hydroxy-2-nonenal;MAPK, mitogen-activated protein kinase; RIPA, radioimmunoprecipitation assay; RT-PCR, reverse transcription-polymerase chain reaction; TTBS, tween 20/tris buf- fered saline *Correspondence to: Laboratory of Food and Biodynamics, Graduate School of Bioagricultural Sciences, Nagoya University, Nagoya 464-8601, Japan.",Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
Supplementary data The supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.redox.2014.11.011 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.271.52.33157 8969167 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.273.48.32312 9822711 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.274.1.264 9867839 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1074/jbc.274.16.10911 10196169 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/S0092-8674(00)81871-1 9039259 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
"[10] R. Hansen, M. Oren, p53; from inductive signal to cellular effect, Current Opinion in Genetics & Development 7 (1) (1997) 46 –51.http://dx.doi.org/ 10.1016/S0959-437X(97)80108-6 9024633 .",OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
"Stark, The p53 network, Journal of Biological Chemistry 273 (1) (1998) 1 –4.http://dx.doi.org/ 10.1074/jbc.273.1.1 9417035 .",OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/ jbc.274.51.36031 10593882 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/ 0092-8674(93)90500-P 8242752 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1016/0092-8674(95)90412-3 7834749 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1006/bbrc.2000.2967 10873624 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1006/abbi.2001.2601 11795877 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
(1999) 33 –37.http://dx.doi.org/ 10.1038/4462 9915498 .HNE p38   p53/Sp1 p53 Cox-2  Proteasome  Fig.,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/ jbc.M009630200 11278531 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1210/ endo.139.3.5832 9492043 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/ jbc.M101167200 11375983 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/ jbc.M011643200 11278953 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/ S0002-9440(10)65230-3 10514410 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1002/ hep.510260317 9303495 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1172/JCI116998 8113389 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1074/jbc.272.9.5952 9038215 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1074/jbc.274.8.5038 9988750 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/S0360-3016(00)00671-4 10974444 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
"[54] K. Müller-Decker, K. Scholz, F. Marks, G. Fürstenberger, Differential expression of prostaglandin H synthase isozymes during multistage carcinogenesis in mouse epidermis, Molecular Carcinogenesis 12 (1) (1995) 31 –41.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.3892/ijo.10.3.503 21533404 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1073/pnas.89.24.12028 1465435 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1038/363281a0 8387645 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1371/ journal.pone.0062832 23650532 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.M003894200 10825178 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/ 10.1371/journal.pone.0041742 22911849 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1038/sj.onc.1205181 11850850 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.M109745200 11923280 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/ S0304-419X(00)00006-8 10722929 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/0092-8674(95)90127-2 8521479 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/S0092-8674(02)09420-5 9630216 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1074/jbc.274.48.34141 10567385 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1046/j.1365-2443.1998.00207.,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1002/ana.10483 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1016/S0002-9343(00)00547-7 11063960 .,OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
http://dx.doi.org/10.1021/bi035215a 14636064 .,Non-OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
"[80] M. Aki, T. Tamura, F. Tokunaga, S. Iwanaga, Y. Kawamura, N. Shimbara, S. Kagawa, K. Tanaka, A. Ichihara, cDNA cloning of rat proteasome subunit RC1, a homologue of RING10 located in the human MHC class II region, FEBS Letters 301 (1) (1992) 65 –68.http://dx.doi.org/10.1016/0014-5793(92)80211-X 1451788 .",OADS,/arxiv_data1/oa_pdf/e9/a8/main.PMC4309852.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
"HNE can be found in meat products, or in ﬁsh in concentration reaching 5 mg/kg in case of prolonged storage [3,4]and in PUFA forti ﬁed infant formula andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.016 2213-2317/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: a.m.u, atomic mass unit; DHN, 1,4-dihydroxy-2-nonene; DHN-MA, 1,4-dihydroxy-2-nonane mercapturic acid; dpm, desintegration per minute; HNA,4-hydroxy-2-nonenoic acid; HNA-MA, 4-hydroxy-2-nonanoic mercapturic acid;HNE, 4-hydroxynon-2-enal; 3HNE, [4-3H]-4-hydroxynon-2-enal;12C-HNE, 4-hy- droxynon-2-enal;13C-HNE, [1,2-13C2]-4-hydroxynon-2-enal; HPLC –HRMS, High Pressure Liquid Chomatography –High Resolution Mass Spectrometry; MS/MS, tandem mass spectrometry nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1007/s11746- 002-0598-z .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/ 10.1007/s11746-004-1031-3 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/ 10.1271/bbb.70.815 16636446 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1080/ 02652030701422465 17852396 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1179/135100007X162257 17263907 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1126/science.4012327 4012327 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/ 10.1016/S0009-2797(01)00259-9 11566294 .,OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/ 10.1080/15287394.2011.567952 21541880 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
"[11] J. Alary, F. Bravais, J.P. Cravedi, L. Debrauwer, D. Rao, G. Bories, Mercapturic acid conjugates as urinary end metabolites of the lipid peroxidation product 4-hydroxy-2-nonenal in the rat, Chemical Research in Toxicology 8 (1) (1995) 34–39.http://dx.doi.org/10.1021/tx00043a004 7703364 .",Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1021/tx980068g 9815199 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
"[16] I. Jouanin, V. Sreevani, E. Rathahao, F. Guéraud, A. Paris, Synthesis of the lipid peroxidation product 4-hydroxy-2(E)-nonenal with13C stable isotope in- corporation, Journal of Labelled Compounds and Radiopharmaceuticals 51 (2)(2008) 87 –92.http://dx.doi.org/10.1002/jlcr.1485 .",Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1021/tx2003036 21967605 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/ 10.1016/S0378-4274(99)00301-X 10713486 .J.,OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1074/jbc.M114.602458 25274632 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1007/s00726- 009-0445-2 20020161 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1016/0006-2952(80)90029-5 7437088 .,OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1074/jbc.M105487200 11524419 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1158/1055-9965.EPI-06-0085 17119057 .,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
"[34] G. Peiro, J. Alary, J.-P. Cravedi, E. Rathahao, J.-P. Steghens, F. Guéraud, Dihy- droxynonene mercapturic acid, a urinary metabolite of 4-hydroxynonenal, as a biomarker of lipid peroxidation, Biofactors (Oxford England) 24 (1 –4) (2005) 89–96.http://dx.doi.org/10.1002/biof.5520240110 16403967 .",Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
http://dx.doi.org/10.1093/carcin/bgl127 16885197 .J.,Non-OADS,/arxiv_data1/oa_pdf/f3/7d/main.PMC4309853.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
The nucleus is one of the most prominent cellular organelles and it is continuously exposed to ROS derived from numerousContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.009 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: BSA, bovine serum albumin; CoCl 2, cobalt chloride; FA, fatty acids; hnRNPs, heterogeneous nuclear ribonucleoproteins; H2AX, histone 2AX; HHE, hy-droxy-hexenal; HNE, hydroxy-nonenal; LPP, lipid peroxidation products; MCL,Markov cluster algorithm; MS, mass-spectroscopy; NAFLD, non-alcoholic fatty liverdisease; NASH, nonalcoholic steatohepatitis; OHE, oxo-hexenal; ONE, oxo-nonenal;PPAR α, peroxisome proliferator-activated receptor α; PGC-1 α, peroxisome-pro- liferator-activated receptor- γcoactivator 1 α; PUFA, poly unsaturated fatty acids; ROS, reactive oxygen species; VEGF, vascular endothelial growth factor nCorresponding author.",Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
Supplementary material The Supplementary data associated with this article can be found online version at http://dx.doi.org/10.1016/j.redox.2014.12.,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1089/ars.2011.3897 21254858 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1146/annurev.pharm- tox.46.120604.141122 16402904 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1089/ars.2009.2609 19737086 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"Strand, K. Schef ﬂer, M. Bjørås, L. Eide, The distribution of DNA damage is deﬁned by region-speci ﬁc susceptibility to DNA damage formation rather than repair differences, DNA Repair 18 (2014) 44 –51.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1242/jcs.037333 19420234 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1002/bies.20720 18293361 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/ 10.1016/j.cbi.2006.11.004 17188672 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"Baker, L. A. Balart, S. Dash, Free fatty acids induce ER stress and block antiviral activityof interferon alpha against hepatitis C virus in cell culture, Virology Journal 9 (2012) 143. http://dx.doi.org/10.1186/1743-422X-9-143 22863531 .",Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2012.02.014 22343340 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"[14] T. Mosmann, Rapid colorimetric assay for cellular growth and survival: ap- plication to proliferation and cytotoxicity assays, Journal of ImmunologicalMethods 65 (1 –2) (1983) 55 –63.http://dx.doi.org/10.1016/0022-1759(83) 90303-4 6606682 .",Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1016/S1385-299X(00)00021-0 10906491 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1128/MCB.01337-08 19188445 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1021/ac302356z 23186270 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1194/jlr.,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1093/nar/28.18.3442 10982861 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1007/s10620-014-3031-8 24464211 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/ 10.1021/tx300002q 22502949 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1016/j.ajpath.2012.08.004 22982442 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/ 10.1016/j.bbalip.2009.04.004 19393338 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1021/tx700347w 18232660 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1016/j.free- radbiomed.2006.09.012 17157187 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1039/ c0pp00369g 21448498 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1038/labinvest.2011.55 21464822 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/ 10.1111/apt.12046 22966992 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/ 10.3748/wjg.14.4120 18636654 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"[32] S. Yang, C. Xia, S. Li, L. Du, L. Zhang, R. Zhou, Defective mitophagy driven by dysregulation of rheb and KIF5B contributes to mitochondrial reactive oxygen species (ROS)-induced nod-like receptor 3 (NLRP3) dependent proin-ﬂammatory response and aggravates lipotoxicity, Redox Biology 3 (2014) 63–71.http://dx.doi.org/10.1016/j.redox.2014.04.001 25462067 .",Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"[33] M. Marmunti, M. Gavazza, A. Catalá, Non-enzymatic and enzymatic lipidperoxidation of microsomes and nuclei obtained from rat liver, Molecular and Cellular Biochemistry 265 (1 –2) (2004) 1 –9.http://dx.doi.org/10.1023/B: MCBI.0000044302.59193.00 15543928 .",OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1074/jbc.M113.467662 23733185 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1021/bi200029w 21438592 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
"Vaca, M. Harms-Ringdahl, Interaction of lipid peroxidation products with nuclear macromolecules, Biochimica et Biophysica Acta 1001 (1) (1989) 35–43.http://dx.doi.org/10.1016/0005-2760(89)90304-4 2912492 .",OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1016/0005-2760(95)00162-6 7488640 .,OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1021/ pr500324y 25010493 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1021/ja503604t 25099620 .,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
http://dx.doi.org/10.1242/jcs.019042 20519579 .S.,Non-OADS,/arxiv_data1/oa_pdf/62/7c/main.PMC4309854.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
"The neutral sphingomyelinase 2 (nSMase2), encoded by the smpd3 gene, is a redox-sensitive [6] enzyme that plays a key role in ceramide generation uponContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.004 2213-2317/ &2014 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: nSMase2, neutral sphingomyelinase type 2; HAS2, hyaluronan synthase 2; HA, hyaluronan; LDL, low density lipoprotein nCorresponding author at: INSERM, UMR1048, BP 84225, 31432 Toulouse Cedex 4, France.",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
FEBSLetters 531 (1) (2002) 47 –53.http://dx.doi.org/10.1016/S0014-5793(02)03489-0 12401201 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1021/bi061307z 16981685 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1084/ jem.181.6.1949 7759991 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1242/jcs.00153 12415011 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1007/978-1-4020-8831-5_18 18751923 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1038/381800a0 8657285 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1074/jbc.272.26.16281 9195931 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1371/journal.pone.0009826 20352118 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/ 10.1016/j.bbalip.2013.04.014 23651497 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
"Nikolova-Karakashian, Neutral sphingomyeli- nase-2 is a redox sensitive enzyme: role of catalytic cysteine residues in regulationof enzymatic activity through changes in oligomeric state, Biochemical Journal (2014) , http://dx.doi.org/10.1042/BJ20140665 25287744 .",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
"mediates monoamine oxidase A-associated cardiac cell apoptosis, Circulation Re- search 100 (1) (2007) 41 –49.http://dx.doi.org/10.1161/01.",Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/ 10.2353/ajpath.2007.061285 17591962 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1165/rcmb.2009- 0422OC 20448054 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1158/1535-7163.MCT-11-0705 22452947 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1002/bdrc.20057 16425255 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/ 10.2174/187152011797655131 21707487 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.4161/auto.25560 23846383 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1038/nrm3735 24401948 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/ 10.4161/auto.5.4.8390 19337026 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1042/BST0370253 19143642 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1074/jbc.M112371200 11864979 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1074/jbc.273.42.27389 9765267 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1161/01.,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1016/j.tox.2008.07.048 18694801 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1084/jem.20132451 25049335 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/ 10.1016/j.jhep.2014.06.009 24946279 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1007/s00109- 014-1134-5 24584950 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1038/ eye.2012.89 22595911 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1016/j.ejps.2008.04.006 18534829 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1016/j.placenta.2013.05.009 23806178 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
"Rugolo, A. Calatroni, Differential effect of molecular mass hyaluronan on lipopolysaccharide-induceddamage in chondrocytes, Innate Immunity 16 (1) (2010) 48 –63.http://dx.doi.org/ 10.1177/1753425909340419 19710088 .",OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.3233/BME-2012-0713 22785367 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/ 10.1016/S1043-6618(03)00050-1 12676512 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1038/35019501 10934466 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1679/ aohc.61.125 9650887 .,Non-OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
http://dx.doi.org/10.1016/8756-3282(91) 90070-Y 1793673 .,OADS,/arxiv_data1/oa_pdf/e6/a1/main.PMC4309855.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
The nomenclature is based on evolutionary relation- ships between CYP450 enzymes and not on similarity in substrate proﬁles because of the overlapping substrate pro ﬁles of many CYPContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.11.008 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
The human genome project has identi ﬁed 57 human genes coding for the various P450 enzymes ( http://drnelson.utmem.edu/Cyto chromeP450.html )O R( http://drnelson.uthsc.edu/human.P450.ta ble.html ).,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
[53] and in http://www.imm.ki.se/ CYPalleles/ .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/j.redox.2013.01.014 24024158 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0003-9861 (58)90436-3 13534720 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1038/nprot.2009.121 19661994 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1126/sci- ence.147.3656.400 14221486 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.3109/03602538308991409 6413186 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"[13] J.B. Schenkman, I. Jansson, Spectral analyses of cytochromes P450, Methods in Molecular Biology 320 (2006) 11 –18.http://dx.doi.org/10.1385/1-59259- 998-2:11 16719370 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/ 10.1007/s00216-008-2244-0 18622598 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0006-2952(87)90645-9 3663241 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0006-291X(67)90104- 0 4383050 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.3109/ 03602539308993979 8404461 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.3109/ 03602538909103580 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1002/hep.23267 19821517 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"[30] D. Mansuy, The great diversity of reactions catalyzed by cytochromes P450, Comparative Biochemistry and Physiology Part C: Pharmacology, Toxicology and Endocrinology 121 (1998) 5 –14.http://dx.doi.org/10.1016/S0742-8413 (98)10026-9 9972447 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/j.copbio.2007.09.010 18006294 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"Guengerich, Cytochrome p450 and chemical toxicology, Chemical Re- search in Toxicology 21 (1) (2008) 70 –83.http://dx.doi.org/10.1021/ tx700079z 18052394 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/ 10.1074/jbc.R112.431916 23632021 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1208/ aapsj080112 16584116 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1021/tx0002583 11409933 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.3109/ 03602539009041082 2272285 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1111/j.1432-1033.1982.tb06820.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.3109/ 00498259109039456 1848383 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1146/annurev.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1124/mol.110.064246 20430864 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1124/mol.112.084616 23530090 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0003-9861(85) 90822-7 4004255 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0006-2952(89)90338-9 2495801 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"MacDonald, Chemical mechanisms of catalysis by cyto- chromes P-450: a uni ﬁed view, Accounts of Chemical Research 17 (1) (1984) 9–16.http://dx.doi.org/10.1021/ar00097a002 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1038/clpt.2013.220 24196843 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"The role of the CYP family of enzymes, Mutation Research 482 (1 – 2) (2001) 11 –19.http://dx.doi.org/10.1016/S0027-5107(01) 00205-6 11535244 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"[59] M. Ingelman-Sundberg, Genetic polymorphisms of cytochrome P450 2D6 (CYP2D6): clinical consequences, evolutionary aspects and functional di-versity, Pharmacogenomics Journal 5 (1) (2005) 6 –13.http://dx.doi.org/ 10.1038/sj.tpj.6500285 15492763 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1210/mend-1-8-542 3153476 .A.I.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"Waxman, P450 gene induction by structurally diverse xenochemicals: central role of nuclear receptors CAR, PXR, and PPAR, Archives of Biochem- istry and Biophysics 369 (1) (1999) 11 –23.http://dx.doi.org/10.1006/ abbi.1999.1351 10462436 .",OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1007/s00204- 008-0332-8 18618097 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0163-7258(88) 90022-8 3289052 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1038/clpt.1990.164 2121408 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0006- 2952(58)90024-8 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/0163-7258 (90)90096-K 2181495 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1080/ 004982599238704 10199591 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1124/dmd.32.5.512 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"Lindros, Centrilobular expression of ethanol-inducible cytochrome P-450 (IIE1) in rat liver, Biochemical and Biophysical Research Communications 157 (1) (1988) 55–60.http://dx.doi.org/10.1016/S0006-291X(88)80010-X 2904264 .",OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/ 10.1007/s00204-009-0432-0 19448996 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1006/abbi.1993.1053 8380968 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1006/abbi.1993.1054 8380969 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1002/hep.22222 18393316 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1074/ jbc.271.20.12063 8662637 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1124/dmd.104.002402 15576447 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"[88] M. Ingelman-Sundberg, S.C. Sim, Pharmacogenetic biomarkers as tools for improved drug therapy; emphasis on the cytochrome P450 system, Bio- chemical and Biophysical Research Communications 396 (1) (2010) 90 – 94. http://dx.doi.org/10.1016/j.bbrc.2010.02.162 20494117 .",OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1371/ journal.pone.0082562 24340040 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.2217/ 14622416.9.9.1331 18781859 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"Rossier, The AmpliChipCYP450 test: cytochrome P450 2D6 genotype assessment and phenotype prediction, Pharmacogenomics Journal 9 (2009) 34 –41.http://dx.doi.org/10.1038/ tpj.2008.7 18591960 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
"Guengerich, Mechanisms of drug toxicity and relevance to pharmaceu- tical development, Drug Metabolism and Pharmacokinetics 26 (1) (2011) 3–14.http://dx.doi.org/10.2133/dmpk.DMPK-10-RV-062 20978361 .",Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.1124/ pr.110.003525 21737533 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/ 10.1016/j.abb.2007.04.033 17537393 .,OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
http://dx.doi.org/10.2174/ 15680266113136660158 24047135 .,Non-OADS,/arxiv_data1/oa_pdf/bd/37/main.PMC4309856.pdf
This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"Fourth, a portion of mitochondria can bud off andContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.11.006 2213-2317/ &2014 The Authors.",OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"This is an open access article under the CC BY-NC-SA license ( http://creativecommons.org/licenses/by-nc-sa/3.0/ ).Abbreviations: APAP, acetaminophen; Bag4, Bcl2-associated athanogene 4; Bcl2L1, Bcl-2 like 1; BNIP3, Bcl-2/adenovirus E1B 19 kDa protein-interacting protein 3; CCCP,m-chloro phenyl hydrazine; Clec16a, C-type lectin domain family 16, member A; Drp1,dynamin-related protein 1; Fis1, mitochondrial ﬁssion 1; FUNDC1, Fun14 domain containing 1; Hif-1, hypoxia-inducing factor 1; HSPA1L, heat shock 70 kDa protein1-like; LC3, microtubule-associated protein 1 light-chain 3; LIR, LC3-interacting region;MEFs, mouse embryonic ﬁbroblasts; Mff, mitochondria ﬁssion factor; Mfn1, mitofusin 1; Mfn2, mitofusin 2; MDV, mitochondria-derived vesicles; MID49, mitochondrial dynamics protein of 49 kDa; Miro, mitochondrial Rho GTPase; MUL1, mitochondrialubiquitin ligase 1; Nrdp1, neuregulin receptor degradation protein 1; OPA1, opticatrophy 1; PARL, presenilin-associatedrh omboid-like; PGAM5, phosphoglycerate mutase family member 5; PINK1, PTEN-induc ed putative kinase 1; ROS, reactive oxy- gen species; Smurf1, Smad-speci ﬁc E3 ubiquitin protein ligase 1; SQSTM1, sequesto- some 1; SNPH, syntaphilin; TOMM7, translocase of outer mitochondrial membrane 7;TOMM20, translocase of outer mitochondrial membrane 20; UBA, ubiquitin-associated; Usp30, ubiquitin-speci ﬁc peptidase 30; VDAC, voltage-dependent anion channel nCorrespondence to: Department of Pharmacology, Toxicology and Therapeutics, University of Kansas Medical Center, MS 1018 3901 Rainbow Blvd., Kansas City,Kansas 66160, USA.",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.ceb.2011.05.007 21705204 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[4] A.M. Van der Bliek, Q. Shen, S. Kawajiri, Mechanisms of mitochondrial ﬁssion and fusion, Cold Spring Harbor Perspectives in Biology 5 (6) (2013) a011072.http://dx.doi.org/10.1101/cshperspect.a011072 23732471 .",OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1371/journal.pone.0052830 23300790 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1074/jbc.M112.413682 23095748 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.4161/auto.24871 24162069 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1515/hsz-2012-0119 22944659 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"Narendra, Mechanisms of mitophagy, Nature Reviews Molecular Cell Biology 12 (1) (2011) 9 –14.http://dx.doi.org/10.1038/nrm3028 21179058 .",OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.cell.2006.06.021 16839884 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/sj.emboj.7601184 16778770 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1091/mbc.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.200704112 17709430 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.200906084 20038678 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.200906083 20038677 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1128/MCB.01483-13 24344202 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/nrm3013 21102612 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.201007152 21149567 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/embor.2011.54 21508961 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1091/mbc.E12-10-0721 23283981 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1126/science.1207385 21885730 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1074/jbc.M607279200 17301055 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/sj.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.cell.2011.11.030 22265414 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/ cddis.2014.18 24577084 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[30] M. Karbowski, A. Neutzner, R.J. Youle, The mitochondrial E3 ubiquitin ligase March5 is required for Drp1 dependent mitochondrial division, Journal of Cell Biology 178 (1)(2007) 71 –84.http://dx.doi.org/10.1083/jcb.200611064 17606867 .",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/sj.embor.7400790 16936636 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.cub.2004.02.004 14972687 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/nrm3877 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1523/JNEUROSCI.6248-09.2010 20335458 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.201302040 23857772 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[37] G. Pekkurnaz, et al., Glucose regulates mitochondrial motility via Milton modi ﬁcation by O-GlcNAc transferase, Cell 158 (1) (2014) 54 –68.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[38] S. Liu, et al., Parkinson's disease-associated kinase PINK1 regulates miro pro- tein level and axonal transport of mitochondria, PLOS Genetics 8 (3) (2012) , http://dx.doi.org/10.1371/journal.pgen.1002537 22396657 .",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.200809125 19029340 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1073/ pnas.0602493103 16818890 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/33416 9560156 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1083/jcb.201008084 21115803 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.bbrc.2008.10.104 18957282 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1093/ hmg/ddp501 19880420 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[49] F. Koyano, et al., Ubiquitin is phosphorylated by PINK1 to activate Parkin, Nature 510 (7503) (2014) 162 – 166. http://dx.doi.org/10.1038/nature13392 24784582 .",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/nature12748 24270810 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1242/jcs.147520 24928900 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1242/jcs.146035 24906799 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1093/hmg/ddr048 21296869 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1093/hmg/ddq419 20871098 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/ncb2012 20098416 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/nature13418 24896179 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1074/jbc.M110.119537 20573959 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1371/journal.pone.0020975 21687634 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1177/1535370213489446 23856904 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.4161/auto.6.8.13426 20890124 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1073/pnas.1405752111 25294927 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1523/JNEUROSCI.1917-11.2011 21753002 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1074/jbc.M112.411363 23152496 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[72] J. Yun, et al., MUL1 acts in parallel to the PINK1/parkin pathway in regulating mitofusin and compensates for loss of PINK1/parkin, Elife 3 (2014) e01958.http://dx.doi.org/10.7554/eLife.01958 24898855 .",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1074/jbc.M800102200 18281291 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1128/MCB.00166-09 19273585 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/nat- ure07006 18454133 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/ncb2422 22267086 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.molcel.2014.02.034 24746696 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.4161/auto.29568 25126723 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[80] I. Novak, et al., Nix is a selective autophagy receptor for mitochondrial clear- ance, EMBO Reports 11 (1) (2010) 45 –51.http://dx.doi.org/10.1038/em- bor.2009.256 20010802 .",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"Phoon, M. Schlame, Metabolism and function of mitochondrial cardiolipin, Progress in Lipid Research 55 (2014) 1 –16.http://dx.doi.org/ 10.1016/j.plipres.2014.04.001 .",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1038/ncb2837 24036476 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/ 10.1038/nature10546 22020285 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.cmet.2012.10.005 23140641 .,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[85] F. Strappazzon, et al., AMBRA1 is able to induce mitophagy via LC3 binding, regardless of Parkin and p62/SQSTM1, Cell Death and Differentiation (2014) , http://dx.doi.org/10.1038/cdd.2014.139 25215947 (Epub ahead of print).",Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
"[87] H. Abeliovich, et al., Involvement of mitochondrial dynamics in the segrega- tion of mitochondrial matrix proteins during stationary phase mitophagy, Nature Communications 4 (2013) 2789. http://dx.doi.org/10.1038/ ncomms3789 24240771 .",OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1002/embj.201385902 .,Non-OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
http://dx.doi.org/10.1016/j.redox.2013.08.005 .H.-M. Ni et al.,OADS,/arxiv_data1/oa_pdf/71/26/main.PMC4309858.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
Hydrogen peroxide produced in the peroxisomeContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2014.12.006 2213-2317/ &2014 The Authors.,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: APX, ascorbate peroxidase; DHAR, dehydroascorbate reductase; GR, glutathione reductase; Grx, glutaredoxins; GSSG, oxidized glutathione; MAPK,mitogen-activated protein kinase; MDAR, monodehydroascorbate peroxidase; PAS, phagophore assembly site; PexAD, peroxisome-associated protein degradation; RADAR, receptor accumulation and degradation pathway; ROS, reactive oxygenspecies; UPS, ubiquitin-proteasome system.",Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"Kastaniotis, A. Gurvitz, The biochemistry of peroxisomal beta-oxidation in the yeast Sacchar- omyces cerevisiae , FEMS Microbiology Reviews 27 (1) (2003) 35 –64.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1128/EC.00086-13 23709182 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"van der Klei, Peroxisomal quality control mechanisms, Current Opinion in Microbiology 22C (2014) 30 –37.http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"[5] M. Nordgren, M. Fransen, Peroxisomal metabolism and oxidative stress, Biochimie 98 (2014) 56 –62.http://dx.doi.org/10.1016/j.biochi.2013.07.026 23933092 .",OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"Platta, S. Hagen, C. Reidick, R. Erdmann, The peroxisomal receptor dislocation pathway: to the exportomer and beyond, Biochimie 98 (2014) 16 –28.http://dx.doi.",OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1074/jbc.M011661200 11278957 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1042/BJ20040042 14998369 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1016/j.bba- lip.2012.05.004 22659048 .,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1111/1567-1364.12196 25130273 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1074/jbc.M111686200 11875065 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/ 10.1128/EC.00216-06 16936141 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1016/S1360-1385(01)01898-2 11286918 .,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1046/j.0960-7412.2003.001605.x 12943550 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/ 10.1093/pcp/pcn038 18308759 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1105/tpc.109.065979 20215589 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1111/j.1365- 313X.2005.02503.x 16146528 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1105/tpc.107.050989 17951448 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1104/ pp.109.137703 19329564 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1104/pp.111.190223 22186608 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1093/ jxb/ern365 19174456 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/ 10.1016/j.ceb.2009.04.015 19515549 .,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1111/j.1365-313X.2011.04535.x 21309870 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1074/jbc.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2008.07.010 18694816 .,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1083/ jcb.135.1.123 8858168 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1091/mbc.E09-01-0037 19570913 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1038/ncb2027 20154681 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1083/ jcb.200611012 17452527 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1128/ MCB.00388-09 19687296 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1074/jbc.M112.381566 22733816 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1093/pcp/pcu017 24492254 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1073/ pnas.0811329106 19246395 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1534/genetics.112.146100 23150599 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.4161/auto.24543 23614977 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.4161/auto.27852 24451165 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1083/jcb.200909154 20385774 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1083/jcb.201102092 21576396 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1016/j.devcel.2007.12.011 18331717 .,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/ 10.1083/jcb.201307050 24535825 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1038/emboj.2012.151 22643220 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1091/mbc.E06-06-0554 17079731 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1016/j.yexcr.2008.09.015 18848543 .,OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"Yamashita, Y. Fujiki, Peroxin Pex14p is the key component for coordinated autophagic degradation of mammalian peroxisomes by directbinding to LC3-II, Genes to Cells (2014) , http://dx.doi.org/10.1111/gtc.12198 25358256 .",OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1038/embor.2013.40 23559066 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1083/jcb.201402128 25287303 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1105/tpc.113.113407 24179123 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1007/s00418-009-0564-6 19229553 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
http://dx.doi.org/10.1105/ tpc.113.117960 24368791 .,Non-OADS,/arxiv_data1/oa_pdf/7b/c6/main.PMC4309859.pdf
"The concept of oxidative stress was updated to include the role ofredox signaling [7], and there were efforts of rede ﬁning oxidative stress [8,9].Contents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/redoxRedox Biology http://dx.doi.org/10.1016/j.redox.2015.01.002 2213-2317/ &2015 Published by Elsevier B.V. E-mail address: sies@uni-duesseldorf.deRedox Biology 4 (2015) 180 –183",Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1002/ange.19860981203 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1515/hsz-2012-0111 22944698 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1089/ars.2006.8.1865 16987039 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1152/ ajpcell.00283.2008 18684987 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
"Davies, F. Kelly, Free radical biology —terminology and critical thinking, FEBS Letters 558 (1 –3) (2004) 3 –6.http://dx.doi.org/10.1016/S0014- 5793(03)01526-6 14982062 .",Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1016/j.freeradbiomed.2014.03.025 24681256 .,OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1111/j.1432-1033.1993.tb18025.x 7688300 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
"[15] H. Selye, A syndrome produced by diverse nocuous agents, Nature 138 (3479) (1936) 32. http://dx.doi.org/10.1038/138032a0 .",Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1038/nri3423 23618831 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1146/annurev.me.02.020151.001551 14847556 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1074/jbc.R113.464131 23861437 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/ 10.1007/978-1-61779-885-6_24 22665313 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1016/j.bbapap.2014.03.007 24657586 .,OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1038/nrm2256 17848967 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1006/ bbrc.1997.6943 9240432 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1073/ pnas.1401712111 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1074/jbc.R114.619304 .,Non-OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1016/j.molcel.2014.08.017 25242142 .,OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1016/S0140-6736(13)62365-X 24581668 .,OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
"[34] N. Kaludercic, S. Deshwal, F. Di Lisa, Reactive oxygen species and redox com- partmentalization, Frontiers in Physiology 5 (2014) 285. http://dx.doi.org/ 10.3389/fphys.2014.00285 [Pubmed: 25161621 ].",OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
http://dx.doi.org/10.1016/j.bbabio.2014.02.005 24530357 .,OADS,/arxiv_data1/oa_pdf/b3/d2/main.PMC4309861.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):1-6 http://dx.doi.org/10.3341/kjo.2015.29.1.1 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Original ArticleDacryoscintigraphic Findings in the Children with Tearing Hyung Chul Kim1, A Ran Cho2, Helen Lew1 1Department of Ophthalmology, Bundang CHA Hospital, CHA University, Seongnam, Korea 2Seoul St. Mary’s Eye Hospital, Suwon, Korea Purpose:  To investigate the diagnostic effectiveness of dacryoscintigraphy in children with tearing; to evaluate  tear clearance rate as a diagnostic factor of dacryoscintigraphy in children with tearing; and to analyze the re - sults of treatment according to dacryoscintigraphic findings in children with tearing.",Non-OADS,/arxiv_data1/oa_pdf/fe/b9/kjo-29-1.PMC4309863.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):14-22 http://dx.doi.org/10.3341/kjo.2015.29.1.14 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.14 Original ArticleTransient Corneal Edema is a Predictive Factor for Pseudophakic  Cystoid Macular Edema after Uncomplicated Cataract Surgery Jae Rock Do1, Jong-Hyun Oh1, Roy S. Chuck2, Choul Yong Park1 1Department of Ophthalmology, Dongguk University Ilsan Hospital, Goyang, Korea 2Department of Ophthalmology and Visual Sciences, Montefiore Medical Center, Albert Einstein College of Medicine, Bronx, NY, USA Purpose:  To report transient corneal edema after phacoemulsification as a predictive factor for the development  of pseudophakic cystoid macular edema (PCME).",Non-OADS,/arxiv_data1/oa_pdf/0d/f0/kjo-29-14.PMC4309864.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):23-30 http://dx.doi.org/10.3341/kjo.2015.29.1.23 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.23 Original ArticleStructural Analysis of Different Incision Sizes and Stromal Hydration  in Cataract Surgery Using Anterior Segment Optical Coherence  Tomography Jong-Wook Bang, Jong-Hyun Lee, Jin-Hyoung Kim, Do-Hyung Lee Department of Ophthalmology, Ilsan Paik Hospital, Inje University College of Medicine, Goyang, Korea Purpose:  To analyze healing changes of corneal wounds of different corneal incision sizes with or without stro - mal hydration in cataract surgery using anterior segment optical coherence tomography.",Non-OADS,/arxiv_data1/oa_pdf/59/f0/kjo-29-23.PMC4309865.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):31-39 http://dx.doi.org/10.3341/kjo.2015.29.1.31 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.31 Original ArticleDetecting the Progression of Normal Tension Glaucoma: A  Comparison of Perimetry, Optic Coherence Tomography, and  Heidelberg Retinal Tomography Jae-Yoon Yoon1,2, Jong Kyung Na2, Chan Kee Park2 1Department of Ophthalmology, Saevit Eye Hospital, Goyang, Korea 2Department of Ophthalmology and Visual Science, Seoul St. Mary’s Hospital, The Catholic University of Korea College of Medicine,  Seoul, Korea Purpose:  We compared the abilities of Stratus optical coherence tomography (OCT), Heidelberg retinal tomog - raphy (HRT) and standard automated perimetry (SAP) to detect the progression of normal tension glaucoma  (NTG) in patients whose eyes displayed localized retinal nerve fiber layer (RNFL) defect enlargements.",Non-OADS,/arxiv_data1/oa_pdf/fd/6f/kjo-29-31.PMC4309866.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):40-46 http://dx.doi.org/10.3341/kjo.2015.29.1.40 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.40 Original ArticleComparison of Clinical Characteristics and Progression Rates of  Bilaterally and Unilaterally Progressing Glaucoma Daun Jeong, Kyung Rim Sung, Jung Hwa Na Department of Ophthalmology, Asan Medical Center, University of Ulsan College of Medicine, Seoul, Korea Purpose:  To compare the clinical characteristics of unilaterally progressing glaucoma (UPG) and simultaneously  bilaterally progressing glaucoma (BPG) in medically treated cases.",Non-OADS,/arxiv_data1/oa_pdf/75/65/kjo-29-40.PMC4309867.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):47-52 http://dx.doi.org/10.3341/kjo.2015.29.1.47 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.47 Original ArticleLong-term Results from Cyclocryotherapy Applied to the 3 O’clock  and 9 O’clock Positions in Blind Refractory Glaucoma Patients Byoung Seon Kim1, Young Jun Kim1, Seong Wook Seo1,2, Ji Myong Yoo1,2, Seong Jae Kim1,2 1Department of Ophthalmology, Gyeongsang National University School of Medicine, Jinju, Korea 2Gyeongsang Institute of Health Science, Gyeongsang National University, Jinju, Korea Purpose:  To report the long-term follow-up results after cyclocryotherapy, applied to the 3-o’clock and 9-o’clock  positions in blind refractory glaucoma patients.",Non-OADS,/arxiv_data1/oa_pdf/20/d5/kjo-29-47.PMC4309868.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):53-57 http://dx.doi.org/10.3341/kjo.2015.29.1.53 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.53 Original ArticleEffect of Watching 3-Dimensional Television on Refractive Error in  Children Seung-Hyun Kim1, Young-Woo Suh1, Yong-Min Choi1, Ji-Yoon Han1, Gi-Tae Nam1, Eun-Joo You1, Yoonae A. Cho2 1Department of Ophthalmology, Korea University College of Medicine, Seoul, Korea 2Nune Eye Hospital, Seoul, Korea Purpose:  To investigate the effect of watching 3-dimensional (3D) television (TV) on refractive error in children.",Non-OADS,/arxiv_data1/oa_pdf/4e/0b/kjo-29-53.PMC4309869.pdf
Optom Vis Sci  2009 Jan.  http://dx.doi.org/10.1097/01.opx.0000344146.84135.68.,OADS,/arxiv_data1/oa_pdf/4e/0b/kjo-29-53.PMC4309869.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):58-65 http://dx.doi.org/10.3341/kjo.2015.29.1.58 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.58 Original ArticleThe Neuroprotective Effect of Maltol against Oxidative Stress on Rat  Retinal Neuronal Cells  Yookyung Song, Samin Hong, Yoko Iizuka, Chan Yun Kim, Gong Je Seong Institute of Vision Research, Department of Ophthalmology, Yonsei University College of Medicine, Seoul, Korea Purpose:  Maltol (3-hydroxy-2-methyl-4-pyrone), formed by the thermal degradation of starch, is found in coffee,  caramelized foods, and Korean ginseng root.",Non-OADS,/arxiv_data1/oa_pdf/32/63/kjo-29-58.PMC4309870.pdf
"pISSN: 1011-8942  eISSN: 2092-9382 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.66Case Reports of Lacrimal Sac Tu - mors Discovered in Patients with  Persistent Epiphora Following Da - cryocystorhinostomy Dear Editor, Recently, we experienced two cases of lacrimal sac tu - mors discovered in patients who presented with persistent  epiphora after receiving dacryocystorhynostomy (DCR).",Non-OADS,/arxiv_data1/oa_pdf/91/f8/kjo-29-66.PMC4309871.pdf
The slit Korean J Ophthalmol 2015;29(1):66-67 http://dx.doi.org/10.3341/kjo.2015.29.1.66Correspondence  Fig.,Non-OADS,/arxiv_data1/oa_pdf/91/f8/kjo-29-66.PMC4309871.pdf
"Also, the potential complications of IAC, such as  facial tenderness and swelling that were experienced by our  patient, and other factors that lead to the optimal treatment Korean J Ophthalmol 2015;29(1):68-70 http://dx.doi.org/10.3341/kjo.2015.29.1.68",Non-OADS,/arxiv_data1/oa_pdf/8d/eb/kjo-29-68.PMC4309872.pdf
"Multiple treatment modalities including radiotherapy,  intralesional/oral corticosteroid and intralesional sclerosing  therapy can be adopted in conjunction with surgery [1].Korean J Ophthalmol 2015;29(1):70-72 http://dx.doi.org/10.3341/kjo.2015.29.1.70",Non-OADS,/arxiv_data1/oa_pdf/8d/eb/kjo-29-68.PMC4309872.pdf
"pISSN: 1011-8942  eISSN: 2092-9382Korean J Ophthalmol 2015;29(1):7-13 http://dx.doi.org/10.3341/kjo.2015.29.1.7 © 2015 The Korean Ophthalmological Society This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses  /by-nc/3.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.7 Original ArticleRisk Factors for Fluoroquinolone Resistance in Ocular Cultures Junsung Lee, Sangkyung Choi Department of Ophthalmology, Veterans Health Service Medical Center, Seoul, Korea Purpose:  To identify the risk factors associated with fluoroquinolone resistance in patients undergoing cataract  surgery.",Non-OADS,/arxiv_data1/oa_pdf/9b/f7/kjo-29-7.PMC4309873.pdf
"Multiple treatment modalities including radiotherapy,  intralesional/oral corticosteroid and intralesional sclerosing  therapy can be adopted in conjunction with surgery [1].Korean J Ophthalmol 2015;29(1):70-72 http://dx.doi.org/10.3341/kjo.2015.29.1.70",Non-OADS,/arxiv_data1/oa_pdf/5a/09/kjo-29-70.PMC4309874.pdf
"Unlike in previous reports, in the present case, AM was Korean J Ophthalmol 2015;29(1):73-74 http://dx.doi.org/10.3341/kjo.2015.29.1.73 Fig.",Non-OADS,/arxiv_data1/oa_pdf/e5/50/kjo-29-73.PMC4309875.pdf
Ophthalmic Surg Lasers Im - aging  2010 Mar 9. http://dx.doi.org/10.3928/15428877- 20100210-17.,Non-OADS,/arxiv_data1/oa_pdf/e5/50/kjo-29-73.PMC4309875.pdf
"Case 1, a 22-year-old male patient was referred to an out -Korean J Ophthalmol 2015;29(1):74-76 http://dx.doi.org/10.3341/kjo.2015.29.1.74",Non-OADS,/arxiv_data1/oa_pdf/e5/50/kjo-29-73.PMC4309875.pdf
Ophthalmic Surg Lasers Im - aging  2010 Mar 9. http://dx.doi.org/10.3928/15428877- 20100210-17.,Non-OADS,/arxiv_data1/oa_pdf/49/bf/kjo-29-74.PMC4309876.pdf
"Case 1, a 22-year-old male patient was referred to an out -Korean J Ophthalmol 2015;29(1):74-76 http://dx.doi.org/10.3341/kjo.2015.29.1.74",Non-OADS,/arxiv_data1/oa_pdf/49/bf/kjo-29-74.PMC4309876.pdf
"It is predicted to be damaging as shown in Sorting In - tolerant from Tolerant analysis (SIFT, http://sift.jcvi.org).",Non-OADS,/arxiv_data1/oa_pdf/62/09/kjo-29-77.PMC4309877.pdf
They were  prescribed a beta-blocker to prevent further enlargement Korean J Ophthalmol 2015;29(1):77-78 http://dx.doi.org/10.3341/kjo.2015.29.1.77 Fig.,Non-OADS,/arxiv_data1/oa_pdf/62/09/kjo-29-77.PMC4309877.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
"Tumor cells stably ex- pressing E1A are sensitive to NK mediated killing in vitro and in vivo , in part through the upregulation of NKG2D ligands [7].I nContents lists available at ScienceDirect journal homepage: www.elsevier.com/locate/rinimResults in Immunology http://dx.doi.org/10.1016/j.rinim.2015.01.001 2211-2839/ &2015 The Authors.",Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).Abbreviations: E1A, early region 1 A; Ad, adenovirus; NKG2D, natural killer group 2 D; MCA, methylcholanthrene; OVA, ovalbumin; NK, natural killer; WT, wildtype; RAE-1, retinoic acid early inducible; B6, C57BL/6; TPD 50, tumor producing dose 50 nCorrespondence to: Medical College of Wisconsin, 9000 W. Wisconsin Avenue, Milwaukee, WI 53226-4874, USA.",Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Immunity 2002;17(1):19 –29.http://dx.doi.org/10.1016/S1074-7613(02)00333-3 .,OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Science 1999;285(5428):730 –2.http://dx.doi.org/10.1126/ science.285.5428.730 .10426994 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Immunity 2000;12(6):721 –7.http://dx.doi.org/10.1016/S1074-7613(00)80222-8 .,OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Nature Immunology 2001;2(3):255 –60.http://dx.doi.org/ 10.1038/85321 .11224526 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Nature 2005;436(7054):1186 – 90.http://dx.doi.org/10.1038/nature03884 .15995699 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Nature Immunology 2000;1(2):119 –26.http://dx.doi.org/10.1038/77793 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Journal of Experimental Medicine 2005;202(11):1477 –82.http://dx.doi.org/ 10.1084/jem.20050240 .16314433 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Science 1999;285(5428):727 –9.http://dx.doi.org/ 10.1126/science.285.5428.727 .10426993 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
PLOS One 2010;5(9) .http://dx.doi.org/10.1371/journal.pone.0012635 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Virology 2000;277(1):48 –57.http://dx.doi.org/10.1006/ viro.2000.0571 .11062035 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
http://dx.doi.org/10.1016/j.immuni.2008.02.016 .18394936 .,OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
http://dx.doi.org/10.1371/journal.pone.0091370 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Nature Immunology 2013;14(11):1127 –36.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Blood 2007;109(4):1568 –73.http://dx.doi.org/10.1182/ blood-2006-06-031856 .17023580 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Proceedings of the National Academy of Sciences of the United States of America 1986;83(18):6965 –9.http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Journal of Immunology 2003;170(8):4119 –26.http://dx.doi.org/ 10.4049/jimmunol.170.8.4119 .12682242 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
Journal of Immunology 2000;165(8):4522 –7.http://dx.doi.org/ 10.4049/jimmunol.165.8.4522 .11035092 .,Non-OADS,/arxiv_data1/oa_pdf/ae/8b/main.PMC4309920.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1016/j.nicl.2014.12.013 2213-1582/Published by Elsevier Inc.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
Inline Supplementary Table S1 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
S1 can be found on- line at http://dx.doi.org/10.1016/j.nicl.2014.12.013 .,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
S2 can be found online at http://dx.doi.org/10.1016/j.nicl.2014.12.013 .,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
S3 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
S3 can be found online at http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
Supplementary data Supplementary data associated with this article can be found in the online version at http://dx.doi.org/10.1016/j.nicl.2014.12.013 .,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1146/annurev.psych.60.110707.16351418771388 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1523/JNEUROSCI.3340-04.200415496656 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.2307/2346101 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1093/brain/awf189 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1038/mp.2013.7823774715 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1126/science.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
"Neuroimage 49 (1), 44 –56.http://dx.doi.org/10.1016/j.neuroimage.2009.08.024 .",OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1016/j.cub.2007.05.06817714666 .,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
"7, 356. http://dx.doi.org/ 10.3389/fnhum.2013.0035623874279 .",Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1093/brain/aws16022791801 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
"The Elements of Statistical Learning: Data Min- ing, Inference and Prediction 763. http://dx.doi.org/10.1007/978-0-387-84858-7 .",Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.7156/najms.,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
2013. http://dx.doi.org/10.1155/2013/93515424415902 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1016/j.neubiorev.2012.02.00722353426 .,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1093/brain/awl16416835247 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
"Challenging the use of adult neuropsychological models for explaining neurodevelopmental disorders: developed versus developing brainsQ JExp Psychol (Hove) 66 (1), 1 –14.http://dx.doi.org/10.1080/17470218.2012.",Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1002/aur.162 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1093/brain/ awp30620008375 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/ 10.1023/A:1005592401947 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/ 10.1007/BF021721457814313 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
"7 (September), 599. http://dx.doi.org/ 10.3389/fnhum.2013.0059924093016 .",Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1016/j.neuron.2011.09.,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1016/j.neuroimage.2013.,OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/ 10.1093/cercor/bhr16221725037 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1093/brain/awq27920926367 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
http://dx.doi.org/10.1111/jpc.1209223350819 .,Non-OADS,/arxiv_data1/oa_pdf/fa/77/main.PMC4309950.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.008 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
Supplementary data related to this article can be found online at http://doi.dx.org/10.1016/j.nicl.2015.01.008 .,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"Neuroimage 47 (2), 618 –627.http://dx.doi.org/10.1016/ j.neuroimage.2009.04.05719398016 .",OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"NeuroImage 14 (3), 595 –606.http://dx.doi.org/10.1006/nimg.2001.086211506533 .",Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.06.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.3233/ JAD-13036224037033 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"Imaging 37 (1), 76 –84.http://dx.doi.org/10.1002/jmri.2379022972747 .",Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"Imaging 13 (2), 70 –81.http://dx.doi.org/10.1007/ BF0316837110843252 .",Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"Neuroimage 65, 511–521.http://dx.doi.org/10.1016/j.neuroimage.2012.09.05823036450 .",OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.neuroimage.2010.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.03.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1002/ana.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1212/WNL.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1109/TITB.2006.87419117390989 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"NeuroImage 6 (1), 13 –25.http://dx.doi.org/10.1006/nimg.",OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.neuroimage.2004.09.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/ 10.1093/brain/awn23918835868 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1093/brain/awm31918202106 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1001/archneurol.2009.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"73 (1), 1–23.http://dx.doi.org/10.1016/j.ijmedinf.2003.11.02415036075 .",OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.neuroimage.2008.07.00918692144 .,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/S0895-6111(96)00013- 48954228 .,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"Available from: https://http://www.rsna.org/RadLex.aspx .Radiological Society of North America, Medical Image Research Center, 2014b.",Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
Available from: https ://http://www.rsna.org/MIRC.aspx .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"11 (1), 58 –69.http://dx.doi.org/ 10.1109/TITB.2006.88436417249404 .",Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.mri.2004.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/ 10.1016/S0895-6111(96)00014-68954229 .,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1109/ TMI.2004.83080315338732 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/ 10.1109/TMI.2002.80311112575879 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
"14 (4), 897 –903.http://dx.doi.org/ 10.1109/TITB.2009.203815220064763 .",Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1109/TMI.2005.85392317427733 .,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1371/journal.pone.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1002/hbm.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1109/TMI.,Non-OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
http://dx.doi.org/10.1016/j.neuroimage.,OADS,/arxiv_data1/oa_pdf/69/38/main.PMC4309952.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/fb/22/srep08119.PMC4309953.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8119 | DOI: 10.1038/srep08119 5",Non-OADS,/arxiv_data1/oa_pdf/fb/22/srep08119.PMC4309953.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/31/97/srep08116.PMC4309955.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8099 | DOI: 10.1038/srep08099 6",Non-OADS,/arxiv_data1/oa_pdf/4b/21/srep08099.PMC4309965.pdf
"Using a commercial Maxwell equations solver, CST microwave studio (https://www.cst.com/Products/CSTMWS), we simulated thepropagation of half-sine packets in the ADM.",Non-OADS,/arxiv_data1/oa_pdf/a9/de/srep08100.PMC4309966.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/42/b4/srep08122.PMC4309967.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/12/9a/srep07939.PMC4309968.pdf
Available at: http://www.ipcc.ch/pdf/supporting-material/expert-meeting-2005- 01.pdf.,Non-OADS,/arxiv_data1/oa_pdf/2f/d2/srep08118.PMC4309972.pdf
(2013) Avaiable at: http://www.unep.org/pdf/UNEPN2Oreport.,Non-OADS,/arxiv_data1/oa_pdf/2f/d2/srep08118.PMC4309972.pdf
Additional information Supplementary information accompanies this paper at http://www.nature.com/ scientificreports Competing financial interests: The authors declare no competing financial interests.,Non-OADS,/arxiv_data1/oa_pdf/2f/d2/srep08118.PMC4309972.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-nd/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8118 | DOI: 10.1038/srep08118 9",Non-OADS,/arxiv_data1/oa_pdf/2f/d2/srep08118.PMC4309972.pdf
"To view a copy of this license, visit http://creativecommons.org/licenses/by-nc-sa/4.0/ www.nature.com/ scientificreports SCIENTIFIC REPORTS | 5 : 8120 | DOI: 10.1038/srep08120 7",Non-OADS,/arxiv_data1/oa_pdf/e7/7d/srep08120.PMC4309975.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.or g/licenses/by-nc/3.0/), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c4/94/euu122.PMC4309991.pdf
"Computational methods and data analysis All the simulations in this paper have been conducted using the soft- ware CHASTE (Cancer Heart and Soft Tissue Environment).23,24 Details of models and numerical methods are as described in the sup- plementary material in Zemzemi et al.15Simulations were run in the Bordeaux federative platform for research in computer sciences and mathematics called PLAFRIM (https://plafrim.bordeaux.inria.fr/).",OADS,/arxiv_data1/oa_pdf/c4/94/euu122.PMC4309991.pdf
2009. http://tel.archives-ouvertes.fr/ tel-00470375/en/ 21.,Non-OADS,/arxiv_data1/oa_pdf/c4/94/euu122.PMC4309991.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.08.001 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/72/db/main.PMC4310008.pdf
"Production and hosting by Elsevier B.V. All rights reserved.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes &Diseases (2014) 1, 132e139",Non-OADS,/arxiv_data1/oa_pdf/72/db/main.PMC4310008.pdf
2014. http://dx.doi.org/10.1136/gutjnl-2014-307436 .,Non-OADS,/arxiv_data1/oa_pdf/72/db/main.PMC4310008.pdf
http://dx.doi.org/10.1016/j.bonr.2014.10.003 2352-1872/© 2014 Elsevier Inc. All rights reserved.,Non-OADS,/arxiv_data1/oa_pdf/5d/69/main.PMC4310009.pdf
"http://dx.doi.org/10.1016/j.gendis.2014.07.002 2352-3042/Copyright ª2014, Chongqing Medical University.",Non-OADS,/arxiv_data1/oa_pdf/20/59/main.PMC4310010.pdf
"Production and hosting by Elsevier B.V. All rights reserved.HOSTED BY Available online at www.sciencedirect.com ScienceDirect journal homepage: http://ees.elsevier.com/gendis/default.asp Genes & Diseases (2014) 1,7 5e86",Non-OADS,/arxiv_data1/oa_pdf/20/59/main.PMC4310010.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non- Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/42/04/atr-03-04-23083.PMC4310015.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/aa/01/atr-03-04-22551.PMC4310016.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-Non - Commercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial  usages, provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/e7/23/atr-03-04-18178.PMC4310017.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/5b/df/hepatmon-14-12-22915.PMC4310018.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/f4/60/hepatmon-14-12-25105.PMC4310019.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International  License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original  work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3c/e9/hepatmon-14-12-23552.PMC4310020.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comNeurosurgery Concepts Neurosurgery concepts: Key perspectives on dendritic cell  vaccines, metastatic tumor treatment, and radiosurgery Gordon Li, Jonathan H. Sherman1, Jin Mo Cho2, Michael Lim3, Alexander A. Khalessi4, Chaim B. Colen5,  Chae Y ong Kim6, Vincent Yat Wang7, Gabriel Zada8, Zachary A. Smith9, Isaac Yang10 Departments of Neurosurgery, Stanford School of Medicine, 1George Washington University, Washington DC, USA, 2Ajou University School of Medicine, Gyeonggi- do, South Korea, 3Johns Hopkins School of Medicine, Maryland, 4University of California San Diego, CA, 5Beaumont Hospital, Grosse Pointe, MI, USA, 6Seoul  National University College of Medicine, Seoul, South Korea, 7University of California San Francisco, CA, 8Keck School of Medicine at University of Southern  California, CA, 9Northwestern Feinberg School of Medicine, IL, 10David Geffen School of Medicine at University of California Los Angeles, CA, US E-mail:  Gordon Li - gordonli@stanford.edu; Jonathan H. Sherman - jsherman0620@gmail.com; Jin Mo Cho - chojinmo@gmail.com;   Michael Lim - mlim3@jhmi.edu; Alexander A. Khalessi - akhalessi@ucsd.edu; Chaim B. Colen - chaim.colen@gmail.com;   Chae Yong Kim - chaeyong.kim@gmail.com; Vincent Yat Wang - wangv@neurosurg.ucsf.edu; Gabriel Zada - gzada@usc.edu;   Zachary A. Smith - zsmithmd@gmail.com; *Isaac Yang - iyang@mednet.ucla.edu   *Corresponding Author Received: 30 June 14  Accepted: 02 July 14  Published: 14 January 15 Abstract Background:  This is a laboratory study to investigate the effect of adding  brain‑derived‑neurotrophic factor (BDNF) in a poly ( N‑isopropylacrylamide‑ g‑poly  (ethylene glycol) scaffold and its effect on spinal cord injury in a rat model.",Non-OADS,/arxiv_data1/oa_pdf/5b/ab/SNI-6-6.PMC4310042.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/6/149389 Copyright: © 2015 Li G.  This is an open‑access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution,  and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/5b/ab/SNI-6-6.PMC4310042.pdf
"Surgical Neurology International 2015, 6:6  http://www.surgicalneurologyint.com/content/6/1/6Phase 1 Trial of a Multiepitope‑pulsed Dendritic Cell  Vaccine for Patients with Newly Diagnosed Glioblastoma.",Non-OADS,/arxiv_data1/oa_pdf/5b/ab/SNI-6-6.PMC4310042.pdf
"Surgical Neurology International 2015, 6:6  http://www.surgicalneurologyint.com/content/6/1/6provides additional support in a growing body of literature  supporting the use of this regimen outside major cancer  centers such as MSKCC.",Non-OADS,/arxiv_data1/oa_pdf/5b/ab/SNI-6-6.PMC4310042.pdf
"Surgical Neurology International 2015, 6:6  http://www.surgicalneurologyint.com/content/6/1/6surgical stabilization following T ype‑II dens fractures in  the geriatric population.",Non-OADS,/arxiv_data1/oa_pdf/5b/ab/SNI-6-6.PMC4310042.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article A modified anterior temporal approach for low‑position  aneurysms of the upper basilar complex Makoto Katsuno, Rokuya Tanikawa1, Naoto Izumi, Masaaki Hashimoto Departments of Neurosurgery, Abashiri Neurosurgical and Rehabilitation Hospital, Abashiri, 1T eishinkai Hospital, Sapporo, Hokkaido, Japan E‑mail: *Makoto Katsuno ‑ mkatsuno@nms.ac.jp; Rokuya Tanikawa ‑ taniroku@gmail.com; Naoto Izumi ‑ aman.izumi@gmail.com;   Masaaki Hashimoto ‑ juandiego634@gmail.com   *Corresponding author Received: 11 August 14  Accepted: 17 September 14  Published: 22 January 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.149843  Quick Response Code: Abstract Background:  Although surgery for aneurysms of the upper basilar complex is  generally accomplished by a pterional or subtemporal approach, both techniques  have disadvantages.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/10/149843 Copyright: © 2015 Katsuno M.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Surgical Neurology International 2015, 6:10  http://www.surgicalneurologyint.com/content/6/1/10some disadvantages.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Surgical Neurology International 2015, 6:10  http://www.surgicalneurologyint.com/content/6/1/10Sylvian vein and drains into the sinus and peeled off the  arachnoid membrane or skull base dura [Figure 3].",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Surgical Neurology International 2015, 6:10  http://www.surgicalneurologyint.com/content/6/1/10us to observe the upper basilar complex, including not  only the contralateral P1 and SCA but also the posterior  thalamoperforating branches.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Surgical Neurology International 2015, 6:10  http://www.surgicalneurologyint.com/content/6/1/10anterior temporal bridging veins, risking venous infarction  and predisposing patients to retractor injury.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Surgical Neurology International 2015, 6:10  http://www.surgicalneurologyint.com/content/6/1/1030% to 75%,[1,5,11,15] where the incidence of oculomotor  nerve palsy, particularly in patients who undergo posterior  clinoidectomy, remains unknown.",Non-OADS,/arxiv_data1/oa_pdf/f5/ca/SNI-6-10.PMC4310043.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Posterior fossa giant tumefactive perivascular spaces: 8-year  follow-up in an adolescent Byron C. Branch, Bundhit Tantiwongkosi1, Wilson Altmeyer1, Viktor Bartanusz Departments of Neurosurgery and 1Radiology, University of T exas Health Science Center, San Antonio, T exas, USA E‑mail: *Byron C. Branch ‑ branch@uthscsa.edu;   Bundhit Tantiwongkosi ‑ tantiwongkos@uthscsa.edu; Wilson Altmeyer ‑ altmeyer@uthscsa.edu;   Viktor Bartanusz ‑ bartanusz@uthscsa.edu   *Corresponding author Received: 27 August 14  Accepted: 28 October 14  Published: 05 January 15 Abstract Background:  Cystic masses in the posterior fossa are ominous appearing lesions  with broad differential diagnosis.",Non-OADS,/arxiv_data1/oa_pdf/55/4c/SNI-6-2.PMC4310044.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/2/148547 Copyright: © 2015 Branch BC.,Non-OADS,/arxiv_data1/oa_pdf/55/4c/SNI-6-2.PMC4310044.pdf
"Surgical Neurology International 2015, 6:2  http://www.surgicalneurologyint.com/content/6/1/2however, much of the etiology and natural history remains  elusive.",Non-OADS,/arxiv_data1/oa_pdf/55/4c/SNI-6-2.PMC4310044.pdf
"Surgical Neurology International 2015, 6:2  http://www.surgicalneurologyint.com/content/6/1/2less commonly within the cerebellar white matter, as they  are thought to develop from the perivascular spaces of the  perforating arteries in these areas.",Non-OADS,/arxiv_data1/oa_pdf/55/4c/SNI-6-2.PMC4310044.pdf
"Surgical Neurology International 2015, 6:2  http://www.surgicalneurologyint.com/content/6/1/2As our knowledge of GTPS increases, it is becoming  evident that while these lesions can appear quite ominous,  they hold a relatively benign prognosis.",Non-OADS,/arxiv_data1/oa_pdf/55/4c/SNI-6-2.PMC4310044.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article A clinical scale to communicate surgical urgency for traumatic  brain injury: A  preliminary study Eric A. Sribnick, John J. Hanfelt1, Sanjay S. Dhall2 Department of Neurosurgery, Emory University, 1365 Clifton Road NE, Building B Suite 2200, 1Department of Biostatistics and Bioinformatics, Emory University,  Rollins School of Public Health, 1518 Clifton Road NE Atlanta, GA 30322, 2Department of Neurosurgical Surgery, University of California at San Francisco,  505 Parnassus Ave., Room 779 M San Francisco, CA 94143‑0112 E‑mail: *Eric A. Sribnick ‑ esribni@emory.edu; John J. Hanfelt ‑ jhanfel@emory.edu; Sanjay S. Dhall ‑ DhallS@neurosurg.ucsf.edu   *Corresponding Author Received: 27 April 14  Accepted: 11 August 14  Published: 05 January 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.148541  Quick Response Code: Abstract Background:  While the Glasgow Coma Scale (GCS) provides a tool for evaluating  traumatic brain injury (TBI) patients, there is no widely used scale that provides  guidance for surgical management.",Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/1/148541 Copyright: © 2015 Sribnick EA.,Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
"Surgical Neurology International 2015, 6:1  http://www.surgicalneurologyint.com/content/6/1/1proof of time and further prospective proper evaluation  and will change and develop over time.",Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
Neuroscience in  press; http://dx.doi.org/10.10.1016.j.neuroscience.,OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
"Surgical Neurology International 2015, 6:1  http://www.surgicalneurologyint.com/content/6/1/1INTRODUCTION Traumatic brain injury (TBI) remains a major health  concern in the United States with an estimated  1.36 million emergency room visits, 275,000 hospital  admissions, and 52,000 deaths.",Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
"Surgical Neurology International 2015, 6:1  http://www.surgicalneurologyint.com/content/6/1/1evaluation, her history indicated that she was intoxicated  and had a fall from the roof of a moving car.",Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
"Surgical Neurology International 2015, 6:1  http://www.surgicalneurologyint.com/content/6/1/1head CT , while patients in the operative group had  7.4 mm of midline shift (P < 0.001).",Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
"Surgical Neurology International 2015, 6:1  http://www.surgicalneurologyint.com/content/6/1/1scale may ultimately provide a similar benefit by more  quickly alerting neurosurgeons of the patients who will  likely need emergent craniotomy.",Non-OADS,/arxiv_data1/oa_pdf/ea/3b/SNI-6-1.PMC4310045.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Characteristics of the stroke alert process in a general Hospital Mark M. Stecker, Kathleen Michel, Karin Antaky, Adam Wolin, Feliks Koyfman Department of Neuroscience, Winthrop University Hospital, Mineola, NY 11501, USA E‑mail: *Mark Stecker ‑ mmstecker@gmail.com; Kathleen Michel ‑ kmichel@winthrop.org; Karin Antaky ‑ kantaky@winthrop.org;   Adam Wolin ‑ awolin96@gmail.com; Feliks Koyfman ‑ fkoyfman@winthrop.org   *Corresponding author Received: 18 April 14  Accepted: 23 September 14  Published: 14 January 15 Abstract Background:  The organized stroke alert is critical in quickly evaluating and treating  patients with acute stroke.",Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/5/149387 Copyright: © 2015 Stecker MM.,Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
"Surgical Neurology International 2015, 6:5  http://www.surgicalneurologyint.com/content/6/1/5with improved outcomes.",Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
"Surgical Neurology International 2015, 6:5  http://www.surgicalneurologyint.com/content/6/1/5alcohol abuse, dyslipidemia, family history of stroke,  hypertension, heart failure, obesity, previous stroke,  previous transient ischemic attack (TIA), prosthetic heart  valve, peripheral vascular disease, renal failure, smoking,  weakness, altered mental status, aphasia, and deep vein  thrombosis (DVT).",Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
"Surgical Neurology International 2015, 6:5  http://www.surgicalneurologyint.com/content/6/1/5stroke alert was computed.",Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
"Surgical Neurology International 2015, 6:5  http://www.surgicalneurologyint.com/content/6/1/5specificity of the initial diagnosis of stroke causes any  problems in the care of these patients.",Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
"Surgical Neurology International 2015, 6:5  http://www.surgicalneurologyint.com/content/6/1/512.",Non-OADS,/arxiv_data1/oa_pdf/6a/1e/SNI-6-5.PMC4310046.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comLetter to the Editor Binswanger disease may benefit from omental arteries Harry S. Goldsmith University of California, Davis Clinical Professor of Neurological Surgery P .O.",Non-OADS,/arxiv_data1/oa_pdf/42/61/SNI-6-4.PMC4310055.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/4/148848 Copyright: © 2015 Goldsmith HS.,Non-OADS,/arxiv_data1/oa_pdf/42/61/SNI-6-4.PMC4310055.pdf
"Surgical Neurology International 2015, 6:4  http://www.surgicalneurologyint.com/content/6/1/4of arteriosclerosis.",Non-OADS,/arxiv_data1/oa_pdf/42/61/SNI-6-4.PMC4310055.pdf
"Surgical Neurology International 2015, 6:4  http://www.surgicalneurologyint.com/content/6/1/47.",Non-OADS,/arxiv_data1/oa_pdf/42/61/SNI-6-4.PMC4310055.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article A proposed grading system for endovascular treatment of  cerebral  arteriovenous malformations: Buffalo score Travis M. Dumont1,5,7, Peter Kan1,5,8, Kenneth V .",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/3/148847 Copyright: © 2015 Dumont TM.,Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3INTRODUCTION The arteriovenous malformation (AVM) grading system  introduced by Spetzler and Martin in 1986[9] has proven  to be useful in guiding treatment of cerebral AVMs with  craniotomy.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3(E).",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3liquid embolic agent of choice; however, we frequently  employ n‑butyl cyanoacrylate (NBCA) in cases where  the microcatheter is not delivered into an ideally distal  position proximal to the AVM nidus, as we have had  superior penetration of the AVM nidus with NBCA in this  setting.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3Table 2: Details of the test cases Case Age  (years),  genderPres.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3Table 2: Contd.... Case Age  (years),  genderPres.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3patients, a total of 13 complications were encountered, of  which 4 were major and 9 were minor [Table 2].RESULTS In the test group, independent variables found to be  correlated with complications included number of  pedicles ( P = 0.01), eloquent location ( P = 0.04),  and small pedicle diameter ( P = 0.05) [Table 3].",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3percent or more obliteration was obtained in all but  eight cases.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology International 2015, 6:3  http://www.surgicalneurologyint.com/content/6/1/3Complete Conference Management, Cordis, Memorial Health  Care System, and SCAI.",Non-OADS,/arxiv_data1/oa_pdf/3c/5c/SNI-6-3.PMC4310056.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Vacuum‑assisted closure of necrotic and infected cranial wound  with loss of dura mater: A  technical note Osama Ahmed, Christopher M. Storey, Shihao Zhang, Marjorie R. Chelly1, Melvin S. Yeoh2,   Anil Nanda Departments of Neurosurgery, 1Orthopedic Surgery/Plastic and Hand Surgery, 2Oral and Maxillofacial Surgery/Head and Neck Surgery, Louisiana State University  Health Sciences Center, Shreveport, LA, USA E‑mail: *Osama Ahmed ‑ oahmed@lsuhsc.edu; Christopher M. Storey ‑ cstore@lsuhsc.edu; Shihao Zhang ‑ szhang@lsuhsc.edu;   Marjorie R. Chelly ‑ mchell@lsuhsc.edu; Melvin S. Yeoh ‑ myeoh@lsuhsc.edu; Anil Nanda ‑ ananda@lsuhsc.edu   *Corresponding author Received: 11 September 14  Accepted: 27 October 14  Published: 22 January 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.149846  Quick Response Code: Abstract Background: Complex cranial wounds can be a problematic occurrence for  surgeons.",Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/11/149846 Copyright: © 2015 Ahmed O.,Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
"Surgical Neurology International 2015, 6:11  http://www.surgicalneurologyint.com/content/6/1/11reconstruction, and what to reconstruct are all taken into  consideration.",Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
"Surgical Neurology International 2015, 6:11  http://www.surgicalneurologyint.com/content/6/1/11 Figure 1: This picture shows the patient after the subdural  hematoma and bone flap were removed.",Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
"Surgical Neurology International 2015, 6:11  http://www.surgicalneurologyint.com/content/6/1/11neurosurgery, plastic surgery, and oral maxillofacial  surgery.",Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
"Surgical Neurology International 2015, 6:11  http://www.surgicalneurologyint.com/content/6/1/11The first report of a scalp and bony defect with a  coinciding dural defect was described by Powers et al .",Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
"Surgical Neurology International 2015, 6:11  http://www.surgicalneurologyint.com/content/6/1/1123.",Non-OADS,/arxiv_data1/oa_pdf/48/1b/SNI-6-11.PMC4310057.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Fibro‑osseous lesion of the cranium in an adolescent patient Brian Park, Kingsley Abode‑Iyamah1, Siang Liao Lee1, Patricia Kirby2, George El‑Khoury3,   Saul Wilson1 University of Iowa, Carver College of Medicine, 1Departments of Neurosurgery, 2Pathology, 3Radiology, University of Iowa Hospitals and Clinics, Iowa City, IA,  USA E‑mail:  Brian Park ‑ brian‑j‑park@uiowa.edu; *Kingsley Abode‑Iyamah ‑ kingsley‑abode‑iyamah@uiowa.edu; Siang Liao Lee ‑ Banlee.1288@gmail.com;   Patricia Kirby ‑ patricia‑kirby@uiowa.edu; George El‑Khoury ‑ George‑el‑khoury@uiowa.edu; Saul Wilson ‑ saul‑wilson@uiowa.edu   *Corresponding author Received: 25 September 14  Accepted: 18  November 14  Published: 22 January 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.149848  Quick Response Code: Abstract Background:  Fibrous dysplasia, ossifying fibroma, and desmoplastic fibroma are  rare benign calvarial lesions, which can have local aggressive behavior.",Non-OADS,/arxiv_data1/oa_pdf/d4/29/SNI-6-12.PMC4310058.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/12/149848 Copyright: © 2015 Park B.,Non-OADS,/arxiv_data1/oa_pdf/d4/29/SNI-6-12.PMC4310058.pdf
"Surgical Neurology International 2015, 6:12  http://www.surgicalneurologyint.com/content/6/1/12occasional headaches, but had no local tenderness or  other neurological symptoms.",Non-OADS,/arxiv_data1/oa_pdf/d4/29/SNI-6-12.PMC4310058.pdf
"Surgical Neurology International 2015, 6:12  http://www.surgicalneurologyint.com/content/6/1/12orbit, and cranium.",Non-OADS,/arxiv_data1/oa_pdf/d4/29/SNI-6-12.PMC4310058.pdf
"Surgical Neurology International 2015, 6:12  http://www.surgicalneurologyint.com/content/6/1/12with ovoid to spindled nuclei in a variably hyalinized  collagenous matrix [Figure 4a‑d].",Non-OADS,/arxiv_data1/oa_pdf/d4/29/SNI-6-12.PMC4310058.pdf
"Surgical Neurology International 2015, 6:12  http://www.surgicalneurologyint.com/content/6/1/12initial pathology was that of a fibro‑osseous lesion most in  keeping with a DF .",Non-OADS,/arxiv_data1/oa_pdf/d4/29/SNI-6-12.PMC4310058.pdf
Available from: https://expertconsult.inkling.com/store/ book/cronenwett-rutherfords-vascular-surgery-2-volume-set-8th/.,Non-OADS,/arxiv_data1/oa_pdf/71/a0/JRMS-19-1034.PMC4310074.pdf
URL  http://www.jstatsoft.org/v51/i03/.,OADS,/arxiv_data1/oa_pdf/b7/46/JRMS-19-1051.PMC4310078.pdf
Available from: http://www.who.int/mediacentre/ factsheets/fs164/en/.,Non-OADS,/arxiv_data1/oa_pdf/75/4c/JRMS-19-1062.PMC4310080.pdf
Available from:  http://www.timi.org.,Non-OADS,/arxiv_data1/oa_pdf/54/12/JRMS-19-1068.PMC4310081.pdf
Available From: http://healthsocialaccountability.org [Last  accessed on 2010 Dec].,OADS,/arxiv_data1/oa_pdf/61/66/JRMS-19-1111.PMC4310090.pdf
"The comparative analysis between the NOA and OA group samples was carried out using the t-test (p-values) and the Benjamini-Hochberg False Discovery Rate (FDR) correction (adjusted p-values) using SAM (http://www-stat.stanford.edu/ ,tibs/ SAM/).",OADS,/arxiv_data1/oa_pdf/68/34/srep07922.PMC4310093.pdf
GO and KEGG pathway analysis .Gene Ontology (GO) and KEGG pathway analyses were performed using Cytoscape V2.7 (http://cytoscape.org/) with the ClueGo V1.3 plug-in [11].,OADS,/arxiv_data1/oa_pdf/68/34/srep07922.PMC4310093.pdf
"Pearson correlation coefficients between a particular miRNA and itspredicted target mRNAs were computed using R (http://www.R-project.org) to determine whether the expression levels of each miRNA and of its mRNA targets were negatively correlated (correlation ,0 and Fisher P corrected by FDR ,0.05) 19.F o r each miRNA-target found to meet the above-mentioned criteria, we designed a variable theta ( h) to present the strength of the relationship.",OADS,/arxiv_data1/oa_pdf/68/34/srep07922.PMC4310093.pdf
Available from: http://www.auanet.org/ common/pdf/education/clinical‑guidance/Benign‑Prostatic‑Hyperplasia.,Non-OADS,/arxiv_data1/oa_pdf/aa/ed/UA-7-17.PMC4310110.pdf
Available from: http://www.uroweb.org/gls/ pdf/12_Male_LUTS_LR.pdf.,Non-OADS,/arxiv_data1/oa_pdf/aa/ed/UA-7-17.PMC4310110.pdf
"All patients  underwent the minimum preoperative evaluation recommended  by the American Urological Association (AUA) Clinical  Guidelines (http://www.auanet.org), including medical history  and physical examination with digital rectal exam, International  Prostate Symptom Score (I‑PSS) and urinalysis.",Non-OADS,/arxiv_data1/oa_pdf/ae/34/UA-7-36.PMC4310114.pdf
"Available from: http://www.who.int/reproductivehealth/ topics/infertility//978247789/en/index.html.Assessed september 24, 2013.",Non-OADS,/arxiv_data1/oa_pdf/c3/13/UA-7-63.PMC4310120.pdf
Available from: http://www.cdsi.gov.sa/.,Non-OADS,/arxiv_data1/oa_pdf/c3/13/UA-7-63.PMC4310120.pdf
Available from: http://www.medic8.com/news/very‑high‑ incidence‑  of‑infertility‑in‑gulf‑region‑3991/.,Non-OADS,/arxiv_data1/oa_pdf/c3/13/UA-7-63.PMC4310120.pdf
2013 April; 6 (2):art 17. http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/87/41/UA-7-74.PMC4310123.pdf
Available from: http://www.emedicine.medscape.com/article/2036769.,Non-OADS,/arxiv_data1/oa_pdf/3f/aa/UA-7-8.PMC4310125.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Symptomatic foramen of Magendie arachnoid cyst in an elderly  patient Yasuhiko Hayashi, Daisuke Kita, Takuya Watanabe, Akifumi Y oshikawa, Jun‑ichiro Hamada Department of Neurosurgery, Kanazawa University, Kanazawa, Ishikawa, Japan E‑mail: *Yasuhiko Hayashi ‑ yahayashi@med.kanazawa‑u.ac.jp; Daisuke Kita ‑ kitad@med.kanazawa‑u.ac.jp; Takuya Watanabe ‑ twatanabe@ns.m.kanazawa‑u.ac.jp;  Akifumi Yoshikawa ‑ yoshikawa@med.kanazawa‑u.ac.jp; Jun‑ichiro Hamada ‑ jhamada@med.kanazawa‑u.ac.jp   *Corresponding author Received: 01 April 14   Accepted: 21 October 14  Published: 20 January 15 Abstract Background:  Arachnoid cysts (ACs) are congenital anomalies of the central  nervous system and arise in virtually all locations where the arachnoid membrane  exists.",Non-OADS,/arxiv_data1/oa_pdf/65/8a/SNI-6-7.PMC4310131.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/7/149611 Copyright: © 2015 Hayashi Y.,Non-OADS,/arxiv_data1/oa_pdf/65/8a/SNI-6-7.PMC4310131.pdf
"Surgical Neurology International 2015, 6:7  http://www.surgicalneurologyint.com/content/6/1/7We present here the case of an elderly patient with a  symptomatic AC located in the foramen of Magendie  that was successfully treated with surgical intervention.",Non-OADS,/arxiv_data1/oa_pdf/65/8a/SNI-6-7.PMC4310131.pdf
"Surgical Neurology International 2015, 6:7  http://www.surgicalneurologyint.com/content/6/1/7Recurrence of the cyst has not been detected on follow‑up  MRI for 4 years.",Non-OADS,/arxiv_data1/oa_pdf/65/8a/SNI-6-7.PMC4310131.pdf
"Surgical Neurology International 2015, 6:7  http://www.surgicalneurologyint.com/content/6/1/76.",Non-OADS,/arxiv_data1/oa_pdf/65/8a/SNI-6-7.PMC4310131.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comCase Report Rapid aneurysm growth and rupture in systemic lupus  erythematosus Christopher S. Graffeo, Omar Tanweer1, Cesar Fors Nieves2, H. Michael Belmont2, Peter M. Izmirly2,  Tibor Becske3,4, Paul P .",Non-OADS,/arxiv_data1/oa_pdf/1d/6f/SNI-6-9.PMC4310132.pdf
Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/9/149617 Copyright: © 2015 Graffeo CS.,Non-OADS,/arxiv_data1/oa_pdf/1d/6f/SNI-6-9.PMC4310132.pdf
"Surgical Neurology International 2015, 6:9  http://www.surgicalneurologyint.com/content/6/1/9INTRODUCTION Rapid aneurysm growth is reported rarely, and risk  factors for aneurysm growth are an area of active debate,  with considerable disagreement in the neurosurgical  literature.",Non-OADS,/arxiv_data1/oa_pdf/1d/6f/SNI-6-9.PMC4310132.pdf
"Surgical Neurology International 2015, 6:9  http://www.surgicalneurologyint.com/content/6/1/9DISCUSSION SAH is a neurosurgical emergency, and 85% of  nontraumatic SAH is due to aneurysm rupture.",Non-OADS,/arxiv_data1/oa_pdf/1d/6f/SNI-6-9.PMC4310132.pdf
"Surgical Neurology International 2015, 6:9  http://www.surgicalneurologyint.com/content/6/1/9a role for autoimmune damage underlying rupture  pathophysiology in SLE patients.",Non-OADS,/arxiv_data1/oa_pdf/1d/6f/SNI-6-9.PMC4310132.pdf
"Surgical Neurology International 2015, 6:9  http://www.surgicalneurologyint.com/content/6/1/920.",Non-OADS,/arxiv_data1/oa_pdf/1d/6f/SNI-6-9.PMC4310132.pdf
"Surgical Neurology InternationalEditor: James I. Ausman, MD, PhD   University of California, Los  Angeles, CA, USAOPEN ACCESS For entire Editorial Board visit :    http://www.surgicalneurologyint.comOriginal Article Anti-epileptic prophylaxis in traumatic brain injury:  A retrospective analysis of patients undergoing craniotomy  versus decompressive craniectomy Vivek Ramakrishnan, Robert Dahlin, Omid Hariri, Syed A. Quadri, Saman Farr, Dan Miulli,   Javed Siddiqi Department of Neurosurgery, Arrowhead Regional Medical Center, Colton, California, USA  E‑mail:  Vivek Ramakrishnan ‑ vivekandhema@gmail.com; Robert Dahlin ‑ robert.dahlin@nv.touro.edu; Omid Hariri ‑ ohaririucla@gmail.com;   *Syed A. Quadri ‑ dr.saqader@gmail.com; Saman Farr ‑ samanfarr@gmail.com; Dan Miulli ‑ drdmnsx@compuserve.com; Javed Siddiqi ‑ SiddiqiJ@armc.sbcounty.gov   *Corresponding author Received: 18 April 14  Accepted: 23 October 14  Published: 20 January 15 Access this article  online Website: www.surgicalneurologyint.com DOI:   10.4103/2152-7806.149613  Quick Response Code: Abstract Background:  Seizures account for significant morbidity and mortality early in  the course of traumatic brain injury (TBI).",Non-OADS,/arxiv_data1/oa_pdf/7f/6a/SNI-6-8.PMC4310133.pdf
"Available FREE in open access from: http://www.surgicalneurologyint.com/text.asp?2015/6/1/8/149613 Copyright: © 2015 Ramakrishnan V.  This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use,  distribution, and reproduction in any medium, provided the original author and source are credited.",Non-OADS,/arxiv_data1/oa_pdf/7f/6a/SNI-6-8.PMC4310133.pdf
"Surgical Neurology International 2015, 6:8  http://www.surgicalneurologyint.com/content/6/1/8INTRODUCTION Traumatic brain injury (TBI) remains one of the major  causes of death and disability in the industrialized nations  of the world.",Non-OADS,/arxiv_data1/oa_pdf/7f/6a/SNI-6-8.PMC4310133.pdf
"Surgical Neurology International 2015, 6:8  http://www.surgicalneurologyint.com/content/6/1/818 years.",Non-OADS,/arxiv_data1/oa_pdf/7f/6a/SNI-6-8.PMC4310133.pdf
"Surgical Neurology International 2015, 6:8  http://www.surgicalneurologyint.com/content/6/1/8consulted to determine whether to start the patient  on Depakote (Divalproex Sodium), Topamax, or  Phenobarbital.",Non-OADS,/arxiv_data1/oa_pdf/7f/6a/SNI-6-8.PMC4310133.pdf
"Surgical Neurology International 2015, 6:8  http://www.surgicalneurologyint.com/content/6/1/8prophylaxis.",Non-OADS,/arxiv_data1/oa_pdf/7f/6a/SNI-6-8.PMC4310133.pdf
Available at: http://www.clinicaltrial.gov/.,Non-OADS,/arxiv_data1/oa_pdf/3e/82/gcc0054-0091.PMC4310140.pdf
Available from: http://www.iom.int/jahia/webdav/ shared/shared/mainsite/activities/health/PHBLM-SAR-Pub - lic-Report-2010.pdf (accessed: 2014/05).,OADS,/arxiv_data1/oa_pdf/cd/f8/jrm-9-059.PMC4310152.pdf
Avail - able from: http://epp.eurostat.ec.europa.eu/cache/ITY_OFF - PUB/KS-SF-12-031/EN/KS-SF-12-031-EN.PDF (accessed: 2014/05).,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/jrm-9-059.PMC4310152.pdf
Abstract available from:  http://air.unimi.it/handle/2434/70829.,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/jrm-9-059.PMC4310152.pdf
Available from: http://www.hpa.org.uk/webw/HPAweb&HPAwebStandard/ HPAweb_C/1317131996733 (accessed: 2014/05).,Non-OADS,/arxiv_data1/oa_pdf/cd/f8/jrm-9-059.PMC4310152.pdf
Kyouikukatei-jyishicyosa 2003 Available at: http://www.mext.go.jp/b_menu/hakusho/html/hpab200701/001/002/001.htm.,Non-OADS,/arxiv_data1/oa_pdf/d0/a6/jrm-9-051.PMC4310153.pdf
Available  at: http://www.mext.go.jp/b_menu/toukei/chousa04/tairyoku/kekka/k_detail/1298118.htm.,Non-OADS,/arxiv_data1/oa_pdf/d0/a6/jrm-9-051.PMC4310153.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/1f/11/traumamon-19-16054.PMC4310154.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by -nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/06/4c/traumamon-19-16215.PMC4310155.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.Dear Editor, It is well known that the primary function of a tooth  is mastication.",Non-OADS,/arxiv_data1/oa_pdf/02/fb/traumamon-19-17054.PMC4310156.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/10/df/traumamon-19-17092.PMC4310157.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/da/b3/traumamon-19-17403.PMC4310158.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/3f/b5/traumamon-19-17498.PMC4310159.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/6d/99/traumamon-19-17926.PMC4310160.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/8c/48/traumamon-19-18058.PMC4310161.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.1.",Non-OADS,/arxiv_data1/oa_pdf/ae/ea/traumamon-19-18748.PMC4310162.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by -nc/4.0/) which permits copy and redistribute the material just in noncommercial usages,  provided the original work is properly cited.Operation after operation, day after day , without leave  or proper rest, creates a buildup of fatigue and stress.",Non-OADS,/arxiv_data1/oa_pdf/ac/78/traumamon-19-21593.PMC4310163.pdf
Available from: http://en.wikipedia.,Non-OADS,/arxiv_data1/oa_pdf/ac/78/traumamon-19-21593.PMC4310163.pdf
"This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial  4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, pro - vided the original work is properly cited.This corrigendum/addendum supplies corrected statements and proofs of an error by the author.",Non-OADS,/arxiv_data1/oa_pdf/b8/c6/traumamon-19-22699.PMC4310164.pdf
"This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).Keywords: ARMS PCRFMDrs136500299Zebu Introduction Foot and mouth disease (FMD) is one of the highly contagious diseases of domestic animals, caused by foot-and-mouth disease virus (FMDV), a member of the family Picornaviridae, which has a colossal global im- pact, due to the huge number of animals affected.",Non-OADS,/arxiv_data1/oa_pdf/68/74/main.PMC4310182.pdf
http://dx.doi.org/10.1016/j.mgene.2014.12.004 2214-5400/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/68/74/main.PMC4310182.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/ licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/68/74/main.PMC4310182.pdf
Primers were designed according to bovine ITGB6 sequence ( http://probes.pw.usda.gov/cgi-bin/batchprimer3/batchprimer3.cgi ).,Non-OADS,/arxiv_data1/oa_pdf/68/74/main.PMC4310182.pdf
‘BLAST ’program ( http://www.ncbi.nlm.nih.gov/blast ) was used to check the speci ﬁcity of the primers.,OADS,/arxiv_data1/oa_pdf/68/74/main.PMC4310182.pdf
905768 http://dx.doi.org/10.4061/2011/905768 .,Non-OADS,/arxiv_data1/oa_pdf/68/74/main.PMC4310182.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a3/52/jmdh-8-047.PMC4310270.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pJournal of Multidisciplinary Healthcare 2015:8 47–58Journal of Multidisciplinary Healthcare Dove press submit your manuscript | www.dovepress.co m Dove press  47Original researcHopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/JMDH.S7346 9care coordination between specialty care and  primary care: a focus group study of provider  perspectives on strong practices and improvement  opportunities Bo Kim1,2 Michelle a lucatorto3 Kara Hawthorne4 Janis Hersh5 raquel Myers6 a rani elwy1,7 glenn D graham8 1center for Healthcare Organization  and implementation research, edith  nourse rogers Memorial V a Hospital,   Bedford,  2Department of Psychiatry,   Harvard Medical school, Boston,   Ma, 3Office of nursing services,   Department of Veterans affairs,   4chief Business Office, Purchased  care, Washington, Dc , 5new england  Veterans engineering resource  center, Boston, M a, 6sJ Quinney  college of law, University of Utah,   salt lake city, UT,  7Department  of Health Policy and Management,   Boston University school of Public  Health, Boston, M a, 8specialty care  services (10P4 e), Department of  Veterans affairs, Washington, Dc , Usa correspondence: Bo Kim   center for Healthcare Organization   and implementation research,   edith nourse rogers Memorial Va  Hospital,  200 springs road (152),  Bedford, Ma  01730, Usa   Tel +1 781 687 3412  Fax +1 781 687 3106  email bo.kim@va.go vAbstract:  Care coordination between the specialty care provider (SCP) and the primary care  provider (PCP) is a critical component of safe, efficient, and patient-centered care.",Non-OADS,/arxiv_data1/oa_pdf/a3/52/jmdh-8-047.PMC4310270.pdf
"Available from: http://www.ahrq.gov/ professionals/prevention-chronic-care/improve/coordination/atlas2014/ index.htm l. Accessed November 23, 2014.",Non-OADS,/arxiv_data1/oa_pdf/a3/52/jmdh-8-047.PMC4310270.pdf
"Journal of Multidisciplinary Healthcare Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/journal-of-multidisciplinary-healthcare-journa lThe Journal of Multidisciplinary Healthcare is an international, peer- reviewed open-access journal that aims to represent and publish research  in healthcare areas delivered by practitioners of different disciplines.",Non-OADS,/arxiv_data1/oa_pdf/a3/52/jmdh-8-047.PMC4310270.pdf
Visit http://www.dove - press.com/testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a3/52/jmdh-8-047.PMC4310270.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 151–155Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  151Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7558 0Central corneal thickness changes following  manual small incision cataract surgery Olufisayo T emitayo aribaba1 Olusesan adetunji  adenekan1 adeola Olukorede  Onakoya1 adekunle rotimi-samuel1 John Olutola Olatosi2 Kareem Olatunbosun Musa1 akinyele Oyedele Oyefeso1 Folashade Bolanle akinsola1 1guinness eye Centre, lagos  University T eaching hospital,   2Department of anaesthesia, College  of Medicine, University of lagos,   lagos, nigeriaAim:  To determine changes in post-cataract surgery central corneal thickness (CCT) at Lagos  University Teaching Hospital by assessing the time it takes for the cornea to return to its pre - operative thickness value.",Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
"Interest has therefore developed in the assessment Correspondence: Olusesan adetunji  adenekan guinness eye Centre, lagos University  Teaching hospital, idi-araba, surulere,  PMB 12003, lagos, nigeria Tel +234 803 335 0540 email tnelkon@yahoo.co m Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Aribaba et al Running head recto: Central corneal thickness changes following manual SICS DOI: http://dx.doi.org/10.2147/OPTH.S75580",Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
Available  from: http://www.who.int/blindness/causes/priority/en/index1.html .,Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
Available from: http://pbunion.org/ Countriessurveyresults/Nigeria/Nigeria_survey_Summary_report.pdf .,Non-OADS,/arxiv_data1/oa_pdf/72/83/opth-9-151.PMC4310271.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/87/49/opth-9-141.PMC4310274.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 141–149Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  141Original researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S6997 0The use of a virtual reality surgical simulator for  cataract surgical skill assessment with 6 months  of intervening operating room experience shameema sikder1 Jia luo2 P Pat Banerjee2 Cristian luciano2 Patrick Kania2 Jonathan C song1 eman s Kahtani3 Deepak P edward1,3 abdul-elah al T owerki3 1Wilmer eye institute, Johns hopkins  University, Baltimore, MD, Usa;   2College of engineering, University  of illinois at Chicago, Chicago, il, Usa;   3King Khaled eye specialist hospital,   riyadh, saudi arabiaPurpose:  To evaluate a haptic-based simulator, MicroVisTouch™, as an assessment tool  for capsulorhexis performance in cataract surgery.",Non-OADS,/arxiv_data1/oa_pdf/87/49/opth-9-141.PMC4310274.pdf
"Keywords:  medical education, computer simulation, educational assessment, technology  assessment, cataract surgery Introduction Surgical training using simulators has been adopted by many specialties to provide  training in a controlled environment and generate objective assessment of skills to  track progress.1–6 The need for surgical simulators in cataract surgery education is  driven by many forces, including pressure to optimize surgical training with a reduced  work week for trainees.7 The Accreditation Council for Graduate Medical Education  (ACGME) is in the process of mandating milestones that will monitor the development  of surgical competencies in training of residents in surgical specialties, and objective  assessment tools are vitally important in this process.8 The ACGME deems that ophthalmology residents must perform a minimum of  86 cases before they practice as primary cataract surgeons.9 From ACGME published  reports, current ophthalmology residents graduate after performing an average of  150 cases,9 one report states that full surgical maturity is not achieved until the sur - geon has performed between 400 and 1,000 cases.10 This finding suggests that freshly Correspondence: shameema sikder Wilmer eye institute, 7315 Wisconsin  avenue, suite 610-W, Bethesda,   MD 20814, Usa Tel +1 240 482 1100 Fax +1 240 482 1105 email ssikder1@jhmi.ed u Journal name: Clinical Ophthalmology Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Sikder et al Running head recto: Haptic-based simulator for assessment of cataract surgical skill DOI: http://dx.doi.org/10.2147/OPTH.S69970",Non-OADS,/arxiv_data1/oa_pdf/87/49/opth-9-141.PMC4310274.pdf
Available from: http://www.acgme.org/ acgmeweb/Portals/0/PDFs/Milestones/OphthalmologyMilestones.pdf.,Non-OADS,/arxiv_data1/oa_pdf/87/49/opth-9-141.PMC4310274.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/87/49/opth-9-141.PMC4310274.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/87/49/opth-9-141.PMC4310274.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/80/29/opth-9-157.PMC4310279.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Ophthalmology 2015:9 157–167Clinical Ophthalmology Dove press submit your manuscript | www.dovepress.co m Dove press  157Case seriesopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/OPTH.S7295 5T opical difluprednate for the treatment  of Harada’s disease Correspondence: ron P Gallemore retina Macula institute, 4201 Torrance  Boulevard, Torrance, Ca, Usa Tel +1 310 944 9393 Fax +1 310 944 3393 email rongallemoremd@gmail.co m spencer M Onishi Masumi G asahi Calvin Chou ron P Gallemore retina Macula institute, T orrance,   Ca, UsaPurpose:  To describe the use of topical difluprednate for treatment of patients who presented  with Harada’s disease.",Non-OADS,/arxiv_data1/oa_pdf/80/29/opth-9-157.PMC4310279.pdf
This novel Journal name: Clinical Ophthalmology Article Designation: Case Series Y ear: 2015 Volume: 9 Running head verso: Onishi et al Running head recto: Topical difluprednate for the treatment of Harada’s disease DOI: http://dx.doi.org/10.2147/OPTH.S72955,Non-OADS,/arxiv_data1/oa_pdf/80/29/opth-9-157.PMC4310279.pdf
"Clinical Ophthalmology Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-ophthalmology-journa lClinical Ophthalmology is an international, peer-reviewed journal  covering all subspecialties within ophthalmology.",Non-OADS,/arxiv_data1/oa_pdf/80/29/opth-9-157.PMC4310279.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/80/29/opth-9-157.PMC4310279.pdf
Support for collection and archiving was pro-vided through the Australia Terrestrial Ecosystem Research Network (TERN) (http://www.tern.org.au).,OADS,/arxiv_data1/oa_pdf/1e/4c/gcb0021-0062.PMC4310295.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/a2/23/cpaa-7-011.PMC4310326.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pClinical Pharmacology: Advances and Applications 2015:7 11–17Clinical Pharmacology: Advances and Applications Dove press submit your manuscript | www.dovepress.co m Dove press  11OriginAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CPAA.S7347 2Bioavailability of everolimus administered   as a single  5 mg tablet versus five  1 mg tablets:   a randomized, open-label, two-way crossover   study of healthy volunteers Karen Thudium1 Jorge gallo2 emmanuel Bouillaud2 Carolin sachs2 simantini eddy1 Wing Cheung1 1novartis Pharmaceuticals  Corporation, east hanover, nJ,   UsA;  2novartis Pharma A g, Basel,   switzerland Correspondence: Wing Cheung   novartis Pharmaceuticals   Corporation,  1 health Plaza,   east hanover, nJ  07936, UsA   Tel +1 862 778 3444  Fax +1 973 781 5511  email wing.cheung@novartis.co mBackground:  The mammalian target of rapamycin (mTOR) inhibitor everolimus has a  well-established pharmacokinetics profile.",Non-OADS,/arxiv_data1/oa_pdf/a2/23/cpaa-7-011.PMC4310326.pdf
"Clinical Pharmacology: Advances and Applications Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-pharmacology-advances-and-applications-journa lClinical Pharmacology: Advances and Applications is an international,  peer-reviewed, open access journal publishing original research, reports,  reviews and commentaries on all areas of drug experience in humans.",Non-OADS,/arxiv_data1/oa_pdf/a2/23/cpaa-7-011.PMC4310326.pdf
Visit http://www.dovepress.com/testimonials.ph p to read real quotes  from published authors.,Non-OADS,/arxiv_data1/oa_pdf/a2/23/cpaa-7-011.PMC4310326.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/29/46/copd-10-159.PMC4310342.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of COPD 2015:10 159–172International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  159OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7431 5Continuing to Confront COPD International  surveys: comparison of patient and physician  perceptions about COPD risk and management ana M Menezes1 sarah h landis2 Meilan K han3 hana Muellerova2 Zaurbek aisanov4 Thys van der Molen5 Yeon-Mok Oh6 Masakazu Ichinose7 David M Mannino8 Kourtney J Davis9 1Federal University of Pelotas, Pelotas,   Brazil; 2Worldwide epidemiology,   glaxo smithKline, Uxbridge, UK;   3Division of Pulmonary and Critical  Care, University of Michigan, ann  arbor, MI, Usa; 4Pulmonology  research Institute, Moscow,   russia; 5University Medical Center  groningen, University of groningen,   groningen, the netherlands;   6University of Ulsan College of  Medicine, asan Medical Center, seoul,   south Korea; 7T ohoku University  graduate school of Medicine, sendai,   Japan; 8University of Kentucky  College of Public health, lexington,   KY, Usa; 9Worldwide epidemiology,   glaxo smithKline, Wavre, BelgiumPurpose:  Using data from the Continuing to Confront COPD International Physician and Patient  Surveys, this paper describes physicians’ attitudes and beliefs regarding chronic obstructive  pulmonary disease (COPD) prognosis, and compares physician and patient perceptions with  respect to COPD.",Non-OADS,/arxiv_data1/oa_pdf/29/46/copd-10-159.PMC4310342.pdf
"Keywords:  chronic obstructive pulmonary disease, physician survey, patient survey, beliefs,  perceptions Introduction Although chronic obstructive pulmonary disease (COPD) is a preventable and treatable  disease,1 it is associated with significant morbidity and mortality, giving rise to an  enormous social and economic burden.1,2 In 2010, COPD was ranked as the third  leading cause of mortality and the ninth leading cause of disability-adjusted life years  lost worldwide.2,3 The evidence-based guidelines available to aid physicians in the management  and treatment of patients are frequently not fully implemented in clinical practice,  as demonstrated across many regions worldwide.4–11 Reasons for this include a lack Correspondence: sarah h landis Worldwide epidemiology,  glaxosmithKline, stockley Park West,  Uxbridge, UB11 1BT, UK email sarah.h.landis@gsk.co mJournal name: International Journal of COPD Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Menezes et al Running head recto: Comparison of patient and physician perceptions about COPD DOI: http://dx.doi.org/10.2147/COPD.S74315",Non-OADS,/arxiv_data1/oa_pdf/29/46/copd-10-159.PMC4310342.pdf
Available from: http://www.goldcopd.co m.  2.,Non-OADS,/arxiv_data1/oa_pdf/29/46/copd-10-159.PMC4310342.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-chronic-obstructive-pulmonary-disease-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/29/46/copd-10-159.PMC4310342.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/29/46/copd-10-159.PMC4310342.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ee/bb/copd-10-173.PMC4310343.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of COPD 2015:10 173–183International Journal of COPD Dove press submit your manuscript | www.dovepress.co m Dove press  173OrIg Inal researChopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/COPD.S7464 5Comorbidity and health-related quality of life  in patients with severe chronic obstructive  pulmonary disease attending swedish secondary  care units Josefin sundh1 gunnar Johansson2 Kjell larsson3 anders lindén3 Claes-göran löfdahl4 Christer Janson5 Thomas sandström6 1Department of respiratory Medicine,   Örebro University, Örebro, sweden;   2Department of Public health and  Caring science, Family Medicine  and Preventive Medicine, Uppsala  University, Uppsala, sweden; 3Unit for  lung and airway research, Institute  of environmental Medicine, Karolinska  Institutet, stockholm, sweden;   4Department of respiratory Medicine  and allergology, lund University, lund,   sweden; 5Department of Medical  sciences: respiratory Medicine and  allergology, Uppsala University,   Uppsala, sweden; 6Department of  Public health and Clinical Medicine,   Division of Medicine/ respiratory  Medicine, Umeå University, Umeå,   sweden Correspondence: Josefin Sundh   Department of respiratory Medicine,  Örebro University hospital,   70185 Örebro, sweden   Tel +46 70 234 9517   Fax +46 19 186526   email josefin.sundh@orebroll.s eIntroduction:  Our understanding of how comorbid diseases influence health-related  quality  of life (HRQL) in patients with chronic obstructive pulmonary disease (COPD) is limited  and in need of improvement.",Non-OADS,/arxiv_data1/oa_pdf/ee/bb/copd-10-173.PMC4310343.pdf
"Available from: http://www.goldcopd.or g.  Accessed October 11, 2014.",Non-OADS,/arxiv_data1/oa_pdf/ee/bb/copd-10-173.PMC4310343.pdf
"International Journal of COPD Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-copd-journa lThe International Journal of COPD is an international, peer-reviewed  journal of therapeutics and pharmacology focusing on concise rapid  reporting of clinical studies and reviews in COPD.",Non-OADS,/arxiv_data1/oa_pdf/ee/bb/copd-10-173.PMC4310343.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ee/bb/copd-10-173.PMC4310343.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/08/3f/ijgm-8-047.PMC4310344.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 47–53International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  47OrIGInal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJGM.S7384 2Effects and safety profile of betahistine in patients  in the Russian contingent of OSVaLD, an open- label observational study in vestibular vertigo Svetlana Vyacheslavovna  Morozova1 natalia stepanovna  alekseeva2 Sergey Vasilyevich Lilenko3 Eduard Ivanovich Matsnev4 Oleg Anatol’evich Melnikov5 1Department of Ear, Nose, and  Throat, State Budgetary Educational  Institution of Higher Professional  Training, IM Sechenov First Moscow  State Medical University of the  Ministry of Healthcare and Social  Development of the Russian  Federation, Moscow, 2Federal state  Budgetary Institution, Scientific  Neurology Center of the Russian  Academy of Medical Sciences,   Moscow, 3St Petersburg Research  Institute of Ear, Throat, Nose and  Speech, St Petersburg, 4Department of  Physiology and Pathology of Auditory  and Vestibular Systems, Federal  Scientific Center (FSC), Institute  for Biomedical Problems, Russian  Academy of Sciences (RAS), Moscow,   5ANO Guta Clinic, Moscow, Russian  Federation  Correspondence: Sergey Vasilyevich Lilenko   St Petersburg Research Institute of Ear,  Throat, Nose and Speech, Bronnitskaya 9,  St Petersburg, Russian Federation   email lilenko@mail.r uBackground:  We report here data from the .200 patients recruited in Russia to take part in  OSVaLD, a 12-week, open-label, post-marketing surveillance study of the response to betahistine  48 mg/day in vertigo of peripheral vestibular origin carried out in a total of 13 countries.",Non-OADS,/arxiv_data1/oa_pdf/08/3f/ijgm-8-047.PMC4310344.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/08/3f/ijgm-8-047.PMC4310344.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/08/3f/ijgm-8-047.PMC4310344.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/25/46/ijgm-8-041.PMC4310345.pdf
Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pInternational Journal of General Medicine 2015:8 41–46International Journal of General Medicine Dove press submit your manuscript | www.dovepress.co m Dove press  41Short reportopen access to scientific and medical research open Access Full text Article http: //dx.doi.org/10.2147/IJGM.S7658 8effects of Bacillus subtilis  var.,Non-OADS,/arxiv_data1/oa_pdf/25/46/ijgm-8-041.PMC4310345.pdf
"International Journal of General Medicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-general-medicine-journa lThe International Journal of General Medicine is an international,  peer-reviewed open-access journal that focuses on general and internal  medicine, pathogenesis, epidemiology, diagnosis, monitoring and treat - ment protocols.",Non-OADS,/arxiv_data1/oa_pdf/25/46/ijgm-8-041.PMC4310345.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/25/46/ijgm-8-041.PMC4310345.pdf
"Tokyo: Office of Lifestyle-Related Disease Control,  Ministry of Health, Labor and Welfare; 2005. http://wwwo.nih.go.jp/ eiken/english/research/pdf/dris2005_eng.pdf#search=‘Dietry+Refere nce+Intakes+for+Japanese+%282005%29 ’.",Non-OADS,/arxiv_data1/oa_pdf/25/46/ijgm-8-041.PMC4310345.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pDrug, Healthcare and Patient Safety 2015:7 31–41Drug, Healthcare and Patient Safety Dove press submit your manuscript | www.dovepress.co m Dove press  31Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/DHPS.S7197 6Gastrointestinal injury associated with NSAiD  use: a case study and review of risk factors   and preventative strategies Jay L Goldstein1 Byron Cryer2 1Department of Medicine, NorthShore  University HealthSystem, evanston, iL,   USA; 2Division of Gastroenterology,   University of Texas Southwestern  Medical Center and Dallas vA Medical  Center, Dallas, TX, USA Correspondence: Jay L Goldstein   Department of Medicine, North Shore  University HealthSystem, 2650 Ridge  Avenue, evanston, iL 60201, USA   Tel +1 847 570 2510; +1 847 570 2615   Fax +1 847 570 2905   email jgoldstein@northshore.or gAbstract:  Nonsteroidal anti-inflammatory drugs (NSAIDs) are effective anti-inflammatory and  analgesic agents and are among the most commonly used classes of medications worldwide.",Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
"Available from:  http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInforma - tionforPatientsandProviders/ucm150314.ht m. Accessed October 10,  2014.",Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
Available from: http://www.medscape.com/viewarticle/82047 0.,Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
"Available from: http://www.fda.gov/NewsEvents/Newsroom/ PressAnnouncements/2004/ucm108361.ht m. Accessed October 2,  2014.",Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
"Drug, Healthcare and Patient Safety Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-healthcare-and-patient-safety-journa lDrug, Healthcare and Patient Safety is an international, peer-reviewed  open-access journal exploring patient safety issues in the healthcare  continuum from diagnostic and screening interventions through to treat - ment, drug therapy and surgery.",Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/26/41/dhps-7-031.PMC4310346.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/50/0d/dddt-9-631.PMC4310348.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 631–642Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  631Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7473 1Development of intramammary delivery systems  containing lasalocid for the treatment of bovine  mastitis: impact of solubility improvement on  safety, efficacy, and milk distribution in dairy cattle Wen Wang1 Yunmei song1 Kiro Petrovski2 Patricia eats2 Darren J Trott2 hui san Wong2 stephen W Page3 Jeanette Perry2 sanjay garg1 1school of Pharmacy and Medical  science, University of south australia,   adelaide, sa, australia; 2school  of animal and Veterinary sciences,   University of adelaide, adelaide, sa,   australia; 3luoda Pharma Pty ltd,   caringbah, nsW, australiaBackground:  Mastitis is a major disease of dairy cattle.",Non-OADS,/arxiv_data1/oa_pdf/50/0d/dddt-9-631.PMC4310348.pdf
"Globally, the foremost Gram-positive correspondence: sanjay garg centre for Pharmaceutical innovation  and Development (cPiD), school of  Pharmacy and Medical science, University  of south australia, adelaide, sa 5000,  australia Tel +618 8302 1575 Fax +618 8302 2389 email sanjay.garg@unisa.edu.a u Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Wang et al Running head recto: Novel antibacterial compound and formulations for mastitis DOI: http://dx.doi.org/10.2147/DDDT.S74731",Non-OADS,/arxiv_data1/oa_pdf/50/0d/dddt-9-631.PMC4310348.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/50/0d/dddt-9-631.PMC4310348.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/50/0d/dddt-9-631.PMC4310348.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/ff/52/dddt-9-643.PMC4310350.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpDrug Design, Development and Therapy 2015:9 643–653Drug Design, Development and Therapy Dove press submit your manuscript | www.dovepress.co m Dove press  643Original researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/DDDT .S7540 0Organic anion transporter 3- and organic anion  transporting polypeptides 1B1- and 1B3-mediated  transport of catalposide hyeon-Uk Jeong1 Mihwa Kwon2 Y ongnam lee3 Ji seok Y oo3 Dae hee shin3 im-sook song2 hye suk lee1 1college of Pharmacy, The catholic  University of Korea, Bucheon 420-743,   Korea; 2college of Pharmacy and  research institute of Pharmaceutical  sciences, Kyungpook national  University, Daegu 702-701, Korea;   3central r&D institute, Yungjin Pharm  co., ltd., suwon 443-270, KoreaAbstract:  We investigated the in vitro transport characteristics of catalposide in HEK293  cells  overexpressing organic anion transporter 1 (OAT1), OAT3, organic anion transporting polypep - tide 1B1 (OATP1B1), OATP1B3, organic cation transporter 1 (OCT1), OCT2, P-glycoprotein  (P-gp), and breast cancer resistance protein (BCRP).",Non-OADS,/arxiv_data1/oa_pdf/ff/52/dddt-9-643.PMC4310350.pdf
"It contains iridoid and naphthoquinones, and catal - poside is a bioactive iridoid glucoside isolated from C. ovata  (Figure 1).1,2 Recently,  catalposide was reported to be a novel natural ligand of peroxisome proliferation- activated receptor α (PPAR-α), which regulates hepatic lipid metabolism.3 In addition,  it showed inhibitory effects on tumor necrosis factor- α, interleukin 1 β (IL-1β), and  IL-6 production and nuclear factor- κB activation in lipopolysaccharide-activated RAW  264.7 macrophages, as well as cytoprotective effects against oxidative damage caused  by the induction of heme oxygenase-1.4,5 The effective concentration of catalposide  required for the suppression of cytokines, antioxidative effect, and PPAR- α activation correspondence: hye suk lee college of Pharmacy, The catholic  University of Korea, 43 Jibong-ro,  Wonmi-gu, Bucheon 420-743, Korea Tel +82 2 2164 4061 Fax +82 32 342 2013 email sianalee@catholic.ac.k r  im-sook song college of Pharmacy and research  institute of Pharmaceutical sciences,  Kyungpook national University,  80 Daehak-ro, Daegu 702-701, Korea Tel +82 53 950 8575 Fax +82 53 950 8557 email songimsook1@gmail.co m Journal name: Drug Design, Development and Therapy Article Designation: Original Research Y ear: 2015 Volume: 9 Running head verso: Jeong et al Running head recto: OAT3-, OATP1B1-, and OATP1B3-mediated transport of catalposide DOI: http://dx.doi.org/10.2147/DDDT.S75400",Non-OADS,/arxiv_data1/oa_pdf/ff/52/dddt-9-643.PMC4310350.pdf
"Drug Design, Development and Therapy Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/drug-design-development-and-therapy-journa lDrug Design, Development and Therapy is an international, peer- reviewed open-access journal that spans the spectrum of drug design  and development through to clinical applications.",Non-OADS,/arxiv_data1/oa_pdf/ff/52/dddt-9-643.PMC4310350.pdf
Visit  http://www.dovepress.com/testimonials.ph p to read real quotes from  published authors.,Non-OADS,/arxiv_data1/oa_pdf/ff/52/dddt-9-643.PMC4310350.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/3/ e000953.,Non-OADS,/arxiv_data1/oa_pdf/27/4d/jah3-3-e000414.PMC4310353.pdf
” The authors regret this error.The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/4/ e000965.,Non-OADS,/arxiv_data1/oa_pdf/be/b4/jah3-3-e000419.PMC4310354.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/4/e001072.,Non-OADS,/arxiv_data1/oa_pdf/a5/f1/jah3-3-e000456.PMC4310355.pdf
Available at: https://www.sundhed.dk/content/cms/69/4669_2010_apo- pleksi_nat_sfa.pdf.,Non-OADS,/arxiv_data1/oa_pdf/44/61/jah3-3-e000762.PMC4310360.pdf
Available at: http://www.R-project.org/.,Non-OADS,/arxiv_data1/oa_pdf/44/61/jah3-3-e000762.PMC4310360.pdf
"Clinical Trial Registration- —URL: http://ClinicalTrials.gov, Unique identi ﬁer: NCT01864122.",Non-OADS,/arxiv_data1/oa_pdf/dd/5b/jah3-3-e000764.PMC4310362.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov/ Unique identi ﬁer: ID NCT00574119.,Non-OADS,/arxiv_data1/oa_pdf/68/28/jah3-3-e000883.PMC4310370.pdf
"Accompanying Video S1 is available at http://jaha.ahajournals.org/content/ 3/4/e000883/suppl/DC1 Correspondence to: Marvin W. Kronenberg, MD, Vanderbilt Heart and Vascular Institute, Vanderbilt Medical Center East, Suite 5209, 1215 21stAve, South, Nashville, TN 37232.",Non-OADS,/arxiv_data1/oa_pdf/68/28/jah3-3-e000883.PMC4310370.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/2/ e000746.,Non-OADS,/arxiv_data1/oa_pdf/9d/3f/jah3-3-e000906.PMC4310374.pdf
"Accompanying Datas S1 and S2 are available at http://jaha.ahajournals.org/ content/3/4/e000914/suppl/DC1 Correspondence to: Qianyi Wang, MS, 16 Parker Hill Avenue, Boston, MA 02120.",Non-OADS,/arxiv_data1/oa_pdf/37/47/jah3-3-e000914.PMC4310377.pdf
Available at: https://federalregister.gov/a/2013- 26854.,OADS,/arxiv_data1/oa_pdf/37/47/jah3-3-e000914.PMC4310377.pdf
Available at: http://www.cdc.gov/tobacco/data_statistics/sgr/ 50th-anniversary/index.htm.,Non-OADS,/arxiv_data1/oa_pdf/cb/f7/jah3-3-e000933.PMC4310379.pdf
"Available at: http://ndltd.ncl.edu.tw/cgi-bin/gs32/gsweb.cgi?o=dnclcdr&s= id=%22092YM005058012%005058022.&searchmode=basic Accessed June 6, 2014.",OADS,/arxiv_data1/oa_pdf/cb/f7/jah3-3-e000933.PMC4310379.pdf
"An accompanying Movies S1 and S2 are available at http://jaha.ahajournals.org/content/3/4/e000956/suppl/DC1 Correspondence to: Gemma A. Figtree, MBBS, DPhil, FRACP, FAHA, North Shore Heart Research Group, Kolling Institute (University of Sydney), Royal North Shore Hospital, St Leonards, New South Wales 2065, Australia.",Non-OADS,/arxiv_data1/oa_pdf/ef/a8/jah3-3-e000956.PMC4310382.pdf
Clinical Trial Registration- —URL: http://clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/ce/a1/jah3-3-e000975.PMC4310386.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/1f/08/jah3-3-e001005.PMC4310391.pdf
"Disclosures after August 1, 2013 available at http://med.stanford.edu/pro ﬁles/kenneth_ma- haffey.",Non-OADS,/arxiv_data1/oa_pdf/37/c7/jah3-3-e001032.PMC4310394.pdf
Available at: http://www.cms.gov/apps/physician-fee-schedule/search/ search-criteria.aspx.,Non-OADS,/arxiv_data1/oa_pdf/8d/eb/jah3-3-e001063.PMC4310396.pdf
Available at: http://kff.org/medicare/state-indicator/ total-medicare-bene ﬁciaries/.,Non-OADS,/arxiv_data1/oa_pdf/8d/eb/jah3-3-e001063.PMC4310396.pdf
"An accompanying Table S1 is available at http://jaha.ahajournals.org/content/3/4/e001066/suppl/DC1Part of the data was presented as a poster at the annual Scienti ﬁc Sessions of the American Heart Association, in Los Angeles, California, USA, November 3 –7, 2012.",Non-OADS,/arxiv_data1/oa_pdf/e9/35/jah3-3-e001066.PMC4310397.pdf
Clinical Trial Registration- —URL: http://www.clinicaltrials.gov.,Non-OADS,/arxiv_data1/oa_pdf/eb/12/jah3-3-e001072.PMC4310398.pdf
"and Department of Medical-SurgicalSciences and Biotechnologies (E.D.F., G.F.), Sapienza University of Rome, Rome,Italy; Department of AngioCardioNeurology, IRCCS NeuroMed, Pozzilli, Italy (G.F.) An accompanying Data S1 is available at http://jaha.ahajournals.org/ content/3/3/e001072/suppl/DC1 Correspondence to: Lorenzo Loffredo, MD, I Clinica Medica, Viale del Policlinico 155, Rome 00161, Italy.",Non-OADS,/arxiv_data1/oa_pdf/eb/12/jah3-3-e001072.PMC4310398.pdf
"other inhibitor of CRP uses a small-molecule approach to bind and interfere with the acute-phase protein ’s function in vivo.30 However, the respective small molecule evaluated in the reported animal model studies is no longer being considered for development in the clinic (http://pentraxin.word- press.com/rd-programs/).",Non-OADS,/arxiv_data1/oa_pdf/55/7f/jah3-3-e001084.PMC4310401.pdf
Available at: http://www.hcup-us.ahrq.gov/nisoverview.jsp.,Non-OADS,/arxiv_data1/oa_pdf/9e/a5/jah3-3-e001090.PMC4310403.pdf
Avail- able at: http://www.hcup-us.ahrq.gov/reports/methods/methods_topic.jsp.,Non-OADS,/arxiv_data1/oa_pdf/9e/a5/jah3-3-e001090.PMC4310403.pdf
Available at: http://www.hcup- us.ahrq.gov/reports/methods.jsp.,OADS,/arxiv_data1/oa_pdf/9e/a5/jah3-3-e001090.PMC4310403.pdf
Available at: http://www.hcup-us.ahrq.gov/ reports/methods.jsp.,OADS,/arxiv_data1/oa_pdf/9e/a5/jah3-3-e001090.PMC4310403.pdf
(URL: http://www.helse-nord.no/).,OADS,/arxiv_data1/oa_pdf/e2/3d/jah3-3-e001109.PMC4310408.pdf
Available from: http://who.int/mediacentre/factsheets/fs310/en/.,OADS,/arxiv_data1/oa_pdf/e2/3d/jah3-3-e001109.PMC4310408.pdf
Available from URL: http://www.thl.,Non-OADS,/arxiv_data1/oa_pdf/e2/3d/jah3-3-e001109.PMC4310408.pdf
"Then, clopido- grel using patients were matched 1:1 with patients not usingclopidogrel on the propensity score using the Greedy matching macro (http://www.mayo.edu/research/departments-divi- sions/department-health-sciences-research/division- biomedical-statistics-informatics/software/locally-written-sas- macros).",Non-OADS,/arxiv_data1/oa_pdf/b8/8b/jah3-3-e001116.PMC4310409.pdf
Acknowledgments A full listing of Women ’s Health Initiative investigators can be found at http://whiscience.org/publications/WHI_investigators_longlist.,Non-OADS,/arxiv_data1/oa_pdf/af/af/jah3-3-e001127.PMC4310412.pdf
of AF PatientsFemale (%)Mean Age (/C6SD)Paroxysmal AF (%)CHADS 2 (CHA 2DS2VASC) AFNET1(German Competence Network)Germany 2010 Inpatients/ outpatientsPersonalized managementAF 9558 —— — 1.6 to 1.9 AVAIL4USA July 2006 –Sept 2009Inpatients Long-term use of antithrombotic therapiesPatients with ischemic stroke/TIA and AF post discharge291 51.6 76 — 2t o6 CAPTURE5USA (Illinois) Nov 2002 –March 2003Inpatients Comparison of quality indicatorsStroke/TIA 1953 53.2/ 57.166.7/67.5 —— Euro Heart Survey635 countries EuropeSep 2003 –Jul 2004Inpatients/ outpatientsManagement against European guidelinesAF confirmed by ECG or Holter recording3890 43.5 66.4 /C612.2 30.1 0 to 6 GARFIELD (Bayer)750 countries worldwideOngoing (2009 – 2015)Inpatients/ outpatientsEvaluate management and outcomesNewly diagnosed nonvalvular AF with additional risk factor for strokeAiming for 55 000—— — — GLORIA-AF (Boehringer Ingelheim)8Global (62 centers)May 2011 –Jan 2013Inpatients Characteristics influencing choice of therapyNewly diagnosed nonvalvular AF patients at risk for strokeAiming for 55 000—— — — J-RHYTHM9Japan Jan 2009 –July 2009Outpatients Regional use of anticoagulation therapyAF 7937 31.1 69.7 /C69.9 37.1 1.7 /C61.2 National Cardiovascular Data Registry ’s ACTION Registry –Get With the Guidelines10USA July 2008 –Sept 2009Outcomes of patients withacute myocardial infarction and AFMyocardial infarction with AF4947 42.4 Median 78 — 0: 3.7% 1: 12.9%≥2: 80.9% Nationwide Danish study 11Denmark Patient registry data from 1997–2008Inpatients/ outpatientsNet clinical benefit of OACsNon-valvular AF 141 500 47.2 72.6 /C612.9 — 0t o6 (0 to 9) ORBIT-AF12USA June 2010 –Nov 2014Outpatients Characterize treatment and outcomesIncident or prevalent AF 10 126 43 75 46 75% ≥2 (85% ≥2) PINNACLE-AF (http://www.ncdr.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/jah3-3-e001179.PMC4310414.pdf
Available at: http://www.mini-senti- nel.org/work_products/HealthOutcomes/Mini-Sentinel-HOI-Evidence-Review- CVA-TIA-Report.pdf.,Non-OADS,/arxiv_data1/oa_pdf/a7/83/jah3-3-e001179.PMC4310414.pdf
https://federalregister.gov/a/ 2013-26854.,OADS,/arxiv_data1/oa_pdf/1b/70/jah3-3-e001195.PMC4310415.pdf
The online version of the article has been updated and is available at http://jaha.ahajournals.org/content/3/2/e000745.,Non-OADS,/arxiv_data1/oa_pdf/2c/21/jah3-3-e001214.PMC4310417.pdf
Available at: http://www.fda.gov/drugs/resourcesforyou/consumers/ucm390574.htm.,Non-OADS,/arxiv_data1/oa_pdf/b7/6f/jah3-3-e001254.PMC4310420.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/81/8c/sfu115.PMC4310421.pdf
"http://www.esrdnetwork18.org2004 (2 August 2014, date last accessed) 3.",Non-OADS,/arxiv_data1/oa_pdf/81/8c/sfu115.PMC4310421.pdf
"2004. https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ ﬁle/199001/National_ Service_Framework_for_Renal_Services_Part_One_-_Dialysis_ and_Transplantation.pdf (7 July 2014, date last accessed) 5.",Non-OADS,/arxiv_data1/oa_pdf/81/8c/sfu115.PMC4310421.pdf
"2006. http://www.kidney.org/PROFESSIONALS/ kdoqi/guideline_upHD_PD_V A/va_guide5.htm (8 August 2014, date last accessed) 12.",Non-OADS,/arxiv_data1/oa_pdf/81/8c/sfu115.PMC4310421.pdf
"http://www.renal.org/guidelines/modules/vascular-access-for- haemodialysis#Summary1 (7 August 2014, date last accessed) 16.",Non-OADS,/arxiv_data1/oa_pdf/81/8c/sfu115.PMC4310421.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/54/81/sfu117.PMC4310422.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License ( http://creativecommons.org/licenses/by-nc/4.0/ ), which permits non-commercial re-use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/aa/99/sfu120.PMC4310423.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f8/e0/sfu121.PMC4310424.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/3f/52/sfu122.PMC4310425.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/92/d7/sfu123.PMC4310426.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/34/05/sfu124.PMC4310427.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/6e/bb/sfu125.PMC4310428.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/ee/e7/sfu127.PMC4310429.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"2008. http://www.who.int/nmh/publications/9789241597418/en/ (18 November 2014, date last accessed) 2.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
2014 http://circ.ahajournals.org/ content/early/2013/12/18/ 01.cir.0000441139.,Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"http://costprojections.cancer.gov/ (29 July 2014, date last accessed) 12.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"http://www.rwjf.org/content/dam/farm/ reports/reports/2010/rwjf5458 (29 July 2014, date last accessed) 13.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"Geneva, 2005. http://www.who.int/chp/ chronic_disease_report/en/ (18 November 2014, date last accessed) 14.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"Geneva, 2010. http://www3.weforum.org/ docs/WEF_GlobalRisks_Report_2010.pdf (18 November 2014, date last accessed) 15.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"http://www.usrds.org/2013/pdf/v2_ch1_13.pdf (6 September 2014, date last accessed) 33.",Non-OADS,/arxiv_data1/oa_pdf/d0/b4/sfu128.PMC4310430.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
Genotyping and linkage studies We carried out a genome-wide linkage search using Affy- metrix GeneChip ®Human Mapping 250K Sty Arrays accord- ing to the manufacturer ’s protocol ( http://www.affymetrix.,OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
The homology model was visualized using PyMOL ( http://www.pymol.org/ ).,OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
"The mutationc.746G>A; p.R249Q (Reference sequence NM_002316.3) is novel and is not present in databases including 1000 Genomes ( http://www.1000genomes.org/ ), Exome Variant Server ( http://evs.gs.washington.edu/EVS/ ) or the Exome Aggregation Consortium ”(ExAC) data set with exome se- quence data obtained from 63 352 individuals ( http://exac.",OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
Andrews S. FastQC A Quality Control tool for High Throughput Sequence Data .http://www.bioinformatics.babraham.ac.uk/ projects/fastqc/ 11.,Non-OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
https://github.com/lh3/seqtk 12.,Non-OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
http://www.bioinformatics.babraham.,Non-OADS,/arxiv_data1/oa_pdf/0e/82/sfu129.PMC4310431.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b8/72/sfu130.PMC4310432.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/f9/9e/sfu131.PMC4310433.pdf
2005. http://www.satscan.org/ .,Non-OADS,/arxiv_data1/oa_pdf/f9/9e/sfu131.PMC4310433.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/cf/31/sfu132.PMC4310434.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e2/c0/sfu133.PMC4310435.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/5e/d9/sfu134.PMC4310436.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b9/b6/sfu135.PMC4310437.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/c9/3e/sfu136.PMC4310438.pdf
"Later, through an improved mass analyser, more than 1100 proteins were shown to be associated to uEVs [9] leading to the creation of an open access online data- base for public research of speci ﬁc proteic sequences, named Urinary Exosome Protein Database ( http://dir.nhlbi.",OADS,/arxiv_data1/oa_pdf/c9/3e/sfu136.PMC4310438.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/42/f9/sfu137.PMC4310439.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/d9/94/sfu138.PMC4310440.pdf
Clin Kidney J 2015; 8: 14–22 16.http://www.era-edta.org/page-0-0-0-36-eraedtascienti ﬁc workinggroups.html ; accessed 6 December 2014 Received for publication: 9.12.14; Accepted in revised form: 9.12.142 Editorial Comment,Non-OADS,/arxiv_data1/oa_pdf/d9/94/sfu138.PMC4310440.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/b3/62/sfu142.PMC4310441.pdf
http://www.fjd.es/iis_fjd/ ) and even the recent ERA- EDTA research programme call on biomarkers emphasizetranslational research.,Non-OADS,/arxiv_data1/oa_pdf/b3/62/sfu142.PMC4310441.pdf
"These include the French F-CRIN INI-CRCT (Cardiovascular and Renal Clinical Trialists) network ( http://www.fcrin.org/en/support-tools/ ini-crct-cardio-renal-diseases ) and the Spanish REDINREN (Red de Investigación Renal) network ( http://redinren.org/ ) [54,55].",Non-OADS,/arxiv_data1/oa_pdf/b3/62/sfu142.PMC4310441.pdf
Annual Report 2012. http://www.era-edta- reg.org/ ﬁles/annualreports/pdf/AnnRep2012.pdf (accessed 7 December 2014) 13.,Non-OADS,/arxiv_data1/oa_pdf/b3/62/sfu142.PMC4310441.pdf
JAMA 2 0 1 4 ;3 1 1 :5 0 7 –520 31.http://www.ema.europa.eu/ema/index.jsp?curl=pages/medicines/ human/medicines/000791/h uman_med_001055.jsp&mid= WC0b01ac058001d124 (accessed 7 December 2014) 32.,Non-OADS,/arxiv_data1/oa_pdf/b3/62/sfu142.PMC4310441.pdf
"Published by Oxford University Press on behalf of ERA-EDTA.This is an Open Access article distributed under the terms of the Creativ e Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0/), which permits non-commercial re-use, distri bution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/0f/95/sfu143.PMC4310442.pdf
"Siegel JD, Rhinehart E, Jackson M et al .2007 Guideline for Isolation Precautions: Preventing Transmission of Infectious Agents in Healthcare Settings .http://www.cdc.gov/ncidod/dhqp/ pdf/isolation2007.pdf (15 December 2014, date last accessed) 6.",Non-OADS,/arxiv_data1/oa_pdf/0f/95/sfu143.PMC4310442.pdf
"http://www.cdc.gov/vaccines/pubs/downloads/dialysis- guide-2012.pdf (15 December 2014, date last accessed) 8.",Non-OADS,/arxiv_data1/oa_pdf/0f/95/sfu143.PMC4310442.pdf
"0801A, Ottawa, ON K1A 0K9, Canada j Environmental Risk and Health Unit, VITO, Industriezone Vlasmeer 7, 2400 Mol, Belgium k University of Antwerp, Department of Biomedical Sciences, Belgium ©2014 The Authors This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).",Non-OADS,/arxiv_data1/oa_pdf/08/61/nihms-656623.PMC4310547.pdf
"[Available: http://www.epa.gov/ace/  Accessed November 25, 2013] Faust F, Kassie F, Knasmuller S, Boedecker RH, Mann M, Mersch-Sundermann V. The use of the  alkaline comet assay with lymphocytes in human biomonitoring studies.",OADS,/arxiv_data1/oa_pdf/08/61/nihms-656623.PMC4310547.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/08/61/nihms-656623.PMC4310547.pdf
"[Available: http://ntp.niehs.nih.gov/?objectid=960B6F03- A712-90CB-8856221E90EDA46E  [accessed 25 October 2013]] Needham LL, Calafat AM, Barr DB.",Non-OADS,/arxiv_data1/oa_pdf/08/61/nihms-656623.PMC4310547.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307a.PMC4310551.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpNeuropsychiatric Disease and Treatment 2014:10 2307–2314Neuropsychiatric Disease and Treatment Dove press submit your manuscript | www.dovepress.co m Dove press  2307OrigiNal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/NDT .S7303 8Possible association between phantom vibration  syndrome and occupational burnout chao-Pen chen1 chi-cheng Wu2 li-ren chang3 Yu-hsuan lin4 1Department of education, National  Taiwan University hospital,   2Department of Family Medicine,   Min-sheng general hospital, Taoyuan  city, 3Department of Psychiatry,   National Taiwan University,   college of Medicine, 4institute  of Brain science, National Yang-Ming  University, Taipei, TaiwanBackground:  Phantom vibration syndrome (PVS) and phantom ringing syndrome (PRS) occur  in many cell phone users.",Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307a.PMC4310551.pdf
"Both PVS and PRS increased dramatically over the course of correspondence: Yu-hsuan lin  institute of Brain science, National  Yang-Ming University, 177 chung cheng  east road, section 2, Tamsui District,  New Taipei city, Taiwan 251 Tel +886 5578 9317 Fax +886 2 2809 7676 email yuhsuanmed@gmail.co m Journal name: Neuropsychiatric Disease and Treatment Article Designation: Original Research Y ear: 2014 Volume: 10 Running head verso: Chen et al Running head recto: Phantom vibration syndrome and occupational burnout DOI: http://dx.doi.org/10.2147/NDT.S73038",Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307a.PMC4310551.pdf
"Neuropsychiatric Disease and Treatment Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/neuropsychiatric-disease-and-treatment-journa lNeuropsychiatric Disease and Treatment is an international, peer- reviewed journal of clinical therapeutics and pharmacology focusing   on concise rapid reporting of clinical or pre-clinical studies on a   range of neuropsychiatric and neurological disorders.",Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307a.PMC4310551.pdf
Visit http://www.dovepress.com/testimonials.ph p to  read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/34/41/ndt-10-2307a.PMC4310551.pdf
Healthy People 2020 Available at: http://www.healthypeople.gov/2020/topicsobjectives2020/objectiveslist.aspx?topicId = 7.,Non-OADS,/arxiv_data1/oa_pdf/e8/c3/mlr-53-207.PMC4310672.pdf
Dementia: A NICE-SCIE guideline on supporting people with dementia and theircarers in health and social care: British Psychological Society; 2007.Available at: http://www.nice.org.uk/CG42.,Non-OADS,/arxiv_data1/oa_pdf/e8/c3/mlr-53-207.PMC4310672.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/65/26/cia-10-203.PMC4310707.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 203–208Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  203OrIg InAl reseArChopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S6234 6Cardiac autonomic modulation in healthy elderly  after different intensities of dynamic exercise Viviane santos lópez  Droguett1 Amilton da Cruz santos2 Carlos eduardo de  Medeiros2 Douglas Porto Marques2 leone severino do  nascimento2 Maria do socorro  Brasileiro-santos2 1Department of Pathology, Federal  University of Pernambuco, recife,   Pernambuco, Brazil; 2Department  of Physical education, Federal  University of Paraiba, João Pessoa,   Paraiba, BrazilPurpose:  To investigate the heart rate (HR) and its autonomic modulation at baseline and  during dynamic postexercise (PEX) with intensities of 40% and 60% of the maximum HR in  healthy elderly.",Non-OADS,/arxiv_data1/oa_pdf/65/26/cia-10-203.PMC4310707.pdf
"On the other hand, there is also evidence that the risk of sudden death  is increased dramatically during and immediately after exercise.12,13 Although there are  several possible mechanisms for this marked increase in the risk of sudden cardiac death, Correspondence: Maria do socorro  Brasileiro-santos Universidade Federal da Paraíba,  Departamento de educação Física,  Cidade Universitária, Código de  endereçamento Postal 58051-900, João  Pessoa, Paraíba, Brasil Tel +5583 3216 7212 Fax +5583 3216 7212 email sbrasileiro@pq.cnpq.b rJournal name: Clinical Interventions in Aging Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Droguett et al Running head recto: Cardiac autonomic modulation in elderly healthy DOI: http://dx.doi.org/10.2147/CIA.S62346",Non-OADS,/arxiv_data1/oa_pdf/65/26/cia-10-203.PMC4310707.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/65/26/cia-10-203.PMC4310707.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/65/26/cia-10-203.PMC4310707.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpClinical Interventions in Aging 2015:10 237–245Clinical Interventions in Aging Dove press submit your manuscript | www.dovepress.co m Dove press  237REVIEWopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CIA.S7116 5Influence of socioeconomic factors on hospital  readmissions for heart failure and acute  myocardial infarction in patients 65 years and  older: evidence from a systematic review Gianfranco Damiani1 Eleonora Salvatori1 Giulia Silvestrini1 Ivana Ivanova2 Luka Bojovic3 Lanfranco Iodice1 Walter Riccia rdi1 1Department of Public Health,  Università Cattolica Sacro Cuore,  Rome, Italy; 2ERAWEB Project, Faculty  of Medicine, Saints Cyril and Methodius  University of Skopje, Skopje, Macedonia;  3ERAWEB Project, Faculty of Medicine,  University of Nis, Nis, Ser biaPurpose:  Cardiovascular diseases are the leading cause of death and disability worldwide.",Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
"This has resulted in an  increase in life expectancy (80 years across Organisation for Economic Co-operation  and Development countries, which is a gain of more than 10 years since 1960)1 and it  involves a larger proportion of the elderly population in whom chronic diseases and Correspondence: Gianfranco Damiani Department of Public Health, Università  Cattolica Sacro Cuore, Largo F Vito,  1-00168 Roma, Italy Tel +39 630 154 396 Fax +39 635 001 522 Email gdamiani@rm.unicatt.i t Journal name: Clinical Interventions in Aging Article Designation: REVIEW Y ear: 2015 Volume: 10 Running head verso: Damiani et al Running head recto: Socioeconomic factors and readmission of older patients DOI: http://dx.doi.org/10.2147/CIA.S71165 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Or use: http://dvpr.es/1zd4Ms sVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available  from: http://www.who.int/chp/en/.,OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available from: http://civhc.org/getmedia/475510fc- ff67-4655-a915-c9539117eb2f/Care-Transitions-Policy-Brief- FINAL_9.2012.pdf.aspx.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available from: http://www.medpac.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available  from: http://www.burrillreport.com/content/Hospital-Readmissions- Europe_HiRes.pdf.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available from: http://www.rand.org/pubs/ technical_reports/TR1198.html.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available from: http://www.who.int/gho/ncd/mortality_morbidity/ cvd/en/.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
"Clinical Interventions in Aging Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/clinical-interventions-in-aging-journa lClinical Interventions in Aging is an international, peer-reviewed journal  focusing on evidence-based reports on the value or lack thereof of treatments  intended to prevent or delay the onset of maladaptive correlates of aging  in human beings.",Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Visit http://www.dovepress.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
Available from: http://sepas.srhs.,Non-OADS,/arxiv_data1/oa_pdf/7f/e4/cia-10-237.PMC4310718.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/70/78/cmar-7-037.PMC4310719.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.ph pCancer Management and Research 2015:7 37–46Cancer Management and Research Dove press submit your manuscript | www.dovepress.co m Dove press  37Reviewopen access to scientific and medical research Open Access Full T ext Article http: //dx.doi.org/10.2147/CMAR.S7259 2Management of patients with hormone receptor– positive breast cancer with visceral disease:  challenges and treatment options wael A Harb Horizon Oncology Center, Lafayette,   iN, USA Correspondence: wael A Harb   Horizon Oncology Center, 1345 Unity  Place, Suite 365, Lafayette, iN 47905,  USA  Tel +1 765 446 5111   Fax +1 765 838 0972   email wharb@horizonbioadvance.co mAbstract:  Endocrine therapy is an important treatment option for women with hormone  receptor–positive (HR +) advanced breast cancer (ABC), yet many tumors are either intrinsically  resistant or develop resistance to these therapies.",Non-OADS,/arxiv_data1/oa_pdf/70/78/cmar-7-037.PMC4310719.pdf
Or use: http://dvpr.es/1ulgyi U,Non-OADS,/arxiv_data1/oa_pdf/70/78/cmar-7-037.PMC4310719.pdf
"Cancer Management and Research Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/cancer-management-and-research-journa lCancer Management and Research is an international, peer-reviewed  open access journal focusing on cancer research and the optimal use of  preventative and integrated treatment interventions to achieve improved  outcomes, enhanced survival and quality of life for the cancer patient.",Non-OADS,/arxiv_data1/oa_pdf/70/78/cmar-7-037.PMC4310719.pdf
Visit http://www.dovepress.com/   testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/70/78/cmar-7-037.PMC4310719.pdf
The full terms of the License are available at http://creativecommons.org/licenses/by-nc/3.0 /.,Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Information on  how to request permission may be found at: http://www.dovepress.com/permissions.phpInternational Journal of Nanomedicine 2015:10 801–810International Journal of Nanomedicine Dove press submit your manuscript | www.dovepress.co m Dove press  801OrIg INal researchopen access to scientific and medical research Open access Full T ext article http: //dx.doi.org/10.2147/IJN.S7575 8Empirical modeling of the fine particle fraction  for carrier-based pulmonary delivery formulations correspondence: aleksander Mendyk Department of Pharmaceutical  Technology and Biopharmaceutics,  Jagiellonian University Medical college,  Medyczna 9 str, 30-688 Krakow, Poland  Tel +481 2620 5604  Fax +481 2620 5618  email mfmendyk@cyf-kr.edu.p l Adam Pacławski1 Jakub Szlęk1 raymond lau2 renata Jachowicz1 aleksander Mendyk1 1Department of Pharmaceutical  T echnology and Biopharmaceutics,   Jagiellonian University Medical  college, Kraków, Poland; 2school  of chemical and Biomedical  engineering, college of engineering,   Nanyang T echnological University,   singapore Abstract:  In vitro study of the deposition of drug particles is commonly used during development  of formulations for pulmonary delivery.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"For effective drug delivery, interactions  between the drug and carrier have to be powerful enough to produce a homogeneous Journal name: International Journal of Nanomedicine Article Designation: Original Research Y ear: 2015 Volume: 10 Running head verso: Pacławski et al Running head recto: Modeling of fine particle fraction for carrier-based pulmonary delivery DOI: http://dx.doi.org/10.2147/IJN.S75758 Point your SmartPhone at the code above.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Or use: http://dvpr.es/1ICXMw JVideo abstract,Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"International Journal of Nanomedicine Publish your work in this journal Submit your manuscript here:  http://www.dovepress.com/international-journal-of-nanomedicine-journa lThe International Journal of Nanomedicine is an international, peer- reviewed journal focusing on the application of nanotechnology   in diagnostics, therapeutics, and drug delivery systems throughout   the biomedical field.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Visit http://www.dovepress.com/ testimonials.ph p to read real quotes from published authors.,Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Available from: http://www.gcsca.net/IJ/ SurfCharJ.htm l. Accessed January 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Available from: http://imagej.nih.gov/ij /, 1997–2014.",OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Available from: http://rsb.info.nih.gov/ ij/docs/menus/analyze.htm l. Accessed June 1, 2014.",OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Available from: http://www.chemaxon.co m.  Accessed January 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Available from:  http://cran.r-project.org/web/packages/fscaret/index.htm l. Accessed  June 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Available  from: http://www.R-project.org /.,Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Available from: http://cran.r-project.org/web/packages/monmlp/index.,OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
"Available from: http://CRAN.R-project.org/ package=Cubis t. Accessed June 1, 2014.",Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Available from: http://CRAN.R-project.org/package =fugeR.,Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Available  from: http://cran.r-project.org/web/packages/fscaret/vignettes/fscaret.,Non-OADS,/arxiv_data1/oa_pdf/3a/7b/ijn-10-801.PMC4310720.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/65/387.PMC4310731.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/34/28/390.PMC4310732.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/73/f7/406.PMC4310733.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/a5/ad/420.PMC4310734.pdf
Two months after publication it  is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/79/35/430.PMC4310735.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/aa/d1/440.PMC4310736.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/7c/3c/453.PMC4310737.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/de/3d/467.PMC4310738.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/9a/bc/478.PMC4310739.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f3/77/495.PMC4310740.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/eb/5c/506.PMC4310741.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/dd/ea/518.PMC4310742.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/64/25/530.PMC4310743.pdf
Two months after publication it is  available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e6/28/537.PMC4310744.pdf
Two months after publication it is available  to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported Cre - ative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/e5/9a/554.PMC4310745.pdf
Two months after publication it is avail - able to the public under an Attribution–Noncommercial–Share Alike 3.0 Unported  Creative Commons License (http://creativecommons.org/licenses/by-nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/4e/e2/569.PMC4310746.pdf
Two months after publication  it is available to the public under an Attribution–Noncommercial–Share Alike 3.0  Unported Creative Commons License (http://creativecommons.org/licenses/by- nc-sa/3.0).,Non-OADS,/arxiv_data1/oa_pdf/f9/52/583.PMC4310747.pdf
"More papers from this supplement can be found at http://www.microbecolhealthdis.net Received: 13 October 2014; Revised: 30 November 2014; Accepted: 30 November 2014; Published: 28 January 2015 In recent years, research into the human microbiome has captured the imagination of the general public,much in the same way that human genome research permeated public consciousness at the start of the new millennium.",Non-OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non- commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 26309 - http://dx.doi.org/10.3402/mehd.v26.26309 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"Y-axis: number of publications.Michael C. Toh and Emma Allen-Vercoe 2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26309 - http://dx.doi.org/10.3402/mehd.v26.26309",OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"On the left of the ﬁgure, routes of natural colonization are depicted, while on the right, impediments to natural colonization are shown.Human gut microbiota with reference to ASD Citation: Microbial Ecology in Health & Disease 2015, 26: 26309 - http://dx.doi.org/10.3402/mehd.v26.26309 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"Host remodeling of the gut microbiomeMichael C. Toh and Emma Allen-Vercoe 4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26309 - http://dx.doi.org/10.3402/mehd.v26.26309",Non-OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"Gastroenterol 2014; 146: 1547 /C153.Human gut microbiota with reference to ASD Citation: Microbial Ecology in Health & Disease 2015, 26: 26309 - http://dx.doi.org/10.3402/mehd.v26.26309 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"J Microbiol Methods 2013; 95: 167 /C174.Michael C. Toh and Emma Allen-Vercoe 6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26309 - http://dx.doi.org/10.3402/mehd.v26.26309",Non-OADS,/arxiv_data1/oa_pdf/76/7d/MEHD-26-26309.PMC4310852.pdf
"More papers from this supplement can be found at http://www.microbecolhealthdis.net Received: 8 October 2014; Revised: 1 December 2014; Accepted: 1 December 2014; Published: 28 January 2015 In this review, evidence is examined regarding the fundamental nature of autism: is it a pandemic of modern culture, or has it plagued humans for mil- lennia despite the fact that detailed descriptions of thedisease emerged only decades ago?",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution-Noncommercial 3.0 Unported License (http://creativecommons.org/licenses/by-nc/3.0/), permitting all non-commercial use, dist ribution, and reproduction in any medium, provided the original work is properly cited.1 Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"2 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"The three-legged stool in the photograph was designed and created by Kim Turk.Model for the induction of autism Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253 3 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"4 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"Thus, the microbiome could be involved in more distal and more proximal aspects of autism induction, respectively.Model for the induction of autism Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253 5 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"6 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"Second, population-wide normalization of immune function will,if the model suggested by a vast body of scientific studyModel for the induction of autism Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253 7 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"8 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"doi: 10.3233/jad- 131994.Model for the induction of autism Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253 9 (page number not for citation purpose)",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"Microb Ecol Health Dis 2012; 23: 19260, doi: http://dx.doi.org/ 10.3402/mehd.v23i0.19260 73.",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
"10 (page number not for citation purpose)Citation: Microbial Ecology in Health & Disease 2015, 26: 26253 - http://dx.doi.org/10.3402/mehd.v26.26253",Non-OADS,/arxiv_data1/oa_pdf/71/28/MEHD-26-26253.PMC4310853.pdf
Available at: http://www.bls.,Non-OADS,/arxiv_data1/oa_pdf/0b/d3/CEJU-67-00400.PMC4310883.pdf
"(http://www.kankerregister.org/media/docs/StK_publicatie.pdf), consulted 20/03/2012.",Non-OADS,/arxiv_data1/oa_pdf/79/c6/CEJU-67-00404.PMC4310885.pdf
Dostępne na: http://www.uroweb.org/guidelines/online-guidelines.,Non-OADS,/arxiv_data1/oa_pdf/7e/86/CEJU-67-00429.PMC4310891.pdf
URL: http://www.nytimes.com/2014/02/05/opinion/overselling–   testosterone–dangerously.html?_r=0  4.,Non-OADS,/arxiv_data1/oa_pdf/49/19/CEJU-67-E85.PMC4310900.pdf
"Received: December 30, 2013    Revised: February 13, 2014 Accepted:  March 13, 2014    Available online: January 12, 2015  Correspondence: Chi-Un Pae, MD, PhD  Department of Psychiatry, Bucheon St. Mary’s Hospital, The Catholic Univer - sity of Korea College of Medicine, 327 Sosa-ro, Wonmi-gu, Bucheon 420-717, Republic of KoreaTel: +82-32-430-2140, Fax: +82-32-340-2255, E-mail: pae@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.1online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/ba/34/pi-12-1.PMC4310906.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.103   Copyright © 2015 Korean Neuropsychiatric Association   103ORIGINAL ARTICLE Disrupted-in-Schizophrenia-1 SNPs and Susceptibility   to Schizophrenia: Evidence from Malaysia A. Talib Norlelawati1 , Abdullah Kartini2, Kuzaifah Norsidah1,   Musa Ramli2, Abdul Razak Tariq1, and Wan Taib Wan Rohani3 1Department of Basic Medical Sciences, Kulliyyah of Medicine, International Islamic University, Pahang, Malaysia   2Department of Psychiatry, Kulliyyah of Medicine, International Islamic University Malaysia, Pahang, Malaysia   3Faculty of Medicine, University of Sultan Zainal Abidin, Terengganu, Malaysia Objective aaEven though the role of the DICS1 gene as a risk factor for schizophrenia is still unclear, there is substantial evidence from  functional and cell biology studies that supports the connection of the gene with schizophrenia.",Non-OADS,/arxiv_data1/oa_pdf/36/ba/pi-12-103.PMC4310907.pdf
"Received: December 20, 2013    Revised: January 28, 2014 Accepted:  February 20, 2014    Available online: January 12, 2015  Correspondence: A. Talib Norlelawati, MD Department of Basic Medical Sciences, Kulliyyah of Medicine, International  Islamic University Malaysia, 25200 Kuantan, Pahang, Malaysia Tel: 609-5716400, Fax: 609-5716784, E-mail: noleata@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Schizophrenia is a complex set of disturbances in thinking,  perception, affect, and social behaviour.",Non-OADS,/arxiv_data1/oa_pdf/36/ba/pi-12-103.PMC4310907.pdf
"Received: December 25, 2013    Revised: April 14, 2014 Accepted:  April 28, 2014    Available online: October 1, 2014  Correspondence: Y ong-Ku Kim, MD, PhD  Department of Psychiatry, Korea University Ansan Hospital, Korea University  College of Medicine, 123 Jeokgeum-ro, Danwon-gu, Ansan 152-703, Republic  of KoreaTel: +82-31-412-5140, Fax: +82-31-412-5144, E-mail: yongku@korea.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.112online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/8d/49/pi-12-112.PMC4310908.pdf
Frequencies and haplotype reconstructions were calculated  using the SNP analyzer 2.0 (http://snp.istech21.com/snpana - lyzer/2.0/).,OADS,/arxiv_data1/oa_pdf/8d/49/pi-12-112.PMC4310908.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.118 118  Copyright © 2015 Korean Neuropsychiatric Association   ORIGINAL ARTICLE CRY1 Variations Impacts on the Depressive Relapse Rate   in a Sample of Bipolar Patients Antonio Drago1 , Barbara Monti2, Diana De Ronchi3, and Alessandro Serretti3 1I.R.C.C.S.",Non-OADS,/arxiv_data1/oa_pdf/99/11/pi-12-118.PMC4310909.pdf
"“San Giovanni di Dio” , Fatebenefratelli, Via Corsica, 339, Brescia  25125, Italy Tel: +39 051 6584233, Fax: +39 051 521030, E-mail: antonio.drago@unibo.it cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Bipolar Disorder (BD) is a severe chronic disease with peri - ods of remission and relapses.",Non-OADS,/arxiv_data1/oa_pdf/99/11/pi-12-118.PMC4310909.pdf
"3 Suicide is frequent among depressed bipolar patients4 and, along with that, BD ranked in the top  list of the causes of non fatal burden, accounting for 2.5% of the total YLD (years lost for disability), in 2000 [http://www.who.int, and references therein].",Non-OADS,/arxiv_data1/oa_pdf/99/11/pi-12-118.PMC4310909.pdf
An overview of the recent GW AS for BD can be found  at [http://www.genome.gov/gwastudies/].,Non-OADS,/arxiv_data1/oa_pdf/99/11/pi-12-118.PMC4310909.pdf
Available at:  http://www.R-project.org.,Non-OADS,/arxiv_data1/oa_pdf/99/11/pi-12-118.PMC4310909.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.125   Copyright © 2015 Korean Neuropsychiatric Association   125ORIGINAL ARTICLE Gene Interactions and Structural Brain Change in Early-Onset   Alzheimer’s Disease Subjects Using the Pipeline Environment Seok Woo Moon1 , Ivo D. Dinov2,3, Alen Zamanyan2, Ran Shi2, Alex Genco2, Sam Hobel2,   Paul M. Thompson2, Arthur W. Toga2, and the Alzheimer’s Disease Neuroimaging Initiative (ADNI) 1Department of Psychiatry, Konkuk University School of Medicine, Chungju, Republic of Korea   2Laboratory of Neuro Imaging, Institute for Neuroimaging and Informatics, University of Southern California, Los Angeles, CA, USA   3Statistics Online Computational Resource, UMSM, University of Michigan, Ann Arbor, MI, USA Objective aaThis article investigates subjects aged 55 to 65 from the Alzheimer’s Disease Neuroimaging Initiative (ADNI) database to  broaden our understanding of early-onset (EO) cognitive impairment using neuroimaging and genetics biomarkers.",Non-OADS,/arxiv_data1/oa_pdf/3e/52/pi-12-125.PMC4310910.pdf
"Received: November 5, 2013    Revised: February 2, 2014 Accepted:  February 3, 2014    Available online: January 12, 2015  Correspondence: Seok Woo Moon, MD, PhD Dementia Center, Department of Neuropsychiatry, Konkuk University School  of Medicine, 82 Gugwon-daero, Chungju 380-704, Republic of Korea Tel: +82-43-840-8990, Fax: +82-43-857-1380, E-mail: hessem@naver.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Alzheimer’s disease (AD) is the most common form of de - mentia and has a strong genetic component, with up to 80%  heritability, as estimated from twin-concordance studies.1,2 It  is generally divided into two main subtypes.",Non-OADS,/arxiv_data1/oa_pdf/3e/52/pi-12-125.PMC4310910.pdf
"For up-to-date information, see http://www.adni- info.org.",Non-OADS,/arxiv_data1/oa_pdf/3e/52/pi-12-125.PMC4310910.pdf
Acknowledgments Data used in preparation of this article were obtained from the Alzheim - er’s Disease Neuroimaging Initiative (ADNI) database (http://ADNI.loni.,OADS,/arxiv_data1/oa_pdf/3e/52/pi-12-125.PMC4310910.pdf
A complete listing of ADNI  investigators can be found at: http://ADNI.loni.usc.edu/study-design/on - going-investigations/.,Non-OADS,/arxiv_data1/oa_pdf/3e/52/pi-12-125.PMC4310910.pdf
"cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.136online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/15/71/pi-12-136.PMC4310911.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.142 142  Copyright © 2015 Korean Neuropsychiatric Association   BRIEF REPORT Bupropion for Interferon-Alpha-Induced Depression in Patients  with Hepatitis C Viral Infection: An Open-Label Study Wei-Chun Chen1, Hsueh-Chou Lai2,3, Wen-Pang Su2,3, Mahalakshmi Palani1, and Kuan-Pin Su1,3,4  1Department of Psychiatry and Mind-Body Interface Laboratory (MBI-Lab), China Medical University Hospital, Taichung, Taiwan   2Division of Hepatogastroenterology, Department of Medicine, China Medical University Hospital, Taichung, Taiwan   3School of Medicine, College of Medicine, China Medical University, Taichung, Taiwan   4Graduate Institute of Neural and Cognitive Sciences, China Medical University, Taichung, Taiwan Interferon (IFN)-α therapy for chronic hepatitis C virus (HCV) infection is frequently associated with major depressive episodes.",Non-OADS,/arxiv_data1/oa_pdf/b0/61/pi-12-142.PMC4310912.pdf
"Received: December 7, 2013    Revised: January 15, 2014 Accepted:  January 18, 2014    Available online: January 12, 2015  Correspondence: Kuan-Pin Su, MD, PhD Department of Psychiatry, China Medical University Hospital, 2, Yuh-Der Rd,  Taichung 404, Taiwan Tel: +886 4 2206 2121 ext 4126, Fax: +886 4 22361230 E-mail: cobolsu@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION The current standard treatment for patients with chronic  hepatitis C viral (HCV) infection is the cytokine therapy with  interferon-alpha (IFN-alpha).",Non-OADS,/arxiv_data1/oa_pdf/b0/61/pi-12-142.PMC4310912.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.146 146  Copyright © 2015 Korean Neuropsychiatric Association   CASE REPORT  A Long Term Effects of a New Onset Psychosis after DBS Treated   with Quetiapine in a Patient with Parkinson’s Disease  Sara Piccoli1 , Giulia Perini2,3, Silvia Pizzighello1, Alec Vestri1, Giovanni Ferri2,   Tommaso Toffanin2, Halima Follador2, and Andrea Martinuzzi1 1 Rehabilitation Unit for the Acquired Neuropsychological Disorders, “E.",Non-OADS,/arxiv_data1/oa_pdf/ec/bf/pi-12-146.PMC4310913.pdf
"Medea” Sci - entific Institute Conegliano-Pieve di Soligo Research Center, Via Montegrappa, 96 31053-Pieve di Soligo (TV), ItalyTel: +3904389062, Fax: +390438980444, E-mail: sara.piccoli@ps.lnf.it cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Deep Brain Stimulation represents a therapeutic option for  neurological and psychiatric diseases such as PD and Obses - sive-Compulsive Disorder (OCD).1 Its effects on motor symp - toms and quality of life of advanced PD are well established2  and, at least for young-onset patients, seems to last at 10 year  follow-up.3 At the earlier stage of the disease, neurostimula - tion in combination with medical therapy improves motor symptoms better than medical therapy alone.",Non-OADS,/arxiv_data1/oa_pdf/ec/bf/pi-12-146.PMC4310913.pdf
"Received: September 2, 2013    Revised: October 22, 2013 Accepted:  October 22, 2013    Available online: January 12, 2015  Correspondence: Ömer Faruk Akça, MD Department of Child and Adolescent Psychiatry, Necmettin Erbakan Univer - sity, Meram School of Medicine, Meram, Konya, TurkeyTel: +90-332-223-6859, Fax: +90-362-431-7855 E-mail: dromerakca@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.150online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/bf/fc/pi-12-150.PMC4310914.pdf
"Psychiatry Investig 2015 ;12(1):152-154 Key Words aa Bariatric surgery, Mania, Psychosis, Morbid obesity.http://dx.doi.org/10.4306/pi.2015.12.1.152 Received: September 18, 2013    Revised: October 16, 2013 Accepted:  October 16, 2013    Available online: January 12, 2015  Correspondence: Hitekshya Nepal, MD Department of Psychiatry and Behavioral Sciences, Southern Illinois Univer - sity, 901 W Jefferson Street, Springfield, IL 62794, USATel: +1-570-764-0092, Fax: +1-570-293-0140, E-mail: hitekshya@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/89/04/pi-12-152.PMC4310915.pdf
"Received: October 15, 2013    Revised: February 17, 2014 Accepted:  March 11, 2014    Available online: January 12, 2015  Correspondence: Jee Hyun Ha, MD, PhD Department of Psychiatry, School of Medicine, Konkuk University, 120-1 Neung - dong-ro, Gwangjin-gu, Seoul 143-729, Republic of KoreaTel: +82-2-2030-7569, Fax: +82-2-2030-7748, E-mail: jhnha@naver.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.16online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/b0/d9/pi-12-16.PMC4310916.pdf
"Received: November 22, 2013    Revised: February 26, 2014 Accepted:  April 11, 2014    Available online: January 12, 2015  Correspondence: Jae Hong Park, MD, PhD  Department of Psychiatry, Dong-A University College of Medicine, 26 Dae - singongwon-ro, Seo-gu, Busan 602-715, Republic of KoreaTel: +82-51-240-5467, Fax: +82-51-253-3542, E-mail: drpark@dau.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.23ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/d2/06/pi-12-23.PMC4310917.pdf
"Received: October 11, 2013    Revised: December 14, 2013 Accepted:  December 23, 2013    Available online: January 12, 2015  Correspondence: Soo-Churl Cho, MD, PhD  Division of Child and Adolescent Psychiatry, Department of Psychiatry, Seoul  National University College of Medicine, 101 Daehak-ro, Jongno-gu, Seoul  110-744, Republic of KoreaTel: +82-2-2072-3648, Fax: +82-2-747-2471, E-mail: soochurl@snu.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.29ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/49/55/pi-12-29.PMC4310918.pdf
"Received: February 24, 2014    Revised: August 18, 2014      Accepted:  August 27, 2014    Available online: October 30, 2014  Correspondence: Keun-Ah Cheon, MD, PhD  Division of Child and Adolescent Psychiatry, Y onsei Autism Laboratory, De - partment of Psychiatry and Institute of Behavioral Science in Medicine, Sev- erance Hospital, Y onsei University College of Medicine, 50-1 Y onsei-ro, Seo - daemun-gu, Seoul 120-752, Republic of Korea Tel: +82-2-2228-1633, Fax: +82-2-313-0891, E-mail: kacheon@yuhs.ac  Correspondence: Chang Uk Lee, MD, PhD  Department of Psychiatry, Seoul St. Mary’s Hospital, The Catholic University  of Korea, 222 Banpo-daero, Seocho-gu, Seoul 137-701, Republic of Korea Tel: +82-2-2258-6082, Fax: +82-2-536-8744, E-mail: jihan@catholic.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.37ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/0e/3d/pi-12-37.PMC4310919.pdf
"Received: October 22, 2013    Revised: January 13, 2014 Accepted:  February 15, 2014    Available online: October 1, 2014  Correspondence: Seong-Hoon Jeong, MD, PhD  Department of Psychiatry, Eulji University School of Medicine, Eulji Univer - sity Hospital, 95 Dunsanseo-ro, Seo-gu, Daejeon 302-799, Republic of KoreaTel: +82-42-611-3443, Fax: +82-42-611-3444  E-mail: anselmJeong@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.46online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/eb/3a/pi-12-46.PMC4310920.pdf
URL: http://www-ice.iarc.,Non-OADS,/arxiv_data1/oa_pdf/eb/3a/pi-12-46.PMC4310920.pdf
"Received: September 12, 2013    Revised: October 27, 2013 Accepted:  October 28, 2013    Available online: January 12, 2015  Correspondence: Y oung-Min Park, MD, PhD Department of Psychiatry, Ilsan Paik Hospital, Inje University College of Medi - cine, 170 Juhwa-ro, Ilsanseo-gu, Goyang 411-706, Republic of KoreaTel: +82-31-910-7260, Fax: +82-31-910-7268 E-mail: medipark@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.55online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/ae/de/pi-12-55.PMC4310921.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.61   Copyright © 2015 Korean Neuropsychiatric Association   61ORIGINAL ARTICLE Neural Network Based Response Prediction of rTMS in Major   Depressive Disorder Using QEEG Cordance Turker Tekin Erguzel1 , Serhat Ozekes1, Selahattin Gultekin2,   Nevzat Tarhan3,4, Gokben Hizli Sayar3,4, and Ali Bayram5 1Department of Computer Engineering, Faculty of Engineering and Natural Sciences, Uskudar University, Istanbul, Turkey   2Department of Bioengineering, Faculty of Engineering and Natural Sciences, Uskudar University, Istanbul, Turkey   3Department of Psychiatry, Faculty of Humanities and Social Sciences, Uskudar University, Istanbul, Turkey   4Department of Psychiatry, NPIstanbul Hospital, Istanbul, Turkey   5Biomedical Equipment Technology, Uskudar University, Istanbul, Turkey Objective aaThe combination of repetitive transcranial magnetic stimulation (rTMS), a non-pharmacological form of therapy for treat - ing major depressive disorder (MDD), and electroencephalogram (EEG) is a valuable tool for investigating the functional connectivity  in the brain.",Non-OADS,/arxiv_data1/oa_pdf/fe/6c/pi-12-61.PMC4310922.pdf
"No:14 PK:  34662 Uskudar, IstanbulTel: +90 216 400 22 22, Fax: +90 216 474 12 56 E-mail: turker.erguzel@uskudar.edu.tr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Major depressive disorder is considered to be a chronic, re - lapsing and remitting illness.",Non-OADS,/arxiv_data1/oa_pdf/fe/6c/pi-12-61.PMC4310922.pdf
Available at: http://www.cordance.com.,Non-OADS,/arxiv_data1/oa_pdf/fe/6c/pi-12-61.PMC4310922.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.66 66  Copyright © 2015 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Association of Hair Manganese Level with Symptoms   in Attention-Deficit/Hyperactivity Disorder Dong-Won Shin1, Eun-Ji Kim2, Se-Won Lim1, Young-Chul Shin1, Kang-Seob Oh1, and Eun-Jin Kim1  1Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan University School of Medicine, Seoul, Republic of Korea   2Dr.",Non-OADS,/arxiv_data1/oa_pdf/b1/10/pi-12-66.PMC4310923.pdf
"Received: October 30, 2013    Revised: December 27, 2013 Accepted:  January 2, 2014    Available online: January 12, 2015  Correspondence: Eun-Jin Kim, MD Department of Psychiatry, Kangbuk Samsung Hospital, Sungkyunkwan Uni - versity School of Medicine, 29 Saemunan-ro, Jongno-gu, Seoul 110-746, Repub - lic of KoreaTel: +82-2-2001-8537, Fax: +82-2-2001-2211, E-mail: revise79@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Attention-deficit/hyperactivity disorder (ADHD) is one of  the most common psychiatric disorders of childhood and ad - olescence.1 ADHD has a global prevalence of about 5%.1  ADHD is characterized by symptoms of inattention, hyperac - tivity, and impulsivity.",Non-OADS,/arxiv_data1/oa_pdf/b1/10/pi-12-66.PMC4310923.pdf
Available at: http://www.epa.,OADS,/arxiv_data1/oa_pdf/b1/10/pi-12-66.PMC4310923.pdf
"Received: October 26, 2013    Revised: March 9, 2014 Accepted:  April 28, 2014    Available online: January 12, 2015  Correspondence: Saied Karbalay-Doust, MSc Histomorphometry and Stereology Research Centre, Shiraz University of Medi - cal Sciences, Zand Ave., Shiraz 71348-45794, IranTel: +98-711-2304372, Fax: +98-711-2304372, E-mail: karbalas@sums.ac.ir cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.http://dx.doi.org/10.4306/pi.2015.12.1.73online © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/8e/ad/pi-12-73.PMC4310924.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.81   Copyright © 2015 Korean Neuropsychiatric Association   81ORIGINAL ARTICLE Profiling of Proteins Regulated by Venlafaxine during   Neural Differentiation of Human Cells Mi Sook Doh1, Dal Mu Ri Han1, Dong Hoon Oh2, Seok Hyeon Kim2, Mi Ran Choi1 , and Young Gyu Chai1  1Department of Molecular and Life Sciences, Hanyang University, Ansan, Republic of Korea   2Department of Neuropsychiatry, College of Medicine and Institute of Mental Health, Hanyang University, Seoul, Republic of Korea Objective aaAntidepressants are known to positively influence several factors in patients with depressive disorders, resulting in in - creased neurogenesis and subsequent relief of depressive disorders.",Non-OADS,/arxiv_data1/oa_pdf/88/48/pi-12-81.PMC4310925.pdf
"Received: September 5, 2013    Revised: March 7, 2014 Accepted:  March 25, 2014    Available online: January 12, 2015  Correspondence: Y oung Gyu Chai, PhD Department of Molecular and Life Sciences, Hanyang University, 55 Hanyang - daehak-ro, Sangnok-gu, Ansan 426-791, Republic of KoreaTel: +82-31-400-5513, Fax: +82-31-406-6316, E-mail: ygchai@hanyang.ac.kr  Correspondence: Mi Ran Choi, PhD Department of Molecular and Life Sciences, Hanyang University, 55 Hanyang - daehak-ro, Sangnok-gu, Ansan 426-791, Republic of KoreaTel: +82-31-400-3937, Fax: +82-31-406-6316 E-mail: mrchoi2007@gmail.com cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Treatment with antidepressants promotes a rapid increase  in levels of monoamines in the synaptic cleft, whereas the  clinical effects of antidepressants are observed only after sev - eral weeks to months.1,2 Previous studies have shown that  chronic treatment of antidepressants such as tianeptine and fluoxetine increases expression of brain-derived neurotropic factor (BDNF), mitogen-activated protein kinase, Bcl-xL, and NCAM140, as well as increases cell survival, suggesting that antidepressants affect the cellular and molecular mechanisms in the brain in addition to increasing levels of monoamines.",Non-OADS,/arxiv_data1/oa_pdf/88/48/pi-12-81.PMC4310925.pdf
"Received: December 23, 2013    Revised: February 4, 2014    Accepted:  March 27, 2014    Available online: October 1, 2014  Correspondence: Won-Hyoung Kim, MD Department and Research Institute of Psychiatry, Inha University College of  Medicine, 27 Inhang-ro, Jung-gu, Incheon 400-711, Republic of Korea Tel: +82-32-890-3540, Fax: +82-32-890-3558, E-mail: ckgodman@hanmail.net cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.9ORIGINAL ARTICLEonline © ML Comm",Non-OADS,/arxiv_data1/oa_pdf/06/53/pi-12-9.PMC4310926.pdf
Available at:  http://www.unikorea.go.kr/index.do?,Non-OADS,/arxiv_data1/oa_pdf/06/53/pi-12-9.PMC4310926.pdf
Suicidal rate in South Korea in 2011-Korea National Statistical Office  Available at: http://kostat.go.kr/portal/english/news/1/8/index.,OADS,/arxiv_data1/oa_pdf/06/53/pi-12-9.PMC4310926.pdf
"Print ISSN 1738-3684 / On-line ISSN 1976-3026 OPEN ACCESS http://dx.doi.org/10.4306/pi.2015.12.1.92 92  Copyright © 2015 Korean Neuropsychiatric Association   ORIGINAL ARTICLE Automated Classification to Predict the Progression of   Alzheimer’s Disease Using Whole-Brain Volumetry and DTI Won Beom Jung1, Young Min Lee2,3, Young Hoon Kim4, and Chi-Woong Mun1  1Department of Biomedical Engineering/u-HARC, Inje University, Gimhae, Republic of Korea   2Department of Psychiatry, Pusan National University Hospital, Busan, Republic of Korea   3Medical Research Institute, Pusan National University Hospital, Busan, Republic of Korea   4Department of Psychiatry, Medical School, Inje University, Haeundae Paik Hospital, Busan, Republic of Korea Objective aaThis study proposes an automated diagnostic method to classify patients with Alzheimer’s disease (AD) of degenerative eti - ology using magnetic resonance imaging (MRI) markers.",Non-OADS,/arxiv_data1/oa_pdf/71/7b/pi-12-92.PMC4310927.pdf
"Received: September 2, 2013    Revised: December 29, 2013 Accepted:  December 30, 2013    Available online: January 12, 2015  Correspondence: Chi-Woong Mun, PhD Department of Biomedical Engineering/u-HARC, Inje University, Building A,  197 Inje-ro, Gimhae 621-749, Republic of Korea Tel: +82-55-320-3297, Fax: +82-55-327-3292, E-mail: mcw@inje.ac.kr cc This is an Open Access article distributed under the terms of the Creative Commons  Attribution Non-Commercial License (http://creativecommons.org/licenses/by- nc/3.0 ) which permits unrestricted non-commercial use, distribution, and reproduc - tion in any medium, provided the original work is properly cited.INTRODUCTION Alzheimer’s disease (AD), which is becoming the most  prevalent neurodegenerative disorder with aging of the pop - ulation, leads to an irreversible decline in memory, cognition  and thinking ability.1,2 Mild cognitive impairment (MCI) and  subjective memory impairment (SMI) have been proposed as intermediate states of AD from cognitively normal elderly (CNE) people.",Non-OADS,/arxiv_data1/oa_pdf/71/7b/pi-12-92.PMC4310927.pdf
"MRI data processing Structural image processing Whole-brain structural analyses of cerebral cortical thick - ness and subcortical volume based on T1WI were performed  using FreeSurfer v.5.1 (http://surfer.nmr.mgh.harvard.edu/).30,31  As a fully automated image-processing tool for macroscopi - cally visible brain structures, FreeSurfer constructs models of  brain tissue surfaces and subcortical areas, and is useful to  measure cerebral cortical thickness and subcortical volumes.",OADS,/arxiv_data1/oa_pdf/71/7b/pi-12-92.PMC4310927.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1016/j.nicl.2014.06.015 2213-1582/© 2014 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1016/S1474- 4422(07)70196-517689148 .,OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1016/ j.neuroimage.2011.12.07022245259 .,OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1177/088307381245278422914372 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1212/01.wnl.0000326896.66714.ae18824673 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
"Journal of Neurology 252 (S5), v16 –v24.http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
"NeuroImage 62, 48 –58.http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1007/s00415-012-6475- 922446893 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1093/brain/awm31918202106 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1002/ana.2236621387374 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1016/j.neuroimage.2005.08.,OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1056/NEJMoa06759717582070 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1007/s10072-004-0335-z15727227 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1006/nimg.2001.097811771995 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1177/ 088307381245608422952316 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1371/journal.pone.002113821695053 .,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1016/j.neuroimage.2012.01.06422281674 .,OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
"Human Brain Mapping 17, 48–60.http://dx.doi.org/10.1002/hbm.1005312203688 .",Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.1002/mrm.,Non-OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
http://dx.doi.org/10.3174/ajnr.A350323578679 .408 M. Weygandt et al.,OADS,/arxiv_data1/oa_pdf/70/cf/main.PMC4310929.pdf
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/j.nicl.2015.01.009 2213-1582/© 2015 The Authors.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/4.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/j.nicl.,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1371/journal.pone.003921622720079 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1080/146608200300079536 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.2967/jnumed.107.04484218006619 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.2967/jnumed.109.,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
"169 (1-2), 13 –21.http://dx.doi.org/10.1016/S0022-510X(99)00210-510540002 .",OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1371/journal.pone.005294123300829 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1212/WNL.53.5.105110496265 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1038/nrneurol.2011.15222051914 .,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1371/journal.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1002/ana.1080514755726 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
"http://dx.doi.org/ 10.2967/jnumed.113.13634125278515 .Kawamata, T., Akiyama, H., Yamada, T., McGeer, P.L., 1992.",OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/j.neuroimage.2009.11.05619948230 .,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1038/jcbfm.2012.13122968319 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/ S0140-6736(96)91680-38676624 .,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1093/brain/ awu377 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
"15 (1), 1 –25.http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1007/s11481-010-9243-620872081 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
"J Cereb Blood Flow Metab 32 (1), 1 –5.http://dx.doi.org/10.1038/jcbfm.2011.147 .",Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/j.nbd.2003.12.,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1093/brain/ awh509 .,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.1016/S0969-8051(00)00132-311056365 .,OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
http://dx.doi.org/10.2967/jnumed.112.11888523785173 .414 N.R.,Non-OADS,/arxiv_data1/oa_pdf/73/aa/main.PMC4310932.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Pregnancy, Prenatal Care, and Delivery of Mothers with  Disabilities in Korea  The aim of this study was to investigate the whole picture regarding pregnancy, prenatal  care, obstetrical complications, and delivery among disabled pregnant women in Korea.",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"Keywords:  Disabled Women; Pregnancy; Prenatal Care; Delivery, Obstetric; Obstetrical  ComplicationsNam Gu Lim,1 Jin Yong Lee,2   Ju Ok Park,3 Jung-A Lee,4  and Juhwan Oh5 1Department of Medical Administration, Daejeon  Health Sciences College, Daejeon; 2Public Health  Medical Service, Seoul National University Boramae  Medical Center, Seoul; 3Department of Emergency  Medicine, Seoul National University Hospital, Seoul;  4Institute of Health Policy and Management,  Medical Research Center, Seoul National University,  Seoul; 5JW LEE Center for Global Medicine, Seoul  National University College of Medicine, Seoul,  Korea Received: 15 May 2014 Accepted: 1 October 2014 Address for Correspondence: Jin Yong Lee, MD Public Health Medical Service, Seoul National University  Boramae Medical Center, 20 Boramae-ro 5-gil, Dongjak-gu,  Seoul 156-707 Korea Tel: +82.2-870-2165, Fax: +82.2-831-0714 E-mail: jylee2000@gmail.com Funding:  This study was supported by the National Health  Insurance Corporation in Korea.http://dx.doi.org/10.3346/jkms.2015.30.2.127  • J Korean Med Sci 2015; 30: 127-132 INTRODUCTION Pregnancy and childbirth is an important event in a woman’s  life, regardless of them carrying or not carrying disability.",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"• Pregnancy, Prenatal care, and Delivery among Disabled Women 128  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.127MATERIALS AND METHODS Materials   The study subjects were selected from the NHIC database,  women who terminated pregnancy including delivery and  abortion from January 1, 2010 to December 31, 2010.",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"• Pregnancy, Prenatal care, and Delivery among Disabled Women http://jkms.org   129 http://dx.doi.org/10.3346/jkms.2015.30.2.127(P< 0.001) (Table 3).",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"• Pregnancy, Prenatal care, and Delivery among Disabled Women 130  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.127Obstetrical complications  In regards to the eight obstetrical complications we operationally  defined in this study, 11.3% of disabled women experienced at  least one complication, which was higher than non-disabled  women with 7.6% ( P< 0.001).",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"• Pregnancy, Prenatal care, and Delivery among Disabled Women http://jkms.org   131 http://dx.doi.org/10.3346/jkms.2015.30.2.127index, if a pregnant woman had less than 4 visits to the doctor  for prenatal care, this would be evaluated as inadequate.",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
ORCID Nam Gu Lim http://orcid.org/0000-0002-9351-6422 Jin Yong Lee http://orcid.org/0000-0002-7752-2697 Ju Ok Park http://orcid.org/0000-0002-1024-3626 Jung-A Lee http://orcid.org/0000-0001-9724-2417 Juhwan Oh http://orcid.org/0000-0002-0784-5108 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"• Pregnancy, Prenatal care, and Delivery among Disabled Women 132  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.1273.",Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
Available at http://www.mogef.go.kr/korea/view/ policyGuide/policyGuide04_02_03.jsp?func=view&currentPage=0&key_ type=&key=&search_start_date=&search_end_date=&class_ id=0&idx=633834 [accessed on 23 January 2014].,Non-OADS,/arxiv_data1/oa_pdf/9c/a1/jkms-30-127.PMC4310936.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357High Occupational Stress and Low Career Satisfaction of Korean  Surgeons Surgery is a demanding and stressful field in Korea.",Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
"Keywords:  Occupational Stress; Surgeon; Physicians; Career Satisfaction; Working Hours;  Exercise; BurnoutSang Hee Kang,1 Yoon Jung Boo,1   Ji Sung Lee,2 Hyung Joon Han,1   Cheol Woong Jung,1 and Chong Suk Kim1 1Department of Surgery, Korea University College of  Medicine, Seoul; 2Department of Medical Statistics,  Clinical Research Center, Asan Medical Center,  Seoul, Korea Received: 24 June 2014 Accepted: 1 October 2014 Address for Correspondence: Yoon Jung Boo, MD Division of Pediatric Surgery, Department of Surgery,   Korea University College of Medicine, 73 Inchon-ro,   Seongbuk-gu, Seoul 136-705, Korea Tel: +82.2-920-6844, Fax: +82.2-928-1631 E-mail: drboo@korea.ac.kr Funding:  Funds received from the Korean Surgical Society (2012  Research fund) were used to cover the administrative costs of  performing the survey, data entry, and statistical analysis.http://dx.doi.org/10.3346/jkms.2015.30.2.133  • J Korean Med Sci 2015; 30: 133-139 INTRODUCTION A surgeon is a medical doctor with the trained specialty to op ­ erate in need of variety of surgical procedure.",Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons 134  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.133Korean Surgical Society and under oversight of the institutional  review board (IRB) of the Korea University Anam hospital.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
"• Occupational Stress of Korean Surgeons http://jkms.org   135 http://dx.doi.org/10.3346/jkms.2015.30.2.133 When we implemented multiple linear regression analysis  on all variables which were significantly related to occupational  stress in the univariate analysis, long working hours and exer ­ cise were factors independently associated with occupational  stress of Korean surgeons (Table 3).",OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons 136  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.133stress of surgeons in Korea.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org   137 http://dx.doi.org/10.3346/jkms.2015.30.2.133were widely used in other countries in order to obtain the burn ­ out rate and the relation to the KOSS score of this group of peo ­ ples (12).,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons 138  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.133dents and nonrespondents (23).,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
ORCID Sang Hee Kang http://orcid.org/0000-0002-6097-8831 Yoon Jung Boo http://orcid.org/0000-0002-3796-6699 Ji Sung Lee http://orcid.org/0000-0001-8194-3462 Hyung Joon Han http://orcid.org/0000-0002-7830-5352 Cheol Woong Jung http://orcid.org/0000-0002-0776-8202 Chong Suk Kim http://orcid.org/0000-0003-0050-6549  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org   139 http://dx.doi.org/10.3346/jkms.2015.30.2.133Oncology 2005; 68: 23-32.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.133Appendix 1.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.133    ­ Pediatric surgery     ­ Breast endocrine surgery     ­ Transplantation & vascular surgery     ­ Trauma surgery & Intensive critical care medicine     ­ Colorectal surgery 8.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.133       ­ Never        ­ One day        ­  Two days        ­ Three days        ­ More than four days 15.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13321.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13328.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13335.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13342.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13349.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13356.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
• Occupational Stress of Korean Surgeons http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.13364.,Non-OADS,/arxiv_data1/oa_pdf/f3/aa/jkms-30-133.PMC4310937.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Serum Levels of IL-8 and ICAM-1 as Biomarkers for Progressive  Massive Fibrosis in Coal Workers’ Pneumoconiosis Coal workers’ pneumoconiosis (CWP) is characterized as a chronic inflammation of the lung  associated with activation of macrophages and endothelial cells in the lung.",Non-OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
"Keywords:  Coal Workers’ Pneumoconiosis; Intercellular Adhesion Molecule-1; Interleukin-8;  Macrophage Inflammatory Protein-1 Alpha; Progressive Massive FibrosisJong Seong Lee, Jae Hoon Shin,   and Byung-Soon Choi Occupational Lung Diseases Institute, Korea  Workers’ Compensation & Welfare Service, Incheon,  Korea Received: 10 July 2014 Accepted: 17 September 2014 Address for Correspondence: Jong Seong Lee, PhD Occupational Lung Diseases Institute, Korea Workers’  Compensation & Welfare Service, 478 Munemi-ro,   Bupyeong-gu, Incheon 403-711, Korea Tel: +82.32-540-4981, Fax: +82.32-540-4997 E-mail: ljs5075@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.2.140  • J Korean Med Sci 2015; 30: 140-144 INTRODUCTION  Coal workers’ pneumoconiosis (CWP) is characterized by a  progressive fibrotic lung disease.",Non-OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
• IL-8 and ICAM-1 in Coal Workers’ Pneumoconiosis http://jkms.org   141 http://dx.doi.org/10.3346/jkms.2015.30.2.140(KCOMWEL).,Non-OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
• IL-8 and ICAM-1 in Coal Workers’ Pneumoconiosis 142  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.140Serum cytokine levels The mean level of ICAM-1 was significantly different based on  smoking status ( P= 0.049).,OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
• IL-8 and ICAM-1 in Coal Workers’ Pneumoconiosis http://jkms.org   143 http://dx.doi.org/10.3346/jkms.2015.30.2.140sponse to alcohol (14) and the hepatitis virus (15).,Non-OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
ORCID Jong Seong Lee http://orcid.org/0000-0002-1672-0171 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
• IL-8 and ICAM-1 in Coal Workers’ Pneumoconiosis 144  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.140nary intercellular adhesion molecule-1 (ICAM-1) in C57Bl/6 mice.,OADS,/arxiv_data1/oa_pdf/43/53/jkms-30-140.PMC4310938.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Phenotypic and Functional Analysis of HL-60 Cells Used in  Opsonophagocytic-Killing Assay for Streptococcus pneumoniae Differentiated HL-60 is an effector cell widely used for the opsonophagocytic-killing assay  (OPKA) to measure efficacy of pneumococcal vaccines.",Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
"Keywords:  Opsonophagocytic-Killing Assay; Streptococcus pneumonia ; HL-60;  DifferentiationKyung-Hyo Kim,1 Ju Young Seoh,2   and Su Jin Cho1 Departments of 1Pediatrics and 2Microbiology,  School of Medicine, Ewha Womans University,  Seoul, Korea Received: 14 August 2014 Accepted: 25 September 2014 Address for Correspondence: Su Jin Cho, MD Department of Pediatrics, School of Medicine, Ewha Womans  University, 1071 Anyangcheon-ro, Yangcheon-gu,   Seoul 158-710, Korea  Tel: +82.2-2660-2859, Fax: +82.2-2653-3718 E-mail: sujin-cho@ewha.ac.kr Funding:  This study was supported by the grant from the  Ministry of Food and Drug Safety (11172MFDS360) to KHK.http://dx.doi.org/10.3346/jkms.2015.30.2.145  • J Korean Med Sci 2015; 30: 145-150 INTRODUCTION Streptococcus pneumonia e is a significant pathogen for young  children and the elderly worldwide (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
"• Phenotypic and Functional Characteristics of Differentiated HL-60 Cells 146  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.145MD, USA), 0.2% sodium bicarbonate and appropriate antibiotics  in 5% CO 2–humidified incubator at 37°C and the culture me- dium was changed every 3-4 days.",Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
"• Phenotypic and Functional Characteristics of Differentiated HL-60 Cells http://jkms.org   147 http://dx.doi.org/10.3346/jkms.2015.30.2.145tained over 95% through day 1, 2, 3, 4, and 5 after addition of  DMF , ATRA, or VitD 3.",Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
• Phenotypic and Functional Characteristics of Differentiated HL-60 Cells 148  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.145expression of the differentiated HL-60 cells correlated well with  OPKA activity in all 3 agents (Table 2).,OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
• Phenotypic and Functional Characteristics of Differentiated HL-60 Cells http://jkms.org   149 http://dx.doi.org/10.3346/jkms.2015.30.2.145to play a critical role in the opsonophagocytosis of S. pneumoni - ae.,Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
ORCID Kyung-Hyo Kim http://orcid.org/0000-0002-0333-6808  Ju Young Seoh http://orcid.org/0000-0002-1168-5354 Su Jin Cho http://orcid.org/0000-0002-3851-9073 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
"• Phenotypic and Functional Characteristics of Differentiated HL-60 Cells 150  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.145Leroy O, Nohynek H. Antibody response to an eleven valent diphtheria-  and tetanus-conjugated pneumococcal conjugate vaccine in Filipino in - fants.",Non-OADS,/arxiv_data1/oa_pdf/32/f0/jkms-30-145.PMC4310939.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Experience of Advance Directives in a Hospice Center To protect patient autonomy when confronting death, the importance of advance  directives (ADs) has recently became an issue and gradually accepted in Korea.",Non-OADS,/arxiv_data1/oa_pdf/5e/84/jkms-30-151.PMC4310940.pdf
"Keywords:  Advance Directives; Hospice Care; NeoplasmsBong Han Kong,1,2 Ho Jung An,1,2  Hyun Seon Kim,1,2 So-Young Ha,1,2 Il-Kyu Kim,1,2 Jung Eun Lee,1,2  Youn Jung Park,1,2 Yi-Jin Kang,2  Young Rye Kim,2 and Hoon-Kyo Kim1,2 1Department of Medical Oncology, and 2Hospice  Center, St. Vincent’s Hospital, College of Medicine,  The Catholic University of Korea, Suwon, Korea Received: 22 June 2014 Accepted: 23 September 2014 Address for Correspondence: Hoon-Kyo Kim, MD Department of Medical Oncology, St. Vincent’s Hospital, College  of Medicine, The Catholic University of Korea, 93 Jungbu-daero,  Paldal-gu, Suwon 442-723, Korea Tel: +82.31-249-7127, Fax: +82.31-255-8203 E-mail: miongsok@catholic.ac.krhttp://dx.doi.org/10.3346/jkms.2015.30.2.151  • J Korean Med Sci 2015; 30: 151-154 INTRODUCTION Advance directives (ADs) document patients’ wishes with re - spect to end-of-life care and who will make health care deci - sions for patients when they become incompetent (1).",Non-OADS,/arxiv_data1/oa_pdf/5e/84/jkms-30-151.PMC4310940.pdf
• Advance Directives in Terminal Cancer Patients 152  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.151tional review board of St. Vincent’s Hospital (No.,Non-OADS,/arxiv_data1/oa_pdf/5e/84/jkms-30-151.PMC4310940.pdf
"• Advance Directives in Terminal Cancer Patients http://jkms.org   153 http://dx.doi.org/10.3346/jkms.2015.30.2.151After establishing rapport with patients, the doctor carefully  explained ADs and helped them to complete ADs.",Non-OADS,/arxiv_data1/oa_pdf/5e/84/jkms-30-151.PMC4310940.pdf
• Advance Directives in Terminal Cancer Patients 154  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.151script: Kong BH.,Non-OADS,/arxiv_data1/oa_pdf/5e/84/jkms-30-151.PMC4310940.pdf
ORCID Bong Han Kong http://orcid.org/0000-0002-8408-5173 Ho Jung An http://orcid.org/0000-0003-0821-8365 Hoon-Kyo Kim http://orcid.org/0000-0001-9053-314X REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/5e/84/jkms-30-151.PMC4310940.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Clinical Significance of Aberrant Wnt7a Promoter Methylation in  Human Non-Small Cell Lung Cancer in Koreans The Wnt signaling pathway has regulatory roles in cell proliferation, differentiation, and  polarity.",Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
"Keywords:  Carcinoma, Non-small Cell Lung; Wnt7a; Biologic Markers; E-cadherin Tae-Hyung Kim,1 Ji-Yong Moon,1   Sang-Heon Kim,1 Seung Sam Paik,2   Ho Joo Yoon,1 Dong Ho Shin,1   Sung Soo Park,1 and Jang Won Sohn1  Departments of 1Internal Medicine and 2Pathology,  Hanyang University College of Medicine, Seoul,  Korea Received: 18 July 2014 Accepted: 17 September 2014 Address for Correspondence: Jang Won Sohn, MD Department of Internal Medicine, Hanyang University College of  Medicine, 222 Wangsimri-ro, Seongdong-gu, Seoul 138-791,  Korea Fax: +82.2-2298-9183, Tel: +82.2-2290-8365 E-mail: jwsohn@hanyang.ac.kr Funding:  This work was supported by the research fund of  Hanyang University (HY-2011-I ).http://dx.doi.org/10.3346/jkms.2015.30.2.155  • J Korean Med Sci 2015; 30: 155-161 INTRODUCTION Primary carcinoma of the lung is one of the leading causes of  cancer-related deaths worldwide.",Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
"• Loss of Wnt7a in Non-Small Cell Lung Cancer 156  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.155tified in pancreatic cancer (17, 18).",Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
"• Loss of Wnt7a in Non-Small Cell Lung Cancer http://jkms.org   157 http://dx.doi.org/10.3346/jkms.2015.30.2.155deoxynucleotide triphosphates (final concentration 200 μM  each), 15 pM of each primer (Cosmo, Seoul, Korea), 10 μL of  modified DNA, 0.75 U of TaqTM polymerase (Intron Biotechnol - ogy Inc., Seongnam, Korea), and was adjusted with water to a  final volume of 25 μL.",Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
• Loss of Wnt7a in Non-Small Cell Lung Cancer 158  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.155dows (IBM SPSS 21.0).,Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
• Loss of Wnt7a in Non-Small Cell Lung Cancer http://jkms.org   159 http://dx.doi.org/10.3346/jkms.2015.30.2.155that Wnt7a methylation would cause the loss of E-cadherin ex - pression.,Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
"• Loss of Wnt7a in Non-Small Cell Lung Cancer 160  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.155Therefore, it seems likely that loss of Wnt7a caused by promoter  methylation results in the loss of E-cadherin expression in hu - man NSCLC.",Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
ORCID Tae-Hyung Kim http://orcid.org/0000-0001-7132-2988 Ji-Yong Moon http://orcid.org/0000-0003-2459-3448 Sang-Heon Kim http://orcid.org/0000-0001-8398-4444 Seung Sam Paik http://orcid.org/0000-0002-8607-4072 Ho Joo Yoon http://orcid.org/0000-0002-4645-4863 Dong Ho Shin http://orcid.org/0000-0002-5911-3216 Sung Soo Park http://orcid.org/0000-0003-4736-1447 Jang Won Sohn http://orcid.org/0000-0002-3863-7854    REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
• Loss of Wnt7a in Non-Small Cell Lung Cancer http://jkms.org   161 http://dx.doi.org/10.3346/jkms.2015.30.2.155mutations in lung adenocarcinoma.,Non-OADS,/arxiv_data1/oa_pdf/db/eb/jkms-30-155.PMC4310941.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Diagnostic Performance of Body Mass Index Using the Western  Pacific Regional Office of World Health Organization Reference  Standards for Body Fat Percentage Associations between body mass index (BMI), body fat percentage (BF%), and health risks  differ between Asian and European populations.",Non-OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
"Keywords:  Adiposity; Body Composition; Body Mass Index; Obesity Jong Lull Yoon,1 Jung Jin Cho,1   Kyung Mi Park,2 Hye Mi Noh,1   and Yong Soon Park1 1Department of Family Medicine, Hallym University  College of Medicine, Chuncheon; 2Sejong Samsung  Med Clinic, Kangbuk Samsung Hospital, Sejong,  Korea Received: 21 May 2014 Accepted: 17 September 2014 Address for Correspondence: Jung Jin Cho, MD Department of Family Medicine, Hallym University Sacred Heart  Dongtan Hospital, 7 Keunjaebong-gil, Hwaseong 445-907,  Korea Tel: +82.31-8086-2392, Fax: +82.31-8086-2242 E-mail: fmjjcho@naver.comhttp://dx.doi.org/10.3346/jkms.2015.30.2.162  • J Korean Med Sci 2015; 30: 162-166 INTRODUCTION Obesity can cause hypertension, hyperlipidemia, and cardio ­ vascular disease (1).",Non-OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
"• Diagnostic Performance of BMI for Body Fat Percentage Defined Obesity http://jkms.org   163 http://dx.doi.org/10.3346/jkms.2015.30.2.162MATERIALS AND METHODS Data source and study subjects The data for this study were obtained from the Third Korean  National Health and Nutrition Examination Survey (KNHANES  III), which was a cross ­sectional and nationally representative  sample survey conducted by the Korea Centers for Disease Con ­ trol and Prevention from 2007 to 2009.",OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
• Diagnostic Performance of BMI for Body Fat Percentage Defined Obesity 164  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.162women).,Non-OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
"• Diagnostic Performance of BMI for Body Fat Percentage Defined Obesity http://jkms.org   165 http://dx.doi.org/10.3346/jkms.2015.30.2.162cent evidence, the WPRO of WHO BMI standards are still offi ­ cially used in Korea.",Non-OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
"• Diagnostic Performance of BMI for Body Fat Percentage Defined Obesity 166  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.162with manuscript results and conclusions: Yoon JL, Cho JJ, Park  KM, Noh HM, Park YS.",Non-OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
ORCID Jong Lull Yoon http://orcid.org/0000-0001-8931-0256 Jung Jin Cho http://orcid.org/0000-0001-8871-8858 Kyung Mi Park http://orcid.org/0000-0003-2021-6039 Hye Mi Noh http://orcid.org/0000-0003-2112-1613 Yong Soon Park http://orcid.org/0000-0002-8926-9836 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/67/45/jkms-30-162.PMC4310942.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Drug-induced Hepatotoxicity of Anti-tuberculosis Drugs and  Their Serum Levels The correlation between serum anti-tuberculosis (TB) drug levels and the drug-induced  hepatotoxicity (DIH) remains unclear.",Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
"Keywords:  Therapeutic Drug Monitoring; Hepatotoxicity; TuberculosisIna Jeong,1 Jong-Sun Park,2   Young-Jae Cho,2 Ho Il Yoon,2   Junghan Song,3 Choon-Taek Lee,2   and Jae-Ho Lee2 1Department of Internal Medicine, National Medical  Center, Seoul; 2Division of Respiratory and Critical  Care Medicine, Department of Internal Medicine  and 3Department of Laboratory Medicine, Seoul  National University Bundang Hospital, Seongnam,  Korea Received: 2 July 2014 Accepted: 1 October 2014 Address for Correspondence: Jae-Ho Lee, MD Division of Respiratory and Critical Care Medicine, Department  of Internal Medicine, Seoul National University Bundang  Hospital, 82 Gumi-ro 173beon-gil, Seongnam 463-707, Korea Tel: +82.31-787-7011, Fax: +82.31-787-4052  E-mail: jhlee7@snubh.orghttp://dx.doi.org/10.3346/jkms.2015.30.2.167  • J Korean Med Sci 2015; 30: 167-172 INTRODUCTION Tuberculosis (TB) remains a huge health burden worldwide (1).",Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
• Tuberculosis and Serum Drug Concentration 168  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.167diagnosed with TB were enrolled in the study and patients re - ceived anti-TB medication daily for at least 5 days before serum  anti-TB drug level measurements.,Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
• Tuberculosis and Serum Drug Concentration http://jkms.org   169 http://dx.doi.org/10.3346/jkms.2015.30.2.167assumed to have PZA-induced hepatotoxicity because their liv - er enzyme abnormality normalized after the discontinuation of PZA and reintroduction of RMP and INH.,Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
"• Tuberculosis and Serum Drug Concentration 170  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.167AST and ALT levels (mean ± SD) were 66 ± 24 IU/L and 76 ±   20 IU/L, respectively, and their serum anti-TB drug levels were  not significantly different from those of the non-hepatotoxicity  group (Table 3).",OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
• Tuberculosis and Serum Drug Concentration http://jkms.org   171 http://dx.doi.org/10.3346/jkms.2015.30.2.167vided more definite results.,Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
ORCID Ina Jeong http://orcid.org/0000-0002-0937-9833 Jong-Sun Park http://orcid.org/0000-0003-3707-3636 Young-Jae Cho http://orcid.org/0000-0001-6943-4462 Ho Il Yoon http://orcid.org/0000-0002-5306-3692  Junghan Song http://orcid.org/0000-0003-0576-9938 Choon-Taek Lee http://orcid.org/0000-0001-8030-3332 Jae-Ho Lee http://orcid.org/0000-0002-4766-1231 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
• Tuberculosis and Serum Drug Concentration 172  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.16720.,Non-OADS,/arxiv_data1/oa_pdf/a6/40/jkms-30-167.PMC4310943.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The Risk of Tuberculosis in Korean Patients with Inflammatory  Bowel Disease Receiving Tumor Necrosis Factor- α Blockers The aims of this study were to assess the risk of tuberculosis (TB) and the status of latent  tuberculosis infection (LTBI) in Korean patients with inflammatory bowel disease (IBD)  receiving tumor necrosis factor (TNF)- α blockers.",Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
"Keywords:  Tuberculosis; Latent Tuberculosis; Tumor Necrosis Factor-alpha; Inflammatory  Bowel DiseaseJa Min Byun,1,2 Chang Kyun Lee,1   Sang Youl Rhee,1 Hyo-Jong Kim,1   Jung-Wook Kim,1 Jae-Jun Shim,1   and Jae Young Jang1 1Department of Internal Medicine, Kyung Hee  University School of Medicine, Seoul; 2Department  of Medicine, Kyung Hee University Graduate School,  Seoul, Korea Received: 15 August 2014 Accepted: 1 October 2014 Address for Correspondence: Chang Kyun Lee, MD Division of Gastroenterology and Hepatology, Department of  Internal Medicine, Kyung Hee University School of Medicine,   23 Kyungheedae-ro, Dongdaemun-gu, Seoul 130-872, Korea Tel: +82.2-958-8258, Fax: +82.2-968-1848 E-mail: cklee92@paran.com Funding:  This work was supported by a grant from Kyung Hee  University in 2014 (KHU-20140685).http://dx.doi.org/10.3346/jkms.2015.30.2.173  • J Korean Med Sci 2015; 30: 173-179 INTRODUCTION The striking effectiveness of tumor necrosis factor (TNF)- α block - ade has revolutionized the treatment of several chronic inflam - matory diseases, including inflammatory bowel disease (IBD)  (1).",Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
"• Tuberculosis in Inflammatory Bowel Disease 174  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.173Diagnosis of active TB The Korean Tuberculosis Surveillance System (KTBS), an inter - net-based reporting system, acts as a nation-wide data deposi - tory for consolidated information on TB in Korea (12).",Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
• Tuberculosis in Inflammatory Bowel Disease http://jkms.org   175 http://dx.doi.org/10.3346/jkms.2015.30.2.173thus the clinical course and prognosis remain obscure.,Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
• Tuberculosis in Inflammatory Bowel Disease 176  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.173patients.,Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
• Tuberculosis in Inflammatory Bowel Disease http://jkms.org   177 http://dx.doi.org/10.3346/jkms.2015.30.2.173but also has several novel strengths compared to previous studies.,Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
"• Tuberculosis in Inflammatory Bowel Disease 178  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.173seem legitimate, although further studies are needed (3).",Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
ORCID  Ja Min Byun http://orcid.org/0000-0003-1780-5553 Chang Kyun Lee http://orcid.org/0000-0002-4279-3825 Sang Youl Rhee http://orcid.org/0000-0003-0119-5818 Hyo-Jong Kim http://orcid.org/0000-0002-9675-4557 Jung-Wook Kim http://orcid.org/0000-0002-5383-7934 Jae-Jun Shim http://orcid.org/0000-0003-2497-8663 Jae Young Jang http://orcid.org/0000-0002-7930-1468 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
• Tuberculosis in Inflammatory Bowel Disease http://jkms.org   179 http://dx.doi.org/10.3346/jkms.2015.30.2.17311.,Non-OADS,/arxiv_data1/oa_pdf/fe/7f/jkms-30-173.PMC4310944.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Rapid Increase of Health Care Utilization and Cost due to Benign  Prostatic Hyperplasia in Korean Men: Retrospective Population- based Analysis Using the Health Insurance Review and  Assessment Service Data Using the Korean public health insurance database, we analyzed patients diagnosed as  benign prostatic hyperplasia (BPH) from 2004 to 2008.",Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
"Keywords:  Prostatic Hyperplasia; Epidemiology; Insurance Claim Review Hwancheol Son,1 Juhyun Park,1   Sang Hoon Song,2 Jung Yoon Kang,3  Sung Kyu Hong,4 Hyun Moo Lee,5   Sun-Hee Kim,6 Byung-Joo Park,7  Hyung-Lae Lee,8 and Kyung Seop Lee9 1Department of Urology, SMG-SNU Boramae  Medical Center, Seoul National University College of  Medicine, Seoul; 2Department of Urology, Asan  Medical Center, University of Ulsan College of  Medicine, Seoul; 3Department of Urology, Eulji  University Hospital, Eulji University School of  Medicine, Daejeon; 4Department of Urology, Seoul  National University Bundang Hospital, Seoul  National University College of Medicine, Seongnam;  5Department of Urology, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul; 6Medical Research Collaborating Center,  Seoul National University Hospital, Seoul;  7Department of Preventive Medicine, Seoul National  University College of Medicine, Seoul; 8Department  of Urology, Kyung Hee University Hospital, Kyung  Hee University School of Medicine, Seoul;  9Department of Urology, Dongguk University  Gyeongju Hospital, Dongguk University College of  Medicine, Gyeongju, Korea Received: 30 April 2014 Accepted: 25 September 2014 Address for Correspondence: Kyung Seop Lee, MD Department of Urology, Dongguk University Gyeongju Hospital,  Dongguk University College of Medicine, 87 Dongdae-ro,  Gyeongju 780-350, Korea Tel: +82.54-770-8265, Fax: +82.54-771-0769 E-mail: ksleemd@dongguk.ac.kr Funding:  This study was granted by fund from the Korean  Prostate Society 2010.http://dx.doi.org/10.3346/jkms.2015.30.2.180  • J Korean Med Sci 2015; 30: 180-185 INTRODUCTION Benign prostatic hyperplasia (BPH) is a highly prevalent disease affecting middle aged  and elderly men (1).",Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
"• Increasing Benign Prostatic Hyperplasia Patients in Korea http://jkms.org   181 http://dx.doi.org/10.3346/jkms.2015.30.2.180cal Aid (approximately 3.4%), HIRA records cover all citizens  (approximately 49 million people) in Korea.",Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
• Increasing Benign Prostatic Hyperplasia Patients in Korea 182  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.180cording to the age groups.,Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
• Increasing Benign Prostatic Hyperplasia Patients in Korea http://jkms.org   183 http://dx.doi.org/10.3346/jkms.2015.30.2.180the age groups and years ( P< 0.001).,Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
• Increasing Benign Prostatic Hyperplasia Patients in Korea 184  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.180BPH.,Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
• Increasing Benign Prostatic Hyperplasia Patients in Korea http://jkms.org   185 http://dx.doi.org/10.3346/jkms.2015.30.2.180or conflicts of interest to report.,Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
ORCID Hwancheol Son http://orcid.org/0000-0001-5033-0153 Juhyun Park http://orcid.org/0000-0002-5549-9756 Sang Hoon Song http://orcid.org/0000-0003-4888-483X Jung Yoon Kang http://orcid.org/0000-0003-4200-1020 Sung Kyu Hong http://orcid.org/0000-0002-8344-6774 Hyun Moo Lee http://orcid.org/0000-0003-3969-4540 Sun-Hee Kim http://orcid.org/0000-0002-7120-8250  Byung-Joo Park http://orcid.org/0000-0003-4630-4942 Hyung-Lae Lee http://orcid.org/0000-0002-4338-7423 Kyung Seop Lee http://orcid.org/0000-0002-0554-4272 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
Available at http://www.hira.or.kr/eng/about/05/01/01/index.html  [accessed on 15 May 2014].,Non-OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
Available at http://kosis.kr/eng/statisticsList/statisticsList_01List.jsp?vwcd=MT_ ETITLE&parentId=A [accessed on 15 May 2014].,OADS,/arxiv_data1/oa_pdf/42/3a/jkms-30-180.PMC4310945.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Individual and Socioeconomic Contextual Effects on Depressive  Symptom in Korea: Multilevel Analysis of Cross-sectional  Nationwide Survey This study was aimed to examine the relationship between individual, socioeconomic  context and depressive symptom among Korean population.",Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
"Keywords:  Depression; Depressive Symptom; Social Class; Social Environment;  Socioeconomic Factors; Health Survey; Multilevel Analysis; EpidemiologyEun-Whan Lee and Jae-Hyun Park Department of Social and Preventive Medicine,  Sungkyunkwan University School of Medicine,  Suwon, Korea Received: 10 July 2014 Accepted: 1 October 2014 Address for Correspondence: Jae-Hyun Park, MD Department of Social and Preventive Medicine, Sungkyunkwan  University School of Medicine, 2066 Seobu-ro, Jangan-gu,  Suwon 440-746, Korea Tel: +82.31-299-6301, Fax: +82.31-299-6297 E-mail: pjaehyun@skku.eduhttp://dx.doi.org/10.3346/jkms.2015.30.2.186  • J Korean Med Sci 2015; 30: 186-193 INTRODUCTION Depression is a significant public health concern and contrib - utes substantially to the global burden of disease.",Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
• Factors Associated with Depressive Symptom in Korea http://jkms.org   187 http://dx.doi.org/10.3346/jkms.2015.30.2.186ed on the intraindividual aspect of the syndrome.,Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
• Factors Associated with Depressive Symptom in Korea 188  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.186ssive symptom in each category of variables.,OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
"• Factors Associated with Depressive Symptom in Korea http://jkms.org   189 http://dx.doi.org/10.3346/jkms.2015.30.2.186DISCUSSION The objective of this study was to explore the relationships be - tween individual factors, socioeconomic contextual factors and  depressive symptom among Korean population.",Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
• Factors Associated with Depressive Symptom in Korea 190  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.186Table 3.,Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
"• Factors Associated with Depressive Symptom in Korea http://jkms.org   191 http://dx.doi.org/10.3346/jkms.2015.30.2.186groups are included (32, 33).",Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
• Factors Associated with Depressive Symptom in Korea 192  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.186able relationship with depressive symptom in the Korean pop - ulation.,Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
ORCID Eun-Whan Lee http://orcid.org/0000-0002-4831-344X Jae-Hyun Park http://orcid.org/0000-0001-5860-7487  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
• Factors Associated with Depressive Symptom in Korea http://jkms.org   193 http://dx.doi.org/10.3346/jkms.2015.30.2.18633.,Non-OADS,/arxiv_data1/oa_pdf/c5/20/jkms-30-186.PMC4310946.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Practical Use of Bone Scan in Patients with an Osteoporotic  Vertebral Compression Fracture Rib fractures are one of main causes of chest or flank pain when related to an osteoporotic  vertebral compression fracture (OVCF).",Non-OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
"Keywords:  Osteoporosis, Spine, Compression Fracture, Rib Fracture, Osteoporotic Fracture Deuk Soo Jun,1 Byoung Keun An,1   Chang Hun Yu,2 Kyung Hoon Hwang,3  and Je Won Paik1 1Department of Orthopaedic Surgery, Gil Medical  Center, Gachon University, Incheon; 2Department of  Orthopaedic Surgery, Seoul Jaeil Hospital,  Pyeongtaek; 3Department of Nuclear Medicine, Gil  Medical Center, Gachon University, Incheon, Korea Received: 3 November 2014 Accepted: 6 January 2015 Address for Correspondence: Byoung Keun An, MD Department of Orthopaedic Surgery, Gil Medical Center, Gachon  University, 21 Namdong-daero 774beon-gil, Namdong-gu,   Incheon 405-835, Korea Tel: +82.32-360-8505, Fax: +82.32-468-5437 E-mail: abgajs0710@naver.comhttp://dx.doi.org/10.3346/jkms.2015.30.2.194  • J Korean Med Sci 2015; 30: 194-198 INTRODUCTION Osteoporosis is a systemic musculoskeletal disease that gradu - ally reduces bone mineral density (BMD) and changes bone  microarchitectures (1).",Non-OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
"• The Usefulness of Bone Scan in Osteoporotic Vertebral Compression Fracture http://jkms.org   195 http://dx.doi.org/10.3346/jkms.2015.30.2.194phoplasty, or in need of surgical treatment during follow-up  were excluded.",Non-OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
• The Usefulness of Bone Scan in Osteoporotic Vertebral Compression Fracture 196  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.194perior and inferior to fractured vertebrae were used to estimate  anterior heights of fractured vertebrae before fracture occurrence.,OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
"• The Usefulness of Bone Scan in Osteoporotic Vertebral Compression Fracture http://jkms.org   197 http://dx.doi.org/10.3346/jkms.2015.30.2.194of rib fracture increased the risks of an additional rib fracture, a  hip fracture, or a distal radius fracture by more than two-fold,  and thus, highlighted the significance of rib fracture.",Non-OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
ORCID Deuk Soo Jun http://orcid.org/0000-0001-6244-4828 Byoung Keun An http://orcid.org/0000-0001-9979-440X Chang Hun Yu http://orcid.org/0000-0003-3225-1165  Kyung Hoon Hwang http://orcid.org/0000-0002-4148-4633 Je Won Paik http://orcid.org/0000-0001-9617-7617,Non-OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
• The Usefulness of Bone Scan in Osteoporotic Vertebral Compression Fracture 198  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.194REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/cb/5b/jkms-30-194.PMC4310947.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Association between Objectively Measured Sleep Quality and  Obesity in Community-dwelling Adults Aged 80 Years or Older:   A Cross-sectional Study The purpose of this study was to examine the association between objective measures of  sleep quality and obesity in older community-dwelling people.",Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
"26750349) awarded to  Miji Kim by the Japan Society for the Promotion of Science.http://dx.doi.org/10.3346/jkms.2015.30.2.199  • J Korean Med Sci 2015; 30: 199-206 INTRODUCTION The prevalence of obesity is increasing in all age groups, includ - ing older persons (1).",Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
Kim M • Sleep Quality and Obesity in Older Adults 200  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.199study aimed to examine the association between objective mea - sures of sleep quality and obesity in community-dwelling Japa - nese adults aged ≥ 80 yr.,Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
Kim M • Sleep Quality and Obesity in Older Adults http://jkms.org   201 http://dx.doi.org/10.3346/jkms.2015.30.2.199Mini Mental State Examination (MMSE).,Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
Kim M • Sleep Quality and Obesity in Older Adults 202  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.199our study population was 23.1 kg/m2.,Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
"Kim M • Sleep Quality and Obesity in Older Adults http://jkms.org   203 http://dx.doi.org/10.3346/jkms.2015.30.2.199r= -0.129, P= 0.077, respectively).",Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
"Kim M • Sleep Quality and Obesity in Older Adults 204  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.199er in women, after adjusting for multiple risk factors and medi - cal conditions.",Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
"Kim M • Sleep Quality and Obesity in Older Adults http://jkms.org   205 http://dx.doi.org/10.3346/jkms.2015.30.2.199 In conclusion, poor sleep quality was independently associ - ated with a higher risk of obesity in community-dwelling Japa - nese adults aged 80 yr or older, even after controlling for poten - tially confounding factors, including daily physical activity.",Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
ORCID Miji Kim http://orcid.org/0000-0002-0852-8825 REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
Kim M • Sleep Quality and Obesity in Older Adults 206  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.19925.,Non-OADS,/arxiv_data1/oa_pdf/6e/df/jkms-30-199.PMC4310948.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357Analysis of Anesthesia-related Medical Disputes in the 2009-2014  Period Using the Korean Society of Anesthesiologists Database Using the Korean Society of Anesthesiologists database of anesthesia-related medical  disputes (July 2009-June 2014), causative mechanisms and injury patterns were analyzed.",Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
"Keywords:  Adverse Effects; Injuries; Legislation; Malpractice Woon-Seok Roh,1 Duk-Kyung Kim,2  Young-Hun Jeon,3 Seong-Hyop Kim,4  Seung-Cheol Lee,5 Young-Kwon Ko,6  Yong-Cheol Lee,7 and Gyu-Hong Lee2 1Department of Anesthesiology and Pain Medicine,  School of Medicine, The Catholic University of  Daegu, Daegu; 2Department of Anesthesiology and  Pain Medicine, Samsung Medical Center,  Sungkyunkwan University School of Medicine,  Seoul; 3Department of Anesthesiology and Pain  Medicine, School of Dentistry, Kyungpook National  University, Daegu; 4Department of Anesthesiology  and Pain Medicine, Konkuk University School of  Medicine, Seoul; 5Department of Anesthesiology  and Pain Medicine, College of Medicine, Dong-A  University, Busan; 6Department of Anesthesiology  and Pain Medicine, College of Medicine, Chungnam  National University, Daejeon; 7Department of  Anesthesiology and Pain Medicine, School of  Medicine, Keimyung University, Daegu, Korea Received: 17 June 2014 Accepted: 1 October 2014 Address for Correspondence: Duk-Kyung Kim, MD  Department of Anesthesiology and Pain Medicine, Samsung  Medical Center, Sungkyunkwan University School of Medicine,  81 Irwon-ro, Gangnam-gu, Seoul 135-710, Korea Tel: +82.2-3410-6590; Fax: +82.2-3410-6626 E-mail: dikei@hanmail.nethttp://dx.doi.org/10.3346/jkms.2015.30.2.207  • J Korean Med Sci 2015; 30: 207-213 INTRODUCTION Patients may file a claim if their medical treatment results in an  injury or an unexpected side effect.",Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
"• Anesthesia-related Medical Disputes in Korea 208  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.207tailed description of the data collection process has been report - ed previously (3, 4).",Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
"• Anesthesia-related Medical Disputes in Korea http://jkms.org   209 http://dx.doi.org/10.3346/jkms.2015.30.2.207Indeed, in 45 cases (42.9%), the resulting injuries were deter - mined to be ‘avoidable’ if an appropriate standard of care had  been used (Table 2).",Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
• Anesthesia-related Medical Disputes in Korea 210  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.207after protecting patient confidentiality.,Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
• Anesthesia-related Medical Disputes in Korea http://jkms.org   211 http://dx.doi.org/10.3346/jkms.2015.30.2.207non-anesthesiologists are capable of administering propofol  after the completion of specialized training.,Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
• Anesthesia-related Medical Disputes in Korea 212  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.207the KSA Legislation Committee database enables us to identify  recent changes in anesthetic injury trends.,Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
ORCID Woon-Seok Roh http://orcid.org/0000-0003-4868-9065 Duk-Kyung Kim http://orcid.org/0000-0002-6555-2100 Young-Hun Jeon http://orcid.org/0000-0002-7168-4214 Seong-Hyop Kim http://orcid.org/0000-0001-7764-9818 Seung-Cheol Lee http://orcid.org/0000-0001-8669-5517 Young-Kwon Ko http://orcid.org/0000-0002-0178-6346 Yong-Cheol Lee http://orcid.org/0000-0002-8669-129X Gyu-Hong Lee http://orcid.org/0000-0002-4425-2299   REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
Available at https://www.asahq.org/For-Health - care-Professionals/Standards-Guidelines-and-Statements.aspx [ac - cessed on 7 June 2014].,Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
• Anesthesia-related Medical Disputes in Korea http://jkms.org   213 http://dx.doi.org/10.3346/jkms.2015.30.2.207Society of Plastic and Reconstructive Surgeons.,Non-OADS,/arxiv_data1/oa_pdf/8d/37/jkms-30-207.PMC4310949.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/4.0)  which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.pISSN 1011-8934 eISSN 1598-6357The First Korean Patient with Potocki-Shaffer Syndrome: A Rare  Cause of Multiple Exostoses  Potocki–Shaffer syndrome (PSS, OMIM #601224) is a rare contiguous gene deletion  syndrome caused by haploinsufficiency of genes located on the 11p11.2p12.",Non-OADS,/arxiv_data1/oa_pdf/18/8f/jkms-30-214.PMC4310950.pdf
"Keywords:  Potocki–Shaffer Syndrome; Chromosomal Microarray; Multiple Exostosis;  Parietal Foramina Young Bae Sohn,1 Shin-Young Yim,2  Eun-Hae Cho,3 and Ok-Hwa Kim4 1Department of Medical Genetics; 2Department of  Physical Medicine and Rehabilitation, Ajou  University Hospital, Ajou University School of  Medicine, Suwon; 3Green Cross Genome, Yongin;  4Department of Radiology, Woorisoa Children’s  Hospital, Seoul, Korea Received: 3 June 2014 Accepted: 25 September 2014 Address for Correspondence: Ok-Hwa Kim, MD Department of Radiology, Woorisoa Children’s Hospital,   15 Saemal-ro, Guro-gu, Seoul 152-862, Korea Tel: +82.2-858-0100, Fax: +82.2-856-0033 E-mail: kimoh5828@gmail.com Funding:  This study was supported by the new faculty research  fund of Ajou University School of Medicine.http://dx.doi.org/10.3346/jkms.2015.30.2.214  • J Korean Med Sci 2015; 30: 214-217 INTRODUCTION Potocki–Shaffer syndrome (PSS, OMIM #601224) is a rare con - tiguous gene deletion syndrome caused by heterozygous dele - tions within chromosome 11p11.2p12 (1, 2).",Non-OADS,/arxiv_data1/oa_pdf/18/8f/jkms-30-214.PMC4310950.pdf
• The First Korean Patient with Potocki-Shaffer Syndrome http://jkms.org   215 http://dx.doi.org/10.3346/jkms.2015.30.2.214Fig.,Non-OADS,/arxiv_data1/oa_pdf/18/8f/jkms-30-214.PMC4310950.pdf
"• The First Korean Patient with Potocki-Shaffer Syndrome 216  http://jkms.org http://dx.doi.org/10.3346/jkms.2015.30.2.214DISCUSSION As PSS is a contiguous gene deletion syndrome, the phenotypi - cal spectrum is highly variable depending on the deletion size  and location.",Non-OADS,/arxiv_data1/oa_pdf/18/8f/jkms-30-214.PMC4310950.pdf
• The First Korean Patient with Potocki-Shaffer Syndrome http://jkms.org   217 http://dx.doi.org/10.3346/jkms.2015.30.2.214ORCID Young Bae Sohn http://orcid.org/0000-0002-4664-1941 Shin-Young Yim http://orcid.org/0000-0002-8521-6331 Eun-Hae Cho http://orcid.org/0000-0003-3056-0001 Ok-Hwa Kim http://orcid.org/0000-0001-5502-8746  REFERENCES 1.,Non-OADS,/arxiv_data1/oa_pdf/18/8f/jkms-30-214.PMC4310950.pdf
"The Korean Heart Failure Registry describ-ed 3200 heart failure hospitalizations among twenty-four hospitals Review Article http://dx.doi.org/10.4070/kcj.2015.45.1.1 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Pediatric Heart Failure: Current State and Future Possibilities Joseph W. Rossano, MD1 and Gi Young Jang, MD2 1The Cardiac Center, The Children’s Hospital of Philadelphia, Department of Pediatrics, Perelman School of Medicine at the University of Pennsylvania, Philadelphia, PA, USA   2Department of Pediatrics, Korea University Hospital, Ansan, Korea Heart failure is a complex pathophysiological syndrome that can occur in children from a variety of diseases, including cardiomyopathies,  myocarditis, and congenital heart disease.",Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.from 2004 to 2009.2) Survival four years after hospital admission  was only 70%.",Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
"2 Pediatric Heart Failure http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org common serious acute onset conditions of childhood.11) The majority  of these children have some form of congenital heart disease, with  about 15% having a cardiomyopathy or myocarditis.",Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org pulmonary edema, though specific cardiac imaging with echocar - diogram and/or cardiac MRI is needed.",Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
"4 Pediatric Heart Failure http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org versus adults that are hospitalized with heart failure.55)  Mechanical Circulatory Support It is arguable that the greatest advance in pediatric heart failure  over the last decade has been the increased utilization and success  of VADs for patients with end-stage heart failure.56)57) Until rela - tively recently, the only modality available for small children with  profound and refractory hear failure was extracorporeal mem - brane oxygenation (ECMO).",Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org the Fontan operation, often fare poorly on VADs.",Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
6 Pediatric Heart Failure http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org of the CHART studies.,Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org 42.,Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
8 Pediatric Heart Failure http://dx.doi.org/10.4070/kcj.2015.45.1.1 www.e-kcj.org drug therapy for the reversal of heart failure.,Non-OADS,/arxiv_data1/oa_pdf/63/28/kcj-45-1.PMC4310974.pdf
"Underlying heart diseases included repaired Tetralogy of Fallot (21%), single Editorial http://dx.doi.org/10.4070/kcj.2015.45.1.20 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Increasing Demand for Hospitalization in Adults   with Congenital Heart Disease Hong Ju Shin, MD1 and Jo Won Jung, MD2 1Division of Cardiovascular Surgery, Congenital Heart Disease Center, Severance Cardiovascular Hospital, Department of Thoracic and Cardiovascular Surgery,   Yonsei University College of Medicine, Seoul,   2Division of Pediatric Cardiology, Congenital Heart Disease Center, Severance Cardiovascular Hospital, Department of Pediatrics, Yonsei University College of Medicine,  Seoul, Korea Received: December 29, 2014Accepted: January 9, 2015 Correspondence: Jo Won Jung, MD, Division of Pediatric Cardiology, Con - genital Heart Disease Center, Severance Cardiovascular Hospital, Department of Pediatrics, Yonsei University College of Medicine, 50-1 Yonsei-ro, Seodae - mun-gu, Seoul 120-752, KoreaTel: 82-2-2228-8472, Fax: 82-2-312-9538E-mail: jwjung@yuhs.ac • The authors have no financial conflicts of interest.",Non-OADS,/arxiv_data1/oa_pdf/52/8f/kcj-45-20.PMC4310975.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.ventricular physiology after the Fontan operation (17%), and Eisen - menger syndrome (12%).",Non-OADS,/arxiv_data1/oa_pdf/52/8f/kcj-45-20.PMC4310975.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.20  www.e-kcj.orgmust be prepared for the increase in the number of heart failure  cases in adults with CHD in the near future.,Non-OADS,/arxiv_data1/oa_pdf/52/8f/kcj-45-20.PMC4310975.pdf
"Systematic Original Article http://dx.doi.org/10.4070/kcj.2015.45.1.22 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Impact of Smoking on Clinical Outcomes in Female Patients   with Acute Myocardial Infarction Yun Ah Jeong, MD1, Myung Ho Jeong, MD1, Hae Chang Jeong, MD1, Youngkeun Ahn, MD1,   Young Jo Kim, MD2, Chong Jin Kim, MD3, Myeong Chan Cho, MD4, and   Other Korea Acute Myocardial Infarction Registry (KAMIR) Investigators 1Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju,   2Department of Cardiovascular Medicine, Yeungnam University Hospital, Daegu,   3Department of Cardiovascular Medicine, Kyung Hee University Hospital, Seoul,   4Department of Cardiovascular Medicine, Chungbuk National University Hospital, Cheongju, Korea Background and Objectives: Cigarette smoking has been recognized as a prominent threat to women’s health.",Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.review and meta-analysis found that, compared with non-smokers,  female smokers have a 25% greater risk of coronary heart disease than male smokers.",Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.22 www.e-kcj.org threefold in men who smoked at least 20 cigarettes per day com - pared with never-smokers, and the rate in female heavy smokers  exceeded that of never-smoking men.5) Danish investigators report - ed that the relative risks suggest that women may be more sensi - tive than men to some of the deleterious effects of smoking.3) Until  now, there have been few reports regarding clinical outcomes in fe - male smokers with AMI.6)7) The authors investigated the impact of smoking on the long-term  outcomes in female Korean patients after AMI.",Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
"24 Smoking in Female Acute Myocardial Infarction Patients http://dx.doi.org/10.4070/kcj.2015.45.1.22 www.e-kcj.org vs. 177.8 ±44.3, p<0.001), triglycerides (123.3 ±90.8 vs. 109.0 ±60.3,  <0.001), and low density lipoprotein-cholesterol (LDL-C) (121.8 ±  40.9 vs. 111.9 ±48.2, p<0.001) were higher in the non-smoker group.",Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.22 www.e-kcj.org smokers with AMI.,Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
"26 Smoking in Female Acute Myocardial Infarction Patients http://dx.doi.org/10.4070/kcj.2015.45.1.22 www.e-kcj.org Non-smokers, past smokers, and current smokers lost 5.4, 6.4, and  10.3 years of life, respectively.",Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.22 www.e-kcj.org Cardiology, The Korea Centers for Disease Control and Prevention  (2013-E63005-01), and The Korean Health Technology R &D Project  (HI13C1527), Ministry of Health & Welfare, Republic of Korea.",Non-OADS,/arxiv_data1/oa_pdf/bf/4f/kcj-45-22.PMC4310976.pdf
"28 Copyright © 2015 The Korean Society of CardiologyKorean Circulation Journal Introduction The measurement of carotid intima-media thickness (CIMT) and  carotid plaque with B-mode ultrasound is a noninvasive, sensitive, Original Article http://dx.doi.org/10.4070/kcj.2015.45.1.28 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Analysis of Carotid Ultrasound Findings on Cardiovascular Events   in Patients with Coronary Artery Disease during Seven-Year Follow-Up Hyung Bin Yuk, MD, Hyun Woong Park, MD, Ik Ju Jung, MD, Wan Ho Kim, MD, Ki-Hong Kim, MD,  Dong-Ju Yang, MD, Yo Han Park, MD, Yong Kyun Kim, MD, In Geol Song, MD, and Jang-Ho Bae, MD Division of Cardiology, Heart Center, Konyang University Hospital, Daejeon, Korea Background and Objectives: Both carotid intima-media thickness (CIMT) and carotid plaque are important factors in the primary preven - tion of cardiac disease.",Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.and reproducible tool for identifying and quantifying subclinical vas - cular atherosclerosis and for evaluating the risk of cardiovascular  disease.1) It is widely recognized that the measurement of CIMT and carotid  plaque with carotid ultrasound is not only related to cardiovascular risks such as age, diabetes, and hypertension (HTN), but also to the severity of cardiovascular disease.",Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org automated measurement, reduced the errors in the measuring pro - cess, yielding results four times more accurate and contributing to  the wide utilization of carotid ultrasonography in clinical situa - tions presently.6) Carotid intima-media thickness as well as the degree of coro - nary artery calcification is a widely used method for assessing pa - tients’ risks since the importance of primary prevention of CAD has  been emphasized.",Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
30 Carotid Atherosclerosis in Patients with Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org carotid arteries and bulbs were scanned to evaluate the presence  or absence of plaque.,OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org were significantly higher (HR 2.08, 95% CI 1.40–3.09, p<0.001 and  HR 1.58, 95% CI 1.03–2.42, p=0.035, respectively) than Group I for  MACE.",OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
32 Carotid Atherosclerosis in Patients with Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org spectively).,Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org HTN (HR 2.37, 95% CI 1.30–4.31, p=0.005).",OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
"34 Carotid Atherosclerosis in Patients with Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org MI, heart failure, peripheral disease, revascularization, and previous  stroke were independent predictors for mortality according to the  cardiovascular risk assessment model in patients with established  CAD.",Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org prediction.,OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
36 Carotid Atherosclerosis in Patients with Coronary Artery Disease http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org cused primarily on the risk assessment of carotid plaque and intima- media thickness on cardiovascular incidence rather than their mor - phology.,Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.28 www.e-kcj.org ations between carotid and coronary artery disease in patients with  acute coronary syndromes.,Non-OADS,/arxiv_data1/oa_pdf/12/c1/kcj-45-28.PMC4310977.pdf
"38 Copyright © 2015 The Korean Society of CardiologyKorean Circulation Journal Introduction Hypertrophic cardiomyopathy (HCM) has had a variety of names  because of its diverse clinical manifestations since it was first de -Original Article http://dx.doi.org/10.4070/kcj.2015.45.1.38 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Impact of Coronary Artery Anatomy on Clinical Course and   Prognosis in Apical Hypertrophic Cardiomyopathy:   Analysis of Coronary Angiography and Computed Tomography Dong Geum Shin, MD1, Jung-Woo Son, MD2, Ji Young Park, MD3, Jae Woong Choi, MD3, and Sung Kee Ryu, MD3 1Division of Cardiology, Yonsei Cardiovascular Hospital, Yonsei University College of Medicine, Seoul,   2Division of Cardiology, Chuncheon Sacred Heart Hospital, Hallym University, Chuncheon,   3Division of Cardiology, Department of Internal Medicine, Seoul Eulji Hospital, Eulji University School of Medicine, Seoul, Korea Background and Objectives: Apical hypertrophic cardiomyopathy (AHCM) is an uncommon variant of hypertrophic cardiomyopathy with  a relatively benign course.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.scribed in detail by Braunwald et al.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.38 www.e-kcj.org aneurysm have been reported in some cases.10-14) Despite these re - ports, the natural course of AHCM remains obscure as compared to  that of classical asymmetric septal HCM.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
"40 Impact of Coronary Artery Anatomy in Apical Hypertrophic Cardiomyopathy http://dx.doi.org/10.4070/kcj.2015.45.1.38 www.e-kcj.org Clinical follow-up data The mean follow-up period was 53.1 ±60.7 (median 45.6) months,  and CV events occurred in 22.4% (22/98) patients.",Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.38 www.e-kcj.org atrial fibrillation occurred in 10 (10.0%) patients.,Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
42 Impact of Coronary Artery Anatomy in Apical Hypertrophic Cardiomyopathy http://dx.doi.org/10.4070/kcj.2015.45.1.38 www.e-kcj.org were significantly related to CV events in univariate analysis.,Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.38 www.e-kcj.org were associated with an increased prevalence of CV events.,Non-OADS,/arxiv_data1/oa_pdf/5e/c5/kcj-45-38.PMC4310978.pdf
"44 Copyright © 2015 The Korean Society of CardiologyKorean Circulation Journal Introduction Hypertension (HT), defined as sustained elevation of brachial blood  pressure (BP), is a well-known risk factor for all-cause mortality, car -Original Article http://dx.doi.org/10.4070/kcj.2015.45.1.44 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Effects of Age on Arterial Stiffness and Blood Pressure Variables   in Patients with Newly Diagnosed Untreated Hypertension Soo Kyung Cho, MD1, Sang Ki Cho, MD1, Kye Hun Kim, MD2, Jae Yeong Cho, MD2, Hyun Ju Yoon, MD2,   Nam Sik Yoon, MD2, Young Joon Hong, MD2, Hyung Wook Park, MD2, Ju Han Kim, MD2,   Youngkeun Ahn, MD2, Myung Ho Jeong, MD2, Jeong Gwan Cho, MD2, and Jong Chun Park, MD2 1Department of Internal Medicine, Christian Hospital, Gwangju,   2Department of Cardiology,  Translational Research Center on Aging, Chonnam National University Hospital, Gwangju, Korea Background and Objectives: To investigate the impact of age on arterial stiffness and blood pressure (BP) variables in newly diagnosed  untreated hypertension (HT).Subjects and Methods: A total of 144 patients with newly diagnosed untreated HT were divided into two groups: young group (age  ≤50 years, n=71), and old group (age >50 years, n=73).",Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.diovascular morbidity, and mortality.1) Previous studies have shown  that optimal treatment for HT can decrease cardiovascular events  such as stroke and heart failure.2) However, many patients with HT  on office BP measurements are not truly hypertensive.",Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.44 www.e-kcj.org analysis (PWA).10) PWV is associated with future cardiovascular events  in HT11) in the elderly12)13) or end-stage renal disease,14)15) even in the  general population.16)17) Central aortic pressure and its related vari - ables can be reliably measured by PWA to predict cardiovascular  events more accurately than brachial pressures in hypertensive  patients.18)19) Although both HT and age are associated with param - eters of arterial stiffness, the impact of age on arterial stiffness in  patients with newly diagnosed untreated HT has been poorly eval - uated.",Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
46 Effects of Age on Arterial Stiffness in Hypertension http://dx.doi.org/10.4070/kcj.2015.45.1.44 www.e-kcj.org were summarized in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.44 www.e-kcj.org Correlation between parameters of arterial stiffness and age Overall, age showed significant positive correlation with hfPWV  (r=0.617, p<0.001) and baPWV (r=0.598, p<0.001) (Fig.",Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
48 Effects of Age on Arterial Stiffness in Hypertension http://dx.doi.org/10.4070/kcj.2015.45.1.44 www.e-kcj.org HT.,Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.44 www.e-kcj.org for arterial stiffening and risk in young individuals, but aortic PWV  might be a better measure for old individuals.26) The results of the  present study suggested that PWA variables might be a more sen - sitive marker of arterial stiffness and risk in young HT patients, but  PWV would be a better marker of arterial stiffness in old HT patients.",Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
50 Effects of Age on Arterial Stiffness in Hypertension http://dx.doi.org/10.4070/kcj.2015.45.1.44 www.e-kcj.org principal results of the Conduit Artery Function Evaluation (CAFE) study.,Non-OADS,/arxiv_data1/oa_pdf/78/de/kcj-45-44.PMC4310979.pdf
"51 Copyright © 2015 The Korean Society of CardiologyKorean Circulation Journal Introduction In recent decades, survival from childhood cancer has improved  dramatically due to improved supportive care, more precise risk  stratification and personalized therapeutic approach, and extended application of allogeneic hematopoietic stem cell transplantation Original Article http://dx.doi.org/10.4070/kcj.2015.45.1.51 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Early Left Ventricular Dysfunction in Children after Hematopoietic Stem Cell Transplantation for Acute Leukemia: A Case Control Study Using Speckle Tracking Echocardiography Ji-Hong Yoon, MD, Hye Jin Kim, MD, Eun-Jung Lee, MD, Sena Moon, MD, Jae Young Lee, MD,  Jae Wook Lee, MD, Nack Gyun Chung, MD, Bin Cho, MD, and Hack Ki Kim, MD Department of Pediatrics, Seoul St. Mary’s Hospital, College of Medicine, The Catholic University of Korea, Seoul, Korea Background and Objectives:  Cardiovascular complications are the leading cause of morbidity and mortality in childhood cancer survivors.",Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
52 Cardiac Dysfunction after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org complications have been reported to be the leading cause of mor - bidity and mortality following 5-year of survival.3)4)6)7) Cardiac com - plications may occur within one year after treatment.,Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org diastolic function using Vivid 7 ultrasound machine (GE Medical  Systems, Horten, Norway) within 3 months before HSCT, and 3, 6, 9,  12 months and annually thereafter.",OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
54 Cardiac Dysfunction after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org Conventional echocardiographic parameters Echocardiographic characteristics of patients and controls are  summarized in Table 2.,Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org Risk factors for left ventricular dysfunction after hematopoietic  stem cell transplantation The potential effect of age, sex, BMI, oncologic diagnosis, TBI, use  of CY, acute GVHD after transplant, and cumulative dose of anthra - cyclin on cardiac function were analyzed.",OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
"56 Cardiac Dysfunction after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org adults) who had survived 2 years or longer after HSCT showed that  HSCT recipients experienced increased cardiovascular death {adjust - ed incidence rate difference, 3.6 per 1000 person-years (95% con - fidence interval, 1.7 to 5.5) }.",Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org controls on STE.,Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
58 Cardiac Dysfunction after Hematopoietic Stem Cell Transplantation http://dx.doi.org/10.4070/kcj.2015.45.1.51 www.e-kcj.org function: the prospective P(2)C(2) HIV study.,Non-OADS,/arxiv_data1/oa_pdf/89/af/kcj-45-51.PMC4310980.pdf
"These figures are expected to increase in the future.4) Natural - ly, most CHD patients remain uncured, requiring lifelong follow-up Original Article http://dx.doi.org/10.4070/kcj.2015.45.1.59 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Unscheduled Hospitalization in Adults with Congenital Heart Disease Jun Negishi, MD, Hideo Ohuchi, MD, Kenji Yasuda, MD, Aya Miyazaki, MD,   Nakanishi Norifumi, MD, and Osamu Yamada, MD Department of Pediatric Cardiology, National Cerebral Cardiovascular Center, Suita, Japan Background and Objectives: Little information is available regarding adult patients with congenital heart disease (CHD) who needed un - scheduled hospitalization (USH).",Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.because they often have residual lesions and/or sequelae after cor - rective surgery.1)5) In fact, mortality6) and morbidity7) in adult patients  with CHD is high.",Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
"60 Unscheduled Hospitalization in Adult Patients with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org in USH, patient background, underlying heart disease, cause of hos - pitalization, and prognosis (second USH regardless of cause or  death) were examined.",OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org which was confirmed by intestinal scintigraphy and the observa - tion of edema and/or ascites and hypoalbuminemia.,Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
62 Unscheduled Hospitalization in Adult Patients with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org most frequent cause at 40%.,Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org days.,Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
64 Unscheduled Hospitalization in Adult Patients with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org of USH (hazard ratio: 2.59; 95% confidence interval: 1.19–6.23; p<  0.05) (Table 6).,Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org therapy such as β-blocker and renin-angiotensin-based inhibitor  administration, and nonpharmacological therapy such as cardiac  resynchronization therapy in adult CHD patients with heart fail - ure;14)20) however, the effects of these therapies were limited, sug - gesting that an evidence-based treatment strategy needs to be con - structed for adult CHD patients with specific hemodynamics.",Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
66 Unscheduled Hospitalization in Adult Patients with Congenital Heart Disease http://dx.doi.org/10.4070/kcj.2015.45.1.59 www.e-kcj.org endocarditis: utilization of specific echocardiographic findings.,Non-OADS,/arxiv_data1/oa_pdf/14/69/kcj-45-59.PMC4310981.pdf
"1)3-5) In this  report, we present two unusual cases of immediate stent fracture that occurred after implantation of new-generation DES, a zotarolimus-Case Report http://dx.doi.org/10.4070/kcj.2015.45.1.67 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Two Cases of Immediate Stent Fracture   after Zotarolimus-Eluting Stent Implantation Pil Hyung Lee, MD, Seung-Whan Lee, MD, Jong-Young Lee, MD, Young-Hak Kim, MD, Cheol Whan Lee, MD,  Duk-Woo Park, MD, Seong-Wook Park, MD, and Seung-Jung Park, MD Department of Cardiology, University of Ulsan College of Medicine, Asan Medical Center, Seoul, Korea Drug-eluting stent (DES) implantation is currently the standard treatment for various types of coronary artery disease.",Non-OADS,/arxiv_data1/oa_pdf/0d/58/kcj-45-67.PMC4310982.pdf
"Received: February 23, 2014 Revision Received: May 17, 2014 Accepted: June 9, 2014 Correspondence: Seung-Jung Park, MD, Department of Cardiology, Uni - versity of Ulsan College of Medicine, Asan Medical Center, 86 Asanbyeong - won-gil, Songpa-gu, Seoul 138-736, Korea Tel: 82-2-3010-3152, Fax: 82-2-486-5918 E-mail: sjpark@amc.seoul.kr • The authors have no financial conflicts of interest.This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use,  distribution, and reproduction in any medium, provided the original work  is properly cited.eluting stent (ZES).",Non-OADS,/arxiv_data1/oa_pdf/0d/58/kcj-45-67.PMC4310982.pdf
68 Immediate Zotarolimus-Eluting Stent Fracture http://dx.doi.org/10.4070/kcj.2015.45.1.67 www.e-kcj.org stents.,Non-OADS,/arxiv_data1/oa_pdf/0d/58/kcj-45-67.PMC4310982.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.67 www.e-kcj.org I (29.834 ng/mL, normal level <1.5 ng/mL).",OADS,/arxiv_data1/oa_pdf/0d/58/kcj-45-67.PMC4310982.pdf
70 Immediate Zotarolimus-Eluting Stent Fracture http://dx.doi.org/10.4070/kcj.2015.45.1.67 www.e-kcj.org case.,Non-OADS,/arxiv_data1/oa_pdf/0d/58/kcj-45-67.PMC4310982.pdf
"However, it seems likely that APS predisposes to stent thrombosis because of its propensity for thrombotic Case Report http://dx.doi.org/10.4070/kcj.2015.45.1.71 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Recurrent Stent Thrombosis in a Patient with Antiphospholipid   Syndrome and Dual Anti-Platelet Therapy Non-Responsiveness You-Hong Lee, MD1, Hyoung-Mo Yang, MD1, Seung-Jea Tahk, MD1, You-Sun Hong, MD2, Jin-Sun Park, MD1,   Kyoung-Woo Seo, MD1, Yong-Woo Choi, MD1, and Choong-Kyun Noh, MD1  1Departments of Cardiology and 2Thoracic and Cadiovascular Surgery, Ajou University School of Medicine, Suwon, Korea Antiphospholipid syndrome (APS), the most common acquired hypercoagulable condition, is diagnosed by persistent presence of an - tiphospholipid antibodies and episodes of vascular thrombosis.",Non-OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.complications.",Non-OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
72 Recurrent Stent Thrombosis in Antiphospholipid Syndrome http://dx.doi.org/10.4070/kcj.2015.45.1.71 www.e-kcj.org mid left anterior descending coronary artery (LAD) and significant  stenosis of the mid right coronary artery (Fig.,Non-OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.71 www.e-kcj.org grade 3 flow (Fig.,OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
74 Recurrent Stent Thrombosis in Antiphospholipid Syndrome http://dx.doi.org/10.4070/kcj.2015.45.1.71 www.e-kcj.org regional wall motion abnormalities (hypokinesia of the mid anterior  septum).,Non-OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.71 www.e-kcj.org co-existing clopidogrel resistance and increased anti-cardiolipin  antibodies, the findings were not enough to confirm the diagnosis  of APS because the level of anti-cardiolipin IgG did not meet the lab - oratory criteria (>40 GPL), but it was only slightly elevated (12 GPL).",Non-OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
76 Recurrent Stent Thrombosis in Antiphospholipid Syndrome http://dx.doi.org/10.4070/kcj.2015.45.1.71 www.e-kcj.org stenting in a patient with antiphospholipid antibody syndrome.,Non-OADS,/arxiv_data1/oa_pdf/bf/4c/kcj-45-71.PMC4310983.pdf
"1)2) In contrast, PPHTN is predominantly due to excessive  pulmonary vasoconstriction and vascular remodeling that eventu - ally leads to right-heart failure, but is rarely associated with hypox - ia.1) We reported a case in which a patient had both HPS and PPHTN  at the time of presentation with aggravated HPS subsequent to sildenafil administration for the treatment of PPHTN.Case Report http://dx.doi.org/10.4070/kcj.2015.45.1.77 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Aggravation of Hepatopulmonary Syndrome  after Sildenafil Treatment in a Patient  with Coexisting Portopulmonary Hypertension Seungmin Chung, MD1, Kyungho Lee, MD2, Sung-A Chang, MD1, and Duk-Kyung Kim, MD1 1Division of Cardiology, Heart, Vascular and Stroke Institute, 2Department of Medicine, Samsung Medical Center, Sungkyunkwan University School of Medicine, Seoul, Korea Hepatopulmonary syndrome (HPS) and portopulmonary hypertension (PPHTN) are complications of portal hypertension and cirrhosis.",Non-OADS,/arxiv_data1/oa_pdf/d4/52/kcj-45-77.PMC4310984.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.Case A 58-year-old man with increasing shortness of breath on exer - tion was referred to our hospital.",Non-OADS,/arxiv_data1/oa_pdf/d4/52/kcj-45-77.PMC4310984.pdf
78 Aggravated Hepatopulmonary Syndrome by Sildenafil http://dx.doi.org/10.4070/kcj.2015.45.1.77 www.e-kcj.org 1.37).,Non-OADS,/arxiv_data1/oa_pdf/d4/52/kcj-45-77.PMC4310984.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.77 www.e-kcj.org pulmonary arterial hypertension (PAH)3) such as collagen vascular  disease, congenital heart disease, and pulmonary thromboembo - lism.",Non-OADS,/arxiv_data1/oa_pdf/d4/52/kcj-45-77.PMC4310984.pdf
"80 Aggravated Hepatopulmonary Syndrome by Sildenafil http://dx.doi.org/10.4070/kcj.2015.45.1.77 www.e-kcj.org sildenafil, was reported with IPS and severe hypoxemia.10) Accurate  diagnosis by SC-TTE and drug discontinuation allowed rapid symp - tomatic recovery and improvement of hypoxemia in the presented  case.",Non-OADS,/arxiv_data1/oa_pdf/d4/52/kcj-45-77.PMC4310984.pdf
"It is not pathognomonic of hypothermia, but usually occurs in patients with Case Report http://dx.doi.org/10.4070/kcj.2015.45.1.81 Print ISSN 1738-5520 • On-line ISSN 1738-5555 Case of Recurrent Ventricular Fibrillations with   Osborn Wave Developed during Therapeutic Hypothermia Chang-Yeon Kim, MD, Myung Hwan Bae, MD, Nam Kyun Kim, MD, Young Ae Yang, MD,  Kyu Yeun Kim, MD, Jang Hoon Lee, MD, Jung Su Eun, MD, and Yongkeun Cho, MD Department of Internal Medicine, Kyungpook National University Hospital, Daegu, Korea Therapeutic hypothermia (TH) has been used to protect neurological functions in cardiac arrest patient.",Non-OADS,/arxiv_data1/oa_pdf/4a/0d/kcj-45-81.PMC4310985.pdf
"This is an Open Access article distributed under the terms of the Creative  Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.a core temperature <32°C and the magnitude of the J point eleva - tion correlates inversely with the body temperature.6) Several studies have suggested an arrhythmogenic potential of  the Osborn wave,7-10) but there is no solid evidence that TH-induced  Osborn wave itself is associated with increased mortality.11)12) Here  we report a case of recurrent ventricular fibrillation (VF) after ap- pearance of Osborn wave during mild TH.",Non-OADS,/arxiv_data1/oa_pdf/4a/0d/kcj-45-81.PMC4310985.pdf
"82 Recurrent Ventricular Fibrillations during Therapeutic Hypothermia http://dx.doi.org/10.4070/kcj.2015.45.1.81 www.e-kcj.org electrolytes including sodium, potassium, calcium and magnesium  were within the normal ranges.",Non-OADS,/arxiv_data1/oa_pdf/4a/0d/kcj-45-81.PMC4310985.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.81 www.e-kcj.org Discussion It is generally accepted that TH has the potential to improve the  neurological outcome in comatose patients after cardiac arrest.1)2)  Following initial resuscitation, various mechanisms including isch - emia, reperfusion injury, inflammatory response, and free radical  production are involved in cerebral damage.1)3)5) TH lowers the ce - rebral metabolic rate, blocks the apoptotic pathways, suppresses in - flammatory responses, and attenuates production of free radicals.3-5)  However, possible side effects, such as electrolyte imbalance, he - modynamic instability, infection, seizures, and arrhythmias, can rarely  occur in patients undergoing TH.1)2)5) Electrocardiogram findings of hypothermia include Osborn waves,  atrial and ventricular dysrhythmias, and interval (PR, QRS, QT) pro - longations.11)13)14) Among these, the Osborn wave is a positive deflec - tion occurring at the QRS-ST junction and may originate from a  transmural voltage gradient during early repolarization due to a  transient outward potassium current in the epicardium, but not in  the endocardium.15) As the Osborn wave can be seen in various con - ditions like acidosis, subarachnoid hemorrhage, and hypercalcemia,  it is not pathognomonic of hypothermia.",Non-OADS,/arxiv_data1/oa_pdf/4a/0d/kcj-45-81.PMC4310985.pdf
84 Recurrent Ventricular Fibrillations during Therapeutic Hypothermia http://dx.doi.org/10.4070/kcj.2015.45.1.81 www.e-kcj.org 7.,Non-OADS,/arxiv_data1/oa_pdf/4a/0d/kcj-45-81.PMC4310985.pdf
"9 Copyright © 2015 The Korean Society of CardiologyKorean Circulation Journal Review Article http://dx.doi.org/10.4070/kcj.2015.45.1.9 Print ISSN 1738-5520 • On-line ISSN 1738-5555 The Korean Heart Rhythm Society’s 2014 Statement   on Antithrombotic Therapy for Patients with Nonvalvular   Atrial Fibrillation: Korean Heart Rhythm Society Byung Chun Jung, MD1, Nam Ho Kim, MD2, Gi Byung Nam, MD3, Hyung Wook Park, MD4,   Young Keun On, MD5, Young Soo Lee, MD6, Hong Euy Lim, MD7, Boyoung Joung, MD8,   Tae Joon Cha, MD9, Gyo Seung Hwang, MD10, Seil Oh, MD11, and June Soo Kim, MD5 1Division of Cardiology, Department of Medicine, Daegu Fatima Hospital, Daegu,   2Division of Cardiology, Department of Internal Medicine, Wonkwang University Hospital, Iksan,   3Division of Cardiology, Department of Internal Medicine, University of Ulsan College of Medicine, Seoul,   4Department of Cardiovascular Medicine, Chonnam National University Hospital, Gwangju,   5Division of Cardiology, Department of Medicine, Sungkyunkwan University School of Medicine, Samsung Medical Center, Seoul,   6Department of Cardiology, Internal Medicine, Catholic University of Daegu College of Medicine, Daegu,   7Division of Cardiology, Department of Medicine, Korea University Guro Hospital, Seoul,   8Division of Cardiology, Department of Medicine, Yonsei University Severance Hospital, Seoul,   9Division of Cardiology, Department of Internal Medicine, Kosin University Gospel Hospital, Busan,   10Division of Cardiology, Department of Medicine, Ajou University Hospital, Suwon,   11Department of Internal Medicine, Seoul National University Hospital, Seoul, Korea In patients with nonvalvular atrial fibrillation (AF), the risk of stroke varies considerably according to individual clinical status.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
"This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/  by-nc/3.0) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
"10 The Korean Heart Rhythm Society’s 2014 Statement on Antithrombotic Therapy http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org Introduction The prevalence of atrial fibrillation (AF) is approximately 1.5–2%  of the general population in the developed world, with a tendency  to increase abruptly with age, and is estimated to be about 10% of  the population over 80 years old.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org factor for implementing antithrombotic therapy.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
12 The Korean Heart Rhythm Society’s 2014 Statement on Antithrombotic Therapy http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org with the D150 group (p<0.001).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org blind, double-dummy trial comparing two once-daily regimens of  edoxaban {high dose: 60 mg/day (E60), low dose: 30 mg/day (E30) }  with warfarin.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
14 The Korean Heart Rhythm Society’s 2014 Statement on Antithrombotic Therapy http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org The Recommendation of Korean Heart Rhythm  Society for Patients with Nonvalvular Atrial  Fibrillation (Table 3) 1.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org Table 3.,OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
16 The Korean Heart Rhythm Society’s 2014 Statement on Antithrombotic Therapy http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org renal dysfunction (CrCl <30 mL/min).,Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org lower in both the dabigatran 110 mg (D110) and 150 mg (D150) groups  than in the warfarin group (D110 versus warfarin HR, 0.15; 95% CI,  0.03–0.66 and D150 versus warfarin HR, 0.22; 95% CI, 0.06–0.77).",Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
18 The Korean Heart Rhythm Society’s 2014 Statement on Antithrombotic Therapy http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org Asians was recommended as INR 1.6–2.6 for patients over 70 years  in the APHRS 2013 guideline.,Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
"http://dx.doi.org/10.4070/kcj.2015.45.1.9 www.e-kcj.org prevention in an elderly community population with atrial fibrillation  (the Birmingham Atrial Fibrillation Treatment of the Aged Study,  BAFTA): a randomised controlled trial.",Non-OADS,/arxiv_data1/oa_pdf/e8/11/kcj-45-9.PMC4310986.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/36/10/main.PMC4311021.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.012,OADS,/arxiv_data1/oa_pdf/36/10/main.PMC4311021.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/d3/6d/main.PMC4311022.pdf
1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.10.008,Non-OADS,/arxiv_data1/oa_pdf/d3/6d/main.PMC4311022.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/5e/d8/main.PMC4311023.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.007,OADS,/arxiv_data1/oa_pdf/5e/d8/main.PMC4311023.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/main.PMC4311024.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.010,OADS,/arxiv_data1/oa_pdf/ee/c9/main.PMC4311024.pdf
http://clinicaltrials.gov/show/NCT00382018 ; 2014.,Non-OADS,/arxiv_data1/oa_pdf/ee/c9/main.PMC4311024.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/b6/5e/main.PMC4311025.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.002,OADS,/arxiv_data1/oa_pdf/b6/5e/main.PMC4311025.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0d/ae/main.PMC4311026.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.005,OADS,/arxiv_data1/oa_pdf/0d/ae/main.PMC4311026.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/bd/2a/main.PMC4311027.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.005,OADS,/arxiv_data1/oa_pdf/bd/2a/main.PMC4311027.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/0e/f2/main.PMC4311028.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.009,OADS,/arxiv_data1/oa_pdf/0e/f2/main.PMC4311028.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2015.78.1.1 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:1-7 1Address for correspondence: Jung Hyun Chang, M.D., Ph.D. Division of Pulmonary and Critical Care Medicine, Department of Internal Medicine, Ewha Womans University School of Medicine, 1071 Anyangcheon- ro, Yangcheon-gu, Seoul 158-710, Korea Phone:  82-2-2650-5686, Fax: 82-2-2655-2076, E-mail:  hs1017@ewha.ac.kr Received:  Aug. 13, 2014 Revised:  Nov. 10, 2014 Accepted:  Dec. 11, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/98/d1/trd-78-1.PMC4311029.pdf
The effectiveness of real-time PCR in pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2015.78.1.1  3 www.e-trd.org3.,Non-OADS,/arxiv_data1/oa_pdf/98/d1/trd-78-1.PMC4311029.pdf
"The effectiveness of real-time PCR in pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2015.78.1.1  5 www.e-trd.orginactive TB scaring (6%), combined pleural effusion (5%), and  other medical conditions (6%).",Non-OADS,/arxiv_data1/oa_pdf/98/d1/trd-78-1.PMC4311029.pdf
Available from: http://www.who.int/tb/publica - tions/global_report/en/.,OADS,/arxiv_data1/oa_pdf/98/d1/trd-78-1.PMC4311029.pdf
The effectiveness of real-time PCR in pulmonary tuberculosis http://dx.doi.org/10.4046/trd.2015.78.1.1  7 www.e-trd.org15.,Non-OADS,/arxiv_data1/oa_pdf/98/d1/trd-78-1.PMC4311029.pdf
"A blood flow setting of 1.0–1.5 L  has been considered sufficient to reduce catheter-related dis -CASE REPORThttp://dx.doi.org/10.4046/trd.2015.78.1.18 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:18-22 18Address for correspondence: Woo Hyun Cho, M.D.",Non-OADS,/arxiv_data1/oa_pdf/5a/79/trd-78-18.PMC4311030.pdf
"16, 2014 Accepted:  Sep. 4, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/5a/79/trd-78-18.PMC4311030.pdf
Thrombosis in interventional lung assist http://dx.doi.org/10.4046/trd.2015.78.1.18  19 www.e-trd.orgheparin infusion (Table 2).,Non-OADS,/arxiv_data1/oa_pdf/5a/79/trd-78-18.PMC4311030.pdf
Thrombosis in interventional lung assist http://dx.doi.org/10.4046/trd.2015.78.1.18  21 www.e-trd.orgas well as effectively removed CO2 level in Asians with petite  body figures7.,Non-OADS,/arxiv_data1/oa_pdf/5a/79/trd-78-18.PMC4311030.pdf
"More than 50% of patients with  CUP have metastasis affecting multiple sites and the rest CASE REPORThttp://dx.doi.org/10.4046/trd.2015.78.1.23 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:23-26 23Address for correspondence: Ju Ock Na, M.D., Ph.D. Department of Internal Medicine, Soonchunhyang University College  of Medicine, 31 Soonchunhyang 6gil, Dongnam-gu, Cheonan 330-721,  Korea Phone:  82-41-570-3892, Fax: 82-41-574-5762 E-mail:  juokna@schmc.ac.kr Received:  Aug. 4, 2014 Revised:  Sep. 17, 2014 Accepted:  Sep. 22, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/3d/d0/trd-78-23.PMC4311031.pdf
Squamous cell carcinoma of unknown primary in the intrathoracic lymph node http://dx.doi.org/10.4046/trd.2015.78.1.23  25 www.e-trd.orgnodes enlargement.,Non-OADS,/arxiv_data1/oa_pdf/3d/d0/trd-78-23.PMC4311031.pdf
"All rights reserved.Introduction Drug reaction with eosinophilia and systemic symptoms  (DRESS) syndrome is a rare, potentially life-threatening, drug- induced hypersensitivity reaction that includes skin eruption,  hematologic abnormalities (eosinophilia, atypical lympho -CASE REPORThttp://dx.doi.org/10.4046/trd.2015.78.1.27 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:27-30 27Address for correspondence: An Soo Jang, M.D., Ph.D. Department of Internal Medicine, Soonchunhyang University Bucheon  Hospital, Soonchunhyang University College of Medicine, 170 Jomaru- ro, Wonmi-gu, Bucheon 420-767, Korea Phone:  82-32-621-5114, Fax: 82-32-621-5018 E-mail:  jas877@schmc.ac.kr Received:  Aug. 4, 2014 Revised:  Sep. 19, 2014 Accepted:  Oct. 10, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/be/7e/trd-78-27.PMC4311032.pdf
"DRESS due to isoniazid http://dx.doi.org/10.4046/trd.2015.78.1.27  29 www.e-trd.orgSo we diagnosed DRESS syndrome after re-challenging INH,  anti-tuberculosis drug.",Non-OADS,/arxiv_data1/oa_pdf/be/7e/trd-78-27.PMC4311032.pdf
"All rights reserved.CASE REPORThttp://dx.doi.org/10.4046/trd.2015.78.1.31 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:31-35 31Address for correspondence: Sang Haak Lee, M.D., Ph.D. Department of Internal Medicine, St. Paul’s Hospital, College of Medicine,  The Catholic University of Korea, 180 Wangsan-ro, Dongdaemun-gu,  Seoul 130-709, Korea Phone:  82-2-961-4500, Fax: 82-2-968-7250 E-mail:  agmante@gmail.com Received:  Aug. 6, 2014 Revised:  Sep. 24, 2014 Accepted:  Sep. 24, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/7a/8f/trd-78-31.PMC4311033.pdf
Complications of SEMS in a lymphoma patient http://dx.doi.org/10.4046/trd.2015.78.1.31  33 www.e-trd.orgductive cough with dyspnea began.,Non-OADS,/arxiv_data1/oa_pdf/7a/8f/trd-78-31.PMC4311033.pdf
Complications of SEMS in a lymphoma patient http://dx.doi.org/10.4046/trd.2015.78.1.31  35 www.e-trd.orgairway disease and the Food and Drug Administration advi - sory: a call for restraint.,Non-OADS,/arxiv_data1/oa_pdf/7a/8f/trd-78-31.PMC4311033.pdf
"In fact, CASE REPORThttp://dx.doi.org/10.4046/trd.2015.78.1.36 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:36-40 36Address for correspondence: Youn Seup Kim, M.D.",Non-OADS,/arxiv_data1/oa_pdf/f9/db/trd-78-36.PMC4311034.pdf
"Department of Internal Medicine, Dankook University College of  Medicine, 119 Dandae-ro, Dongnam-gu, Cheonan 330-997, Korea Phone:  82-41-550-3911, Fax: 82-41-556-3256 E-mail:  drys99@dankook.ac.kr Received:  Nov. 16, 2014 Revised:  Dec. 17, 2014 Accepted:  Dec. 17, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial  License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/f9/db/trd-78-36.PMC4311034.pdf
Photodynamic therapy for MPM http://dx.doi.org/10.4046/trd.2015.78.1.36  37 www.e-trd.orgCase Report A 68-year-old male came to our hospital because of dys - pnea.,Non-OADS,/arxiv_data1/oa_pdf/f9/db/trd-78-36.PMC4311034.pdf
Photodynamic therapy for MPM http://dx.doi.org/10.4046/trd.2015.78.1.36  39 www.e-trd.orgthird PDT was intended but failed to be performed due to the  patient’s financial reason.,Non-OADS,/arxiv_data1/oa_pdf/f9/db/trd-78-36.PMC4311034.pdf
"All rights reserved.ORIGINAL ARTICLEhttp://dx.doi.org/10.4046/trd.2015.78.1.8 ISSN: 1738-3536(Print)/2005-6184(Online) • Tuberc Respir Dis 2015;78:8-17 8Address for correspondence: Sang-Do Lee, M.D.",Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
"22, 2014 Revised:  Oct. 22, 2014 Accepted:  Dec. 16, 2014 cc It is identical to the Creative Commons Attribution Non-Commercial License (http://creativecommons.org/licenses/by-nc/3.0/).",Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
AMPK and smoking-induced lung inflammation http://dx.doi.org/10.4046/trd.2015.78.1.8  9 www.e-trd.orgIntroduction Chronic obstructive pulmonary disease (COPD) is charac - terized by persistent airflow limitation that is associated with  an enhanced chronic inflammatory response in the airways  and lungs to noxious particles or gases1.,Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
AMPK and smoking-induced lung inflammation http://dx.doi.org/10.4046/trd.2015.78.1.8  11 www.e-trd.org9.,Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
AMPK and smoking-induced lung inflammation http://dx.doi.org/10.4046/trd.2015.78.1.8  13 www.e-trd.org Figure 4.,Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
"AMPK and smoking-induced lung inflammation http://dx.doi.org/10.4046/trd.2015.78.1.8  15 www.e-trd.orgas, IL-8, granulocyte colony-stimulating factor, leukotriene B4  and monocyte chemoattractant protein (MCP-1) in response  to CSE35.",Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
Available  from: http://goldcopd.org.,Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
AMPK and smoking-induced lung inflammation http://dx.doi.org/10.4046/trd.2015.78.1.8  17 www.e-trd.org34.,Non-OADS,/arxiv_data1/oa_pdf/42/f0/trd-78-8.PMC4311035.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/1c/52/main.PMC4311036.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.007,OADS,/arxiv_data1/oa_pdf/1c/52/main.PMC4311036.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/11/b4/main.PMC4311037.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.003,OADS,/arxiv_data1/oa_pdf/11/b4/main.PMC4311037.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/39/8e/main.PMC4311038.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.013,OADS,/arxiv_data1/oa_pdf/39/8e/main.PMC4311038.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/f2/c8/main.PMC4311039.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.003,OADS,/arxiv_data1/oa_pdf/f2/c8/main.PMC4311039.pdf
The data discussed in thispublication have been deposit ed in NCBI's Gene Expression Omnibus [22] and are accessible through Gene Expression Omnibus Series accession number GSE54537 ( http://www.ncbi.nlm.nih.gov/ geo/query/acc.cgi?acc=GSE54537 ).,OADS,/arxiv_data1/oa_pdf/f2/c8/main.PMC4311039.pdf
http://dx.doi.org/10.1042/CS20140007 .Translational Oncology Vol.,Non-OADS,/arxiv_data1/oa_pdf/f2/c8/main.PMC4311039.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/cb/9d/main.PMC4311040.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.004,OADS,/arxiv_data1/oa_pdf/cb/9d/main.PMC4311040.pdf
This is an open access articleunder the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/15/main.PMC4311041.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.011,OADS,/arxiv_data1/oa_pdf/60/15/main.PMC4311041.pdf
This is an open access article underthe CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/57/3d/main.PMC4311042.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.004,OADS,/arxiv_data1/oa_pdf/57/3d/main.PMC4311042.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/64/43/main.PMC4311043.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.002,OADS,/arxiv_data1/oa_pdf/64/43/main.PMC4311043.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/77/73/main.PMC4311044.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.09.008,OADS,/arxiv_data1/oa_pdf/77/73/main.PMC4311044.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/).,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.006,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/S1470-2045(13)70442-X .662 Personalized In Vitro Cancer Modeling Bartlett et al.,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
"Cancer Res UK 4,1–10http://publications.cancerresearchuk.org/ cancerstats/statsincidence/incidence.html .",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
Survival Trends for Selected Cancers: 1971-2007. http://www.cancerresearchuk.org/can cer-info/cancerstats/survival/common- cancers/-Trends ; 2010.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.semcancer.2005.06.009 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.bbrc.2013.03.008 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1177/1087057106292763 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nprot.2008.226 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.jconrel.2012.04.045 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.cell.2007.08.006 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nature01712 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nrm2236 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.semcancer.2005.05.002 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
"Analyst 136, 473 –478.http://dx.doi.org/10.1039/c0an00609b .",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1007/s10911-004-1402-z .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1007/s12079-011-0132-4 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.actbio.2013.04.028 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1007/s00441-004-1064-6 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1093/ jnci/djj306 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nmeth1085 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1371/journal.pone.0031864 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.cell.2011.02.013 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
"Cell 100, 57–70.http://dx.doi.org/10.1016/s0092-8674(00)81683-9 .",OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nrc727 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
Adv Drug Deliv Rev .http://dx.doi.org/10.1016/j.addr.2014.05.006 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1089/ten.TEA.2009.0668 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1371/journal.pone.0030753 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1371/journal.pone.0041334 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.canlet.2009.04.013 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
"Nat Rev Cancer 4,8 3 9 –849.http://dx.doi.org/10.1038/nrc1477 .",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1002/jor.22154 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1007/s00280-006-0292-8 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1007/s00280-013-2189-7 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.lungcan.2009.07.005 .Translational Oncology Vol.,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nrc2748 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
"Nat Commun 4, 2516. http://dx.doi.org/10.1038/ ncomms3516 .",Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1038/nrc3064 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1158/1078-0432.,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.semcancer.2010.02.003 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
"Cell Cycle 13,4 1 8 –425.http://dx.doi.org/10.4161/cc.27201 .",OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1093/jnci/djn123 .,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1158/1078-0432.CCR-09-0263 .,Non-OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
http://dx.doi.org/10.1016/j.ccr.2006.03.030 .664 Personalized In Vitro Cancer Modeling Bartlett et al.,OADS,/arxiv_data1/oa_pdf/ae/7f/main.PMC4311045.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/60/3e/main.PMC4311046.pdf
1936-5233/14http://dx.doi.org/10.1016/j.tranon.2014.10.001,OADS,/arxiv_data1/oa_pdf/60/3e/main.PMC4311046.pdf
This is an open access article under the CC BY-NC-ND license ( http://creativecommons.org/licenses/by-nc-nd/3.0/ ).,Non-OADS,/arxiv_data1/oa_pdf/81/d0/main.PMC4311047.pdf
1936-5233/14 http://dx.doi.org/10.1016/j.tranon.2014.09.006,Non-OADS,/arxiv_data1/oa_pdf/81/d0/main.PMC4311047.pdf
J Natl Cancer Inst 85:365 –376 12.http://groups.eortc.be/qol/eortc-qlq-c30 European Organsiation for Research and Treatment of Cancer –Quality of Life Department.,Non-OADS,/arxiv_data1/oa_pdf/71/40/520_2014_Article_2358.PMC4311060.pdf
http://ukcatalogue.oup.com/product/ 9780199660391.do 14.,Non-OADS,/arxiv_data1/oa_pdf/71/40/520_2014_Article_2358.PMC4311060.pdf
Available from: http://www.nice.org.uk/ guidance/cg69/ .,Non-OADS,/arxiv_data1/oa_pdf/32/c1/12325_2015_Article_180.PMC4311066.pdf
"Department of Health and Department for Environment, Food & Rural Affairs: UK Five YearAntimicrobial Resistance Strategy 2013 to 2018.Available from: https://www.gov.uk/government/ uploads/system/uploads/attachment_data/ﬁle/2440 58/20130902_UK_5_year_AMR_strategy.pdf .",Non-OADS,/arxiv_data1/oa_pdf/32/c1/12325_2015_Article_180.PMC4311066.pdf
Available from: http://www.alere.co.uk/search/?q= aﬁnion .,Non-OADS,/arxiv_data1/oa_pdf/32/c1/12325_2015_Article_180.PMC4311066.pdf
Available from http://www.hscic.gov.uk/catalogue/ PUB13887 .,Non-OADS,/arxiv_data1/oa_pdf/32/c1/12325_2015_Article_180.PMC4311066.pdf
Draft guideline available from: http://www.nice.org.uk/guidance/ gid-cgwave0607/resources/pneumonia-guideline-consultation-nice-guideline2 .,Non-OADS,/arxiv_data1/oa_pdf/32/c1/12325_2015_Article_180.PMC4311066.pdf
Genital HPV infection—fact sheet: http://www.cdc.gov/std/ hpv/stdfact-hpv.htm .,Non-OADS,/arxiv_data1/oa_pdf/92/7e/12325_2015_Article_178.PMC4311067.pdf
Gardasil (quadrivalent human papillomavirusvaccine): http://www.tga.gov.au/safety/alerts-medi cine-gardasil-130516.htm#.Uu-Qjﬂ5OSo .,Non-OADS,/arxiv_data1/oa_pdf/92/7e/12325_2015_Article_178.PMC4311067.pdf
National Notiﬁable Diseases Surveillance System (NNDSS): http://wwwn.cdc.gov/nndss/ .,Non-OADS,/arxiv_data1/oa_pdf/92/7e/12325_2015_Article_178.PMC4311067.pdf
http://www.nccn.org/professi onals/physician_gls/pdf/ antiemesis.pdf 2.,Non-OADS,/arxiv_data1/oa_pdf/e1/10/520_2014_Article_2400.PMC4311069.pdf
2014; 26(6): 316-318. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214184 ],Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 319-331. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.214173 2.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 332-338. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 347-356. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.214101 7.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2000; 26: 25-40. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 357-359. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 360-362. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 363-364. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 365-367. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.214180 12.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 368-370. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.214099 13.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6): 371-375. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2014; 26(6):  376-383. doi: http://dx.doi.org/10.11919/ j.issn.1002-0829.214172 15.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2004; 25(1): 119-142. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
2003; 29(1): 57. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/04/45/sap-26-06-316.PMC4311104.pdf
"2014; 26(6): 319-331. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214173 ]Shanghai Archives of Psychiatry, 2014, Vol.",Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
This network meta-analysis  method uses the ‘net meta’ package (version 0.6-0) of R  3.1.0 ( http://cran.r-project.org/web/packages/netmeta/ index.html ).,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub 2014 Jan 10. doi: http://dx.doi.org/10.1016/ j.cpr.2014.01.002 2.,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2004;  38(8): 602-612. doi: http://dx.doi.org/10.1111/j.1440- 1614.2004.01423.x4.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub  2014 Apr 4. doi: http://dx.doi.org/10.1111/acps.12275   6.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2005; 61(7): 835-854. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2010; 40(2): 211-223. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2003; 71(6): 973-979. doi: http://dx.doi.org/10.1037/0022- 006X.71.6.973 11.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub 2009 Jul  11. doi: http://dx.doi.org/10.1159/000228248 12.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2005; 61(7): 805-818.  doi: http://dx.doi.org/10.1002/jclp.20127 13.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub 2013 Jun 4. doi: http://dx.doi.org/10.1080/16506073.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
1993; 61(4): 611-619.  doi: http://dx.doi.org/10.1037/0022-006X.61.4.611 15.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2006; 40(1): 9-19.  doi: http://dx.doi.org/10.1111/j.1440-1614.2006.01736.x 16.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2006;  14(3): 255-263. doi: http://dx.doi.org/10.1097/01.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub 2009 Jun 6. doi: http://dx.doi.org/10.1016/ j.beth.2008.12.004 26.,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2001; 344(21): 1594-1602. doi:  http://dx.doi.org/10.1056/NEJM200107263450423 38.,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
1992;  23: 551-570. doi: http://dx.doi.org/ 10.1016/S0005- 7894(05)80221-7 39.,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
1991; 59(1): 167-175. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2003; 71(4): 821- 5. doi: http://dx.doi.org/10.1037/0022-006X.71.4.821 41.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2000; 68(6): 957-964. doi:  http://dx.doi.org/10.1037/0022-006X.68.6.957 42.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2013; 27(6): 585-591.  doi: http://dx.doi.org/ 10.1016/j.janxdis.2013.06.005 44.,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
1996; 27: 565-581. doi: http://dx.doi.org/ 10.1016/ S0005-7894(96)80044-X 45.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2003; 71(2): 309-319.  doi: http://dx.doi.org/10.1037/0022-006X.71.2.309 46.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2003; 71(1): 31-40. doi: http://dx.doi.org/10.1037/0022- 006X.71.1.31 47.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2007; 45(4): 699-713. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub 2009 Feb 13. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2012; 80(3): 490-496. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2011; 79(2):  171-181. doi: http://dx.doi.org/10.1037/a0022489 54.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
Epub 2014 Mar 31. doi: http://dx.doi.org/10.1016/ j.brat.2014.03.007 55.,OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
2013;  81(3): 405-414. doi: http://dx.doi.org/10.1037/a0031690 56.,Non-OADS,/arxiv_data1/oa_pdf/1d/0b/sap-26-06-319.PMC4311105.pdf
"2014; 26(6): 339-346. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214037 ]Shanghai Archives of Psychiatry, 2014, Vol.",Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.,OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.,OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.,OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
2004; 43(5): 717-724. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
1965; 273(18): 947-952. doi: http://dx.doi.org/10.1056/ NEJM196510282731802 8.,Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.cn/ 10.3760/ j:issn:1006-7884.2005.03.00211.,OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.cn/ 10.3760/ j:issn:1006-7884.2006.02.003 12.,Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.cn/ 10.3969/ j.issn.1009-7201.2011.05.010 13.,Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.,OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
doi: http://doi.med.wanfangdata.com.cn/ 10.3969/ j.issn.1673-5110.2011.07.005 18.,Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
2007; 30(3): 401-416. doi: http://dx.doi.org/10.1016/ j.psc.2007.04.008 19.,OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
2004; 10(18): 2219-2229. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/af/78/sap-26-06-339.PMC4311107.pdf
2014; 26(6): 347-356. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214101 ] 1.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi: http://dx.doi.org/10.1080/0092 623X.2011.606884 3.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2008; 23: 201-209.  doi: http://dx.doi.org/10.1002/hup.924 6.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2011;  45: 830-7.   doi: http://dx.doi.org/10.3109/00048674.2011.589044 11.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2006; 21: 251-258.  doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2006; 81: 311-316.  doi: http://dx.doi.org/10.1016/ j.schres.2005.08.013 14.,OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi: http://dx.doi.org/10.1016/S0306- 4530(02)00130-0 15.,OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2005; 17: 201-203.  doi: http://dx.doi.org/10.1038/ sj.ijir.390126016.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
1996; 11: 81-86.  doi:  http://dx.doi.org/10.1016/0924-9338(96)84784-5 17.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi: http://dx.doi.org/10.1007/s00115-010- 3074-9 18.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2002; 181: 49-55.  doi: http://dx.doi.org/10.1192/ bjp.181.1.49 19.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi:  http://dx.doi.org/10.1177/2045125311433581 21.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2012; 38: 281-301.  doi: http://dx.doi.org/10.1080/009262 3X.2011.606883 22.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi:  http://dx.doi.org/10.1592/phco.29.1.64 25.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2009; 36: 182-189.  doi: http://dx.doi.org/10.1590/S0101- 60832009000500002 28.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2008; 29: 89-106.   doi: http://dx.doi.org/10.1159/000126626 29.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2009; 50: 353-360.  doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2008; 2: 234-237.  doi: http://dx.doi.org/10.1097/ YCO.0b013e328017f6c4 40.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2012; 7: 267.   doi: http://dx.doi.org/10.1186/1756-0500-5-267 41.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2011; 12:  1127-1136. doi: http://dx.doi.org/10.2217/pgs.11.46 42.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2010; 30: 711-715.  doi:  http://dx.doi.org/10.1097/JCP .0b013e3181faf0e3 44.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2010;  45: 759-766. doi: http://dx.doi.org/10.1007/s00127-009- 0119-045.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2000; 22: 1085-1096. doi: http://dx.doi.org/10.1016/S0149- 2918(00)80086-7 47.,OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2007; 36:  741-752.  doi: http://dx.doi.org/10.1007/s10508-007-9186-z 49.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2003;  29: 125- 147. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
"2008;  5: 2000- 2001. doi: http://dx.doi.org/10.1111/ j.1743-6109.2008.00890.x (recei ved, 07-29-2014; accepted, 12-14-2014) Cicek Hocaoglu earned her medical degree from Uludag University Faculty of Medicine in 1987.",Non-OADS,/arxiv_data1/oa_pdf/45/1d/sap-26-06-347.PMC4311108.pdf
2014; 26(6): 357-359. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214152 ] Major depressive disorder (MDD) is a disabling mental  disorder with a complicated etiology that involves  the interplay of genetic and environmental factors.,Non-OADS,/arxiv_data1/oa_pdf/65/90/sap-26-06-357.PMC4311109.pdf
2014; 17(4): 1009-1037. doi: http://dx.doi.org/10.1017/ S1461145712001496 2.,Non-OADS,/arxiv_data1/oa_pdf/65/90/sap-26-06-357.PMC4311109.pdf
2004; 55: 296-300. doi: http://dx.doi.org/10.1016/ j.biopsych.2003.08.0077.,Non-OADS,/arxiv_data1/oa_pdf/65/90/sap-26-06-357.PMC4311109.pdf
"2013; 15(10): 403. doi: http://dx.doi.org/10.1007/s11920- 013-0403-2   (received, 2014-10-11; accepted, 2014-10-16) Shanghai Archives of Psychiatry, 2014, Vol.",Non-OADS,/arxiv_data1/oa_pdf/65/90/sap-26-06-357.PMC4311109.pdf
2014; 26(6): 360-362. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214182 ] Major depressive disorder (MDD) is a chronic  recurrent condition.,Non-OADS,/arxiv_data1/oa_pdf/54/57/sap-26-06-360.PMC4311110.pdf
Epub 2010 Jan 06. doi:  http://dx.doi.org/10.1001/archgenpsychiatry.2009.175• 361 •,Non-OADS,/arxiv_data1/oa_pdf/54/57/sap-26-06-360.PMC4311110.pdf
Epub 2008 Dec 24. doi: http://dx.doi.org/10.1016/ j.jad.2008.11.016 4.,OADS,/arxiv_data1/oa_pdf/54/57/sap-26-06-360.PMC4311110.pdf
Epub 2014 Mar 19. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/54/57/sap-26-06-360.PMC4311110.pdf
Epub 2010 Apr 09. doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/54/57/sap-26-06-360.PMC4311110.pdf
"Epub 2011 Jul 02. doi:  http://dx.doi.org/10.1111/j.1532-5415.2011.03457.x                                     (received, 2014-12-05; accepted, 2014-12-12) • 362 •",Non-OADS,/arxiv_data1/oa_pdf/54/57/sap-26-06-360.PMC4311110.pdf
2014; 26(6): 363-364. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214177 ] Si and Wang[1] have done an excellent job in discussing  the pros and cons of combining antidepressants  for individuals with treatment-resistant depression.,Non-OADS,/arxiv_data1/oa_pdf/68/72/sap-26-06-363.PMC4311111.pdf
"2014; 26(6): 365-367. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214180 ] According to the World Health Organization, by 2020 major  depressive disorder will become the second major cause  of disease burden after heart disease.",Non-OADS,/arxiv_data1/oa_pdf/33/39/sap-26-06-365.PMC4311112.pdf
1998; 4 (11): 1241-1243. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/33/39/sap-26-06-365.PMC4311112.pdf
2013;  381(9882): 1987-2015. doi: http://dx.doi.org/10.1016/ S0140-6736(13)61097-1概述： 有关难治性抑郁症（ treatment-resistant depres - sion，TRD）的定义及其亚类一直有争议，从而难以评 估治疗这种慢性致残性病症的不同方案的疗效。根据 TRD的症状严重程度等临床特征以及人口学特征方面 进行分类可能有助于对同一亚类 TRD的识别，并有助 于制定针对特定亚类的干预措施 。关键词： 难治性抑郁症 ，分类，辅助治疗，联合治疗 本文全文中文版从 2015 年01月25日起在 www.shanghaiarchivesofpsychiatry.org 可供免费阅览下载抗抑郁药联合用药以及其他干预策略治疗难治性抑郁症的评价 彭代辉，方贻儒• 366 •,Non-OADS,/arxiv_data1/oa_pdf/33/39/sap-26-06-365.PMC4311112.pdf
2002;  36(3): 384-391. doi: http://dx.doi.org/10.1046/j.1440- 1614.2001.01026.x 9.,Non-OADS,/arxiv_data1/oa_pdf/33/39/sap-26-06-365.PMC4311112.pdf
2014; 26(6): 368-370. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214099 ] 1.,Non-OADS,/arxiv_data1/oa_pdf/49/13/sap-26-06-368.PMC4311113.pdf
Epub 2013 Jan 9. doi: http://dx.doi.org/10.1016/ j.genhosppsych.2012.11.004 7.,OADS,/arxiv_data1/oa_pdf/49/13/sap-26-06-368.PMC4311113.pdf
2003; 23(6): 811-815. doi: http://dx.doi.org/10.1592/ phco.23.6.811.321798.,Non-OADS,/arxiv_data1/oa_pdf/49/13/sap-26-06-368.PMC4311113.pdf
2012:271858.  doi: http://dx.doi.org/10.1155/2012/271858 9.,Non-OADS,/arxiv_data1/oa_pdf/49/13/sap-26-06-368.PMC4311113.pdf
Epub 2005 Dec 13. doi:  http://dx.doi.org/10.1345/aph.1G470 12.,Non-OADS,/arxiv_data1/oa_pdf/49/13/sap-26-06-368.PMC4311113.pdf
2014; 26(6): 371-375. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214171 ] 1.,Non-OADS,/arxiv_data1/oa_pdf/a9/81/sap-26-06-371.PMC4311114.pdf
(a) The World Health Organization (WHO) Global Health  Observatory Data Repository ( http://apps.who.int/ gho/data/?theme=main ) provides statistics on an  array of health-related topics for countries around  the world.,OADS,/arxiv_data1/oa_pdf/a9/81/sap-26-06-371.PMC4311114.pdf
Another similar source is data available on the  website of the Institute of Health Metrics and  Evaluation at the University of Washington in the  United States ( http://www.healthdata.org/ ).,OADS,/arxiv_data1/oa_pdf/a9/81/sap-26-06-371.PMC4311114.pdf
"For example, the United  States Census Bureau ( http://www.census.gov/ data.html ) provides basic demographic data and the  Centers for Dise ase Control and Prevention ( http:// www.cdc.gov ) provides access to data on cause- specific disability, mortality, and an array of health  conditions including injuries and violence, alcohol  use, and tobacco smoking.",Non-OADS,/arxiv_data1/oa_pdf/a9/81/sap-26-06-371.PMC4311114.pdf
2014; 26(6): 376-383. doi: http://dx.doi.org/10.11919/j.issn.1002-0829.214172] 1.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2000;  163(1): 29-38. doi: http://dx.doi.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2002;  58(1): 48-57. doi: http://dx.doi.org/10.1111/j.0006- 341X.2002.00048.x 5.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2004; 60(1): 124-133. doi: http://dx.doi.org/10.1111/j.0006- 341X.2004.00160.x 6.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2003; 29(1): 57. doi: http://dx.doi.org/10.1093/schbul/ sbj026 10.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2010; 78: 912-923. doi:  http://dx.doi.org/10.1037/a0020700 11.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2006; 47: 611-620. doi: http://dx.doi.org/10.1111/j.1469- 7610.2005.01567.x 15.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
Epub  2011 Dec 12. doi: http://dx.doi.org/10.1146/annurev- clinpsy-032511-143152 16.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2007;  63(2): 447-455. doi: http://dx.doi.org/10.1111/j.1541- 0420.2006.00686.x 18.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
1992;  31(2): 210-218. doi: http://dx.doi.org/10.1097/00004583- 199203000-00006 22.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2012; 17(4): 457. doi:  http://dx.doi.org/10.1037/a0029372 24.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2009; 28(26): 3294-3315.  doi: http://dx.doi.org/10.1002/sim.3720 29.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
Retrieved  from http://methodology.psu.edu 30.,Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
2012; 107 (499): 1106-1118. doi:  http://dx.doi.org/10.1080/01621459.2012.695674 Ying Liu (M. Phil M.S.),Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
doi: http://dx.doi.,OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
"Epub  11 Jun 2014. doi: http://dx.doi.org/10.1002/sim.6223  (received, 2014-10-22; accepted, 2014-11-20) Shanghai Archives of Psychiatry, 2014, Vol.",Non-OADS,/arxiv_data1/oa_pdf/7a/f8/sap-26-06-376.PMC4311115.pdf
"2001;104 (4):429-35, http://dx.doi.org/10.1161/hc2901.093198.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2002;105(1):54–60, http://dx.doi.org/10.1161/ hc0102.101509.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2001;65(5):399-403, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2003;89(4):404-10, http://dx.doi.org/ 10.1136/heart.89.4.404.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2008;13(2):245-69, http://dx.doi.org/ 10.1007/s10741-007-9067-5.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2002; 106(24):3079-84, http://dx.doi.org/10.1161/01.CIR.0000041428.99427.06.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2007;115(18):2410-7, http://dx.doi.org/10.1161/ CIRCULATIONAHA.107.686576.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"1992;85(6):2119-31, http://dx.doi.org/10.1161/01.CIR.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2000;15(6):1026-32, http://dx.doi.org/10.1034/j.1399-3003.2000.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"1993;21(5):1101-6, http://dx.doi.org/10.1016/0735-1097(93)90231-O.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2012;67(6):623-7, http://dx.doi.org/10.6061/clinics/ 2012(06)13.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2002;166(11):1443-8, http://dx.doi.org/10.1164/rccm.2202033.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"2000;36(1):242-9, http://dx.doi.org/10.1016/S0735- 1097(00)00702-6.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"1999;31(7):942-8, http://dx.doi.org/10.1097/00005768- 199907000-00005.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"1994;1(4):347-51, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"1993;21(3):822-34, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/2a/9d/cln-70-01-046.PMC4311117.pdf
"3.00.10, Franz Faul, U ¨niversita ¨tKiel, Germany, http://www.psycho.uni-duesseldorf.de/ aap/projects/gpower/) statistical package based on the Tarlov scores.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2002;73(4):1107-15, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2009;37(6):654-60, http://dx.doi.org/10.1016/j.ejvs.2009.02.008.",OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2005;35:1-6, http://dx.doi.org/10.1007/s00595-004- 2889-z.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2003;11(5):375-9, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1997;28(5):946- 50, http://dx.doi.org/10.1161/01.STR.28.5.946.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1999;30(9):1969-73, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2000;20(4):709-17, http://dx.doi.org/10.1097/00004647- 200004000-00008.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1997;100(11):2671-9, http://dx.doi.org/10.1172/JCI119812.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2001;32(9):2185-91, http://dx.doi.org/10.1161/hs0901.094287.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1954;71(3):271-90, http://dx.doi.org/10.1001/archneurpsyc.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1990;186:421-31, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1975;59(2):245-9, http://dx.doi.org/10.1016/0014-5793(75)80385-1.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1993;14(6):1195-201, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2001;24(5):254-64, http://dx.doi.org/10.1097/00002826- 200109000-00002.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2006;23(3-4):318-34, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2009;151(1):94-9, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"1999;30(9):1969-73, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2005;1042(1): 1-5, http://dx.doi.org/10.1016/j.brainres.2005.01.105.",OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2005;45:89-118, http://dx.doi.org/10.1146/annurev.pharmtox.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2003;16(3):393- 401, http://dx.doi.org/10.1097/00019052-200306000-00021.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2011;28(8):1545- 88, http://dx.doi.org/10.1089/neu.2009.1149.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2005;79(3):340-50, http://dx.doi.org/10.1002/jnr.20345.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2009;453(1):73-6, http://dx.doi.org/10.1016/j.neulet.2009.01.062.",OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2010;58(9):1161-7, http://dx.doi.org/ 10.1248/cpb.58.1161.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2000;102(25):3104-10, http://dx.doi.org/10.1161/01.CIR.102.25.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2003;34(2):551-7, http://dx.doi.org/10.1161/01.STR.0000054055.",Non-OADS,/arxiv_data1/oa_pdf/d0/b9/cln-70-01-052.PMC4311118.pdf
"2012;27(1):2-9, http://dx.doi.org/10.1007/s00455-011-9328-2.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"Rev CEFAC, 2009;11(S3):405- 22, http://dx.doi.org/10.1590/S1516-18462009000700017.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2007;16(2):148-56, http://dx.doi.org/10.1044/1058-0360(2007/019).",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2012;55(3):960-72, http://dx.doi.org/10.1044/1092-4388(2011/10- 0357).",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"1995;50(5):M257-62, http://dx.doi.org/10.1093/gerona/50A.5.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2006;21(1):61-5, http://dx.doi.org/10.1007/s00455-005-9011- 6.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2008;23(3):286-90, http://dx.doi.org/10.1007/s00455-007-9142-z.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2008;31(1):3-10, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2008; 119(10):2274–81, http://dx.doi.org/10.1016/j.clinph.2008.06.011.",OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2008;19(4):853-66, http://dx.doi.org/10.1016/j.pmr.2008.06.",OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"2013;61(3):418-22, http://dx.doi.org/10.1111/jgs.",Non-OADS,/arxiv_data1/oa_pdf/8e/34/cln-70-01-041.PMC4311119.pdf
"1997;337(23):1648-53, http://dx.doi.org/10.1056/NEJM199712043372302.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2003;108(3):275-81, http://dx.doi.org/10.1161/ 01.CIR.0000079170.10579.DC.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2010;105(3):312-7, http://dx.doi.org/10.1016/j.",OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2009;169(5):515-23, http://dx.doi.org/10.1001/ archinternmed.2009.11.7.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2011;119(2):72-80, http://dx.doi.org/10.1159/000329920.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2008;102(6):653-7, http://dx.doi.org/10.1016/j.amjcard.2008.05.006.",OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2009;151(7):496-507, http://dx.doi.org/10.7326/ 0003-4819-151-7-200910060-00010.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2010;106(7):988-93, http://dx.doi.org/10.1016/j.amjcard.2010.",OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2002;105(9):1135-43, http://dx.doi.org/10.1161/hc0902.104353.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2009;158(4):659-66, http://dx.doi.org/10.1016/j.ahj.2009.07.024.",OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2008; 53(9):2521-3, http://dx.doi.org/10.1007/s10620-007-0176-8.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2007;100(3):257-9, http://dx.doi.org/10.1097/01.smj.0000257403.04625.36.CLINICS 2015;70(1):18-23 Red Blood Cells in Acute Coronary Syndrome Tenekecioglu E et al.",Non-OADS,/arxiv_data1/oa_pdf/ed/ba/cln-70-01-018.PMC4311120.pdf
"2007;445(7130):866-73, http://dx.doi.org/10.1038/nature05663.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2014;21(9):89-97, http://dx.doi.org/10.2147/CE.S33940.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2004;13(4):193-222, http://dx.doi.org/10.1111/j.0906-6705.2004.00205.x.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2011;65(6):1202-12, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2001;103(3):187-94, http://dx.doi.org/10.1023/A:1013059807998.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2005;110(2-3):203-7, http://dx.doi.org/10.1007/s10633- 005-4830-1.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2004;51(4):563-9, http://dx.doi.org/10.1016/j.jaad.2004.04.012.",OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2004;50(6):859-66, http://dx.doi.org/10.1016/j.jaad.2003.09.",OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2001;79(6):546-59, http://dx.doi.org/10.1034/j.1600-0420.2001.790602.x.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2011;38(5):442-6, http://dx.doi.org/10.1111/j.1346-8138.2010.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2005;24(5):273-9, http://dx.doi.org/10.1155/MI.2005.273.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2004;996(2):202-12, http://dx.doi.org/10.1016/j.brainres.",OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2009;88(4):825-30, http://dx.doi.org/10.1016/j.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2010;51(12):6639-51, http://dx.doi.org/ 10.1167/iovs.10-5431.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2002;21(5):465-84, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"1999;91(2):196-205, http://dx.doi.org/10.1006/clim.1999.4701.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2009;2(2):78-83, http://dx.doi.org/10.1007/s12177-009-9026-6.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2010;51(12):6441-7, http://dx.doi.org/10.1167/iovs.10-5216.",Non-OADS,/arxiv_data1/oa_pdf/49/00/cln-70-01-014.PMC4311121.pdf
"2007;21(2):215-36, http://dx.doi.org/10.1016/j.bpg.2006.10.001.",OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"2000;53 (2):175-81, http://dx.doi.org/10.1016/S0895-4356(99)00171-7.4.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"1996;70(9):970-5, http://dx.doi.org/ 10.11150/kansenshogakuzasshi1970.70.970.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"1999;319(7209):537-40, http://dx.doi.org/10.1136/ bmj.319.7209.537.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"2006;130(5): 1466-79, http://dx.doi.org/10.1053/j.gastro.2005.11.059.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"2013;48 (4):483-90, http://dx.doi.org/10.1007/s00535-012-0681-1 12.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"1999;4(2):94-9, http://dx.doi.org/10.1046/j.1523-5378.1999.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"2009;374 (9699):1449–61, http://dx.doi.org/10.1016/S0140-6736(09)60938-7.",Non-OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"2005;3(2):41-7, http://dx.doi.org/10.1016/j.dmr.2005.02.003.",OADS,/arxiv_data1/oa_pdf/20/ad/cln-70-01-069.PMC4311122.pdf
"2009;467(6):1493-500, http://dx.doi.org/ 10.1007/s11999-009-0801-2.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
Available from: http://www.hcup-us.ahrq.gov/reports/ factsandfigures/2008/exhibit3_1.jsp.,OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2008;38 (5):246-56, http://dx.doi.org/10.2519/jospt.2008.2715.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2005;23(5):1083-90, http://dx.doi.org/10.1016/j.orthres.",OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2002;46(12):3185- 9, http://dx.doi.org/10.1002/art.10649.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2009;41(7):1510-30, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2010;24(11):3023-31, http://dx.doi.org/ 10.1519/JSC.0b013e3181d09ef6.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2009 15;61(2):174-83, http://dx.doi.org/10.1002/art.24167.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2011;43(2):225-31, http://dx.doi.org/10.1249/MSS.0b013e3181eb639a.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2011;66(12):2079-84, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1986;29(8):1039-49, http://dx.doi.org/10.1002/art.1780290816.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2008;40(8):1376-84, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1994;40(5):273-8, http://dx.doi.org/10.1159/000213596.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1995;76(10):961-5, http://dx.doi.org/10.1016/S0003-9993(95)80075-1.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1989;3(4):335-43, http://dx.doi.org/10.3109/02699058909004558.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2008;24(4):701-19, ix, http://dx.doi.org/10.1016/j.cger.",OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2001;30 Suppl 4:3-7, http://dx.doi.org/10.1093/ageing/30.suppl_4.3.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2012;379(9823):1331-40, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2010;468(1):37-44, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2000;18(4):572-9, http://dx.doi.org/10.1002/jor.1100180409.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2013;13(2):274-80, http://dx.doi.org/10.1111/j.1447-0594.2012.00890.x.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1998;53(6):M491-5, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1994;49(2):M85-94, http://dx.doi.org/10.1093/geronj/49.2.M85.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2013;24 (7):2007-13, http://dx.doi.org/10.1007/s00198-013-2285-x.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2005;23(2):152-6, http://dx.doi.org/10.1007/s00774-004- 0554-7.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"2001;56(5):M281-6, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1997;52(4):M218-24, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/7a/92/cln-70-01-007.PMC4311123.pdf
"1998;24(2):275-86, http://dx.doi.org/10.1016/S0889-857X(05) 70009-0.Table 1 - Clinical and epidemiological summary of study results and statistical analysis.",OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"1997;23(2):239-58, http://dx.doi.org/10.1016/S0889-857X(05)70328-8.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"1998;24(2):287-304, http://dx.doi.org/10.1016/S0889-857X(05) 70010-7.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2010;375(9717):846-55, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2011;18(8):781-96, http://dx.doi.org/10.1111/j.1553-2712.2011.01121.x.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2011;25(3):407-21, http://dx.doi.org/10.1016/j.berh.2011.02.001.",OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2009;54(5):695-700, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2006;26(6):703-8, http://dx.doi.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"2004;23(8):701-6, http://dx.doi.org/10.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
"1999;58(4):214-9, http://dx.doi.org/10.1136/ ard.58.4.214.",Non-OADS,/arxiv_data1/oa_pdf/63/c5/cln-70-01-030.PMC4311124.pdf
